Level 1,Level 2,Level 3,Level 4,Molecule,Route,Technical Specifications,ATC Code
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Abacavir,Oral:,300 mg (as Sulfate) Tablet ,J05AF06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Abacavir/Lamivudine,Oral:,120mg/60 mg dispersible tablet,J05AR02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Other hormone antagonists and related agents,Abiraterone,Oral:,250 mg (as Acetate) Tablet ,L02BX03 
For fluid and electrolyte replacement therapy,For fluid and electrolyte replacement therapy,For fluid and electrolyte replacement therapy,For fluid and electrolyte replacement therapy,Acetated Ringer's Solution,Inj.:,"in 500 mL Bottle/Bag (IV Infusion)
Composed of:
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 3 mmol/L
Cl- = 109 mmol/L ",B05BB01
For fluid and electrolyte replacement therapy,For fluid and electrolyte replacement therapy,For fluid and electrolyte replacement therapy,For fluid and electrolyte replacement therapy,Acetated Ringer's Solution,Inj.:,"in 1 L Bottle/Bag (IV Infusion)
Composed of:
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 3 mmol/L
Cl- = 109 mmol/L ",B05BB01
SENSORY ORGANS,OPHTHALMOLOGICALS,OTOLOGICALS,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,Acetazolamide,Oral:,250 mg Tablet ,S01EC01
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS," EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",Mucolytics,Acetylcysteine,Oral:,600 mg Effervescent tablet ,R05CB01
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS," EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",Mucolytics,Acetylcysteine,Oral:,100 mg Sachet ,R05CB01
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS," EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",Mucolytics,Acetylcysteine,Oral:,200 mg Sachet ,R05CB01
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS," EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",Mucolytics,Acetylcysteine,Oral:,100 mg/5 mL Granules for suspension in 150 mL ,R05CB01
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS," EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",Mucolytics,Acetylcysteine,Inj.:,200 mg/mL in 10 mL Ampul (IV Infusion) ,R05CB01
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS," EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",Mucolytics,Acetylcysteine,Inj.:,200 mg/mL in 25 mL Bottle (IV Infusion) ,R05CB01
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS," EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",Mucolytics,Acetylcysteine,Inhalation:,100 mg/mL Solution for inhalation in 3 mL Ampule ,R05CB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS, Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Aciclovir,Oral:,200 mg Tablet *Primary Health Care,J05AB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS, Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Aciclovir,Oral:,400 mg Tablet *Primary Health Care,J05AB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS, Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Aciclovir,Oral:,800 mg Tablet *Primary Health Care,J05AB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS, Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Aciclovir,Oral:,200 mg/5 mL Suspension in 60 mL *Primary Health Care,J05AB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS, Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Aciclovir,Oral:,200 mg/5 mL Suspension in 120 mL *Primary Health Care,J05AB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS, Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Aciclovir,Inj.:,25 mg/mL in 10 mL Vial (IV infusion) ,J05AB01
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ADSORBENTS,Charcoal preparations,Activated Charcoal,Oral:,"Powder USP Grade, given as slurry *Primary Health Care",A07BA01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,OTHER CARDIAC PREPARATIONS,Other cardiac preparations,Adenosine,Inj.:,3 mg/mL in 2 mL Vial (IV) ,C01EB10
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Benzimidazole derivatives,Albendazole,Oral:,400 mg Chewable tablet *Primary Health Care,P02CA03
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Benzimidazole derivatives,Albendazole,Oral:,200 mg/5 mL Suspension in 10 mL *Primary Health Care,P02CA03
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Benzimidazole derivatives,Albendazole,Oral:,200 mg/5 mL Suspension in 60 mL *Primary Health Care,P02CA03
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,"Albumin, Human",Inj.:,"20% in 50 mL Bottle (IV, IV infusion) ",B05AA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,"Albumin, Human",Inj.:,"20% in 100 mL Bottle (IV, IV infusion) ",B05AA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,"Albumin, Human",Inj.:,"25% in 50 mL Bottle (IV, IV infusion) ",B05AA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,"Albumin, Human",Inj.:,"25% in 100 mL Bottle (IV, IV infusion) ",B05AA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,"Albumin, Human",Inj.:,"25% in 50 mL Plastic bag (IV, IV infusion) ",B05AA01
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Nerve depressants,"Alcohol, Ethyl",Oral:,95% USP grade ,V03AZ01
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Nerve depressants,"Alcohol, Ethyl",Inj.:,Absolute in 1 mL Ampul (IV) ,V03AZ01
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Nerve depressants,"Alcohol, Ethyl",Topical:,70% Solution *Primary Health Care,V03AZ01
MUSCULO-SKELETAL SYSTEM,DRUGS FOR TREATMENT OF BONE DISEASES,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,"Bisphosphonates, combinations",Alendronate,Oral:,10 mg (as Sodium) Tablet ,M05BB03
MUSCULO-SKELETAL SYSTEM,DRUGS FOR TREATMENT OF BONE DISEASES,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,"Bisphosphonates, combinations",Alendronate,Oral:,70 mg (as Sodium) Tablet ,M05BB03
MUSCULO-SKELETAL SYSTEM,DRUGS FOR TREATMENT OF BONE DISEASES,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,"Bisphosphonates, combinations",Alendronate + Cholecalciferol/Vitamin D3,Oral:,70 mg (as Sodium) + 5600 IU Tablet ,M05BB03
GENITO URINARY SYSTEM AND SEX HORMONES,UROLOGICALS,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,Alpha-adrenoreceptor antagonists,Alfuzosin,Oral:,10 mg (as Hydrochloride) Tablet ,G04CA01
For long-term administration,Disorders of lipid metabolism,Renal failure,Patients under malnutrition state,All-in-one Admixtures,,"Solution in 400-2500 mL composed of:
Concentration = variable
Protein = 3-6 g/100 mL
Carbohydrates = 6-15 g/100 mL
Lipid = 2-5 g/100 mL
Calories = variable
Electrolytes = variable ",B05BA10
MUSCULO-SKELETAL SYSTEM,ANTIGOUT PREPARATIONS,ANTIGOUT PREPARATIONS,Preparations inhibiting uric acid production,Allopurinol,Oral:,100 mg Tablet ,M04AA01
MUSCULO-SKELETAL SYSTEM,ANTIGOUT PREPARATIONS,ANTIGOUT PREPARATIONS,Preparations inhibiting uric acid production,Allopurinol,Oral:,300 mg Tablet ,M04AA01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANXIOLYTICS,Benzodiazepine derivatives,Alprazolam,Oral:,250 mcg Tablet ,N05BA12
NERVOUS SYSTEM,PSYCHOLEPTICS,ANXIOLYTICS,Benzodiazepine derivatives,Alprazolam,Oral:,500 mcg Tablet ,N05BA12
NERVOUS SYSTEM,PSYCHOLEPTICS,ANXIOLYTICS,Benzodiazepine derivatives,Alprazolam,Oral:,1 mg Tablet ,N05BA12
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Enzymes,Alteplase (Human Recombinant Tissue Type Plasminogen Activator),Inj.:,50 mg Powder (IV infusion) ,B01AD02
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,ANTACIDS,Aluminium compounds,Aluminum + Magnesium,Oral:,"225 mg (as Hydroxide) + 200 mg (as Hydroxide) per 5 mL, Suspension in 60 mL ",A02AB10
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,ANTACIDS,Aluminium compounds,Aluminum + Magnesium,Oral:,"225 mg (as Hydroxide) + 200 mg (as Hydroxide) per 5 mL, Suspension in 120 mL *Primary Health Care",A02AB10
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,ANTACIDS,Aluminium compounds,Aluminum + Magnesium,Oral:,200 mg (as Hydroxide) + 100 mg (as Hydroxide) Tablet ,A02AB10
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Amikacin,Inj.:,"50 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) ",J01GB06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Amikacin,Inj.:,"100 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) ",J01GB06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Amikacin,Inj.:,"125 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) ",J01GB06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Amikacin,Inj.:,"250 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) ",J01GB06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Amikacin,Inj.:,"100 mg (as Sulfate) Vial (IM, IV) ",J01GB06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Amikacin,Inj.:,"250 mg (as Sulfate) Vial (IM, IV) ",J01GB06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Amikacin,Inj.:,"500 mg (as Sulfate) Vial (IM, IV) ",J01GB06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Amikacin,Inj.:,"1 g (as Sulfate) Vial (IM, IV) ",J01GB06
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Amino acid + Carbohydrate + Multivitamins + Electrolytes,Inj.:,Solution for IV injection/infusion in 1000 mL Infusion Set ,B05BA
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Amino acid + Glucose + Electrolytes + Vitamin B1,Inj.:,Solution for peripheral venous infusion in 500 mL ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Amino acid + Glucose + Electrolytes + Vitamin B1,Inj.:,Solution for peripheral venous infusion in 1000 mL ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Amino acid solutions for Hepatic Failure,Inj.:,"Solution in 500 mL composed of:
Concentration = 5-10%
Protein = 35-50 g rich in branched-chain amino acids
Calories = 50-200
Electrolytes = variable ",V06DE
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Amino acid solutions for Immunonutrition/Immunoenhancement,Inj.:,"Solution in 50 mL composed of:
Protein = 20g; L-alanyl-L-glutamine
Calories = 70-90
Electrolytes = none ",V06DE
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Amino acid solutions for Immunonutrition/Immunoenhancement,Inj.:,"Solution in 100 mL composed of:
Protein = 20g; L-alanyl-L-glutamine
Calories = 70-90
Electrolytes = none ",V06DE
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Amino acid solutions for Infants,Inj.:,"Solution in 100 mL composed of:
Concentration = 5-10%
Protein = 5-10g including taurine
Calories = 20-40 kcal
Electrolytes = none ",V06DE
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Amino acid solutions for Renal Condition,Inj.:,"Solution 250-500 mL composed of:
Concentration = 3.5-7%
Protein = 17.5-35 g rich in essential amino acid
Calories = 50-200 kcal ",V06DE
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,3.5% in 500 mL Bottle (IV infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,5% in 100 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,5% in 250 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,5% in 500 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,6% in 100 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,6% in 250 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,7% in 100 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,7% in 500 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,7% in 1 L Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,8.5% in 100 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,8.5% in 500 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,8.5% in 1 L Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,10% in 100 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,10% in 500 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,10% in 1 L Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,11.4% in 100 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,11.4% in 500 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,11.4% in 1 L Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,8% (as Branched chain) in 500 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,9.12% in 20 mL Ampul (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,9.12% in 200 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,10% in 100 mL Bottle (IV Infusion) ,B05BA01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,"Amino acids, crystalline standard",Inj.:,10% in 500 mL Bottle (IV Infusion) ,B05BA01
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Xanthines,Aminophylline/Theophylline ethylenediamine,Inj.:,25 mg/mL in 10 mL Ampul (IV) ,R03DA05
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class III",Amiodarone,Oral:,200 mg (as Hydrochloride) Tablet ,C01BD01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class III",Amiodarone,Inj.:,50 mg/mL (as Hydrochloride) in 3 mL Ampul (IV) ,C01BD01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,Dihydropyridine derivatives,Amlodipine,Oral:,5 mg (as Besilate/Camsylate) Tablet *Primary Health Care,C08CA01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,Dihydropyridine derivatives,Amlodipine,Oral:,10 mg (as Besilate/Camsylate) Tablet *Primary Health Care,C08CA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Penicillins with extended spectrum,Amoxicillin,Oral:,250 mg (as Trihydrate) Capsule *Primary Health Care,J01CA04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Penicillins with extended spectrum,Amoxicillin,Oral:,500 mg (as Trihydrate) Capsule *Primary Health Care,J01CA04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Penicillins with extended spectrum,Amoxicillin,Oral:,100 mg/mL (as Trihydrate) Granules/powder for drops in 15 mL *Primary Health Care,J01CA04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Penicillins with extended spectrum,Amoxicillin,Oral:,250 mg/5 mL (as Trihydrate) Granules/powder for suspension in 60 mL *Primary Health Care,J01CA04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,500 mg (as Trihydrate) + 125 mg (as Potassium clavulanate) Tablet *Primary Health Care,J01CR02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,875 mg (as Trihydrate) + 125 mg (as Potassium clavulanate) Tablet *Primary Health Care,J01CR02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,"200 mg (as Trihydrate) + 28.5 mg (as Potassium clavulanate) per 5 mL, Granules/powder for suspension in 70 mL *Primary Health Care",J01CR02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,"400 mg (as Trihydrate) + 57 mg (as Potassium clavulanate) per 5 mL, Granules/powder for suspension in 70 mL *Primary Health Care",J01CR02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,"600 mg (as Trihydrate) + 42.9 mg (as Potassium clavulanate) per 5 mL, Granules/powder for suspension *Primary Health Care",J01CR02
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFECTIVES,Antibiotics,Amphotericin B *Reserve antimicrobial,Inj.:,"50 mg (as Cholesteryl complex, colloidal dispersion) Vial (Lipid complex) ",A07AA07 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFECTIVES,Antibiotics,Amphotericin B *Reserve antimicrobial,Inj.:,"100 mg (as Cholesteryl complex, colloidal dispersion) Vial (Lipid complex) ",A07AA07 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFECTIVES,Antibiotics,Amphotericin B *Reserve antimicrobial,Inj.:,50 mg Vial (Non-lipid complex) ,A07AA07 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Penicillins with extended spectrum,Ampicillin,Inj.:,"250 mg (as Sodium) Vial (IM, IV) *Primary Health Care",J01CA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Penicillins with extended spectrum,Ampicillin,Inj.:,"500 mg (as Sodium) Vial (IM, IV) *Primary Health Care",J01CA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Penicillins with extended spectrum,Ampicillin,Inj.:,"1 g (as Sodium) Vial (IM, IV) *Primary Health Care",J01CA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Ampicillin + Sulbactam,Inj.:,"500 mg (as Sodium) + 250 mg Vial (IM, IV) ",J01CR01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Ampicillin + Sulbactam,Inj.:,"1000 mg (as Sodium) + 500 mg Vial (IM, IV) ",J01CR01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Ampicillin + Sulbactam,Inj.:,"2000 mg (as Sodium) + 1000 mg Vial (IM, IV) ",J01CR01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Aromatase inhibitors,Anastrozole,Oral:,1 mg Film-coated tablet ,L02BG03
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Anti-D immunoglobulin (Human anti-D immunoglobulin),Inj.:,200 mcg/mL in 1.5 mL Ampul (IM) ,J06BB01
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Anti-rabies serum,Inj.:,200 IU/mL in 5 mL Vial (IM) (Equine) *Primary Health Care,J06BB05
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Anti-rabies serum,Inj.:,400 IU/mL in 5 mL Vial (IM) (Equine) *Primary Health Care,J06BB05
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Anti-tetanus serum,Inj.:,4000 IU/mL in 2.5 mL Vial (IM) (Equine) *Primary Health Care,J06AA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Anti-tetanus serum,Inj.:,1500 IU/0.7 mL Solution for injection Ampul/Vial (IM) (Equine) *Primary Health Care,J06AA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Anti-tetanus serum,Inj.:,1500 IU/mL in 1 mL Ampul/Vial (IM) (Equine) *Primary Health Care,J06AA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Anti-tetanus serum,Inj.:,1500 IU/mL in 1.5 mL Ampul/Vial (IM) (Equine) *Primary Health Care,J06AA02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,Antilymphocyte Immunoglobulin (ALG),Inj.:,100 mg/5 mL Vial (IV) (Equine) ,"L04AA03
"
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS, IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,Antithymocyte Immunoglobulin (ATG),Inj.:,25 mg/5 mL Vial (IV) (Rabbit) ,L04AA04
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Direct factor Xa inhibitors,Apixaban,Oral:,2.5 mg Film-coated tablet ,B01AF02 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Direct factor Xa inhibitors,Apixaban,Oral:,5 mg Film-coated tablet ,B01AF02 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Aripriprazole,Oral:,10 mg Tablet ,N05AX12
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Aripriprazole,Oral:,15 mg Tablet ,N05AX12
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Aripriprazole,Oral:,20 mg Tablet ,N05AX12
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Aripriprazole,Oral:,30 mg Tablet ,N05AX12
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Aripriprazole,Oral:,10 mg Orally disintegrating tablet (ODT) ,N05AX12
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Aripriprazole,Oral:,15 mg Orally disintegrating tablet (ODT) ,N05AX12
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Aripriprazole,Inj.:,300 mg (200 mg/mL) Lyophilized powder for extended-release suspension for injection Pre-filled dual chamber syringe ,N05AX12
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Aripriprazole,Inj.:,400 mg (200 mg/mL) Lyophilized powder for extended-release suspension for injection Pre-filled dual chamber syringe ,N05AX12
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,"Artemisinin and derivatives, combinations",Artemether + Lumefantrin,Oral:,20 mg + 120 mg Tablet *Primary Health Care,P01BF01
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,"Artemisinin and derivatives, plain",Artesunate,Inj.:,60 mg Vial ,P01BE03
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,"Artemisinin and derivatives, plain",Artesunate,Rectal:,50 mg Suppository ,P01BE03
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS","Ascorbic acid (vitamin C), plain",Ascorbic acid (Vitamin C),Oral:,100 mg Tablet *Primary Health Care,A11GA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS","Ascorbic acid (vitamin C), plain",Ascorbic acid (Vitamin C),Oral:,500 mg Tablet *Primary Health Care,A11GA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS","Ascorbic acid (vitamin C), plain",Ascorbic acid (Vitamin C),Oral:,100 mg/5 mL Syrup in 60 mL *Primary Health Care,A11GA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS","Ascorbic acid (vitamin C), plain",Ascorbic acid (Vitamin C),Oral:,100 mg/5 mL Syrup in 120 mL *Primary Health Care,A11GA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS","Ascorbic acid (vitamin C), plain",Ascorbic acid (Vitamin C),Oral:,100 mg/mL Syrup in 15 mL *Primary Health Care,A11GA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS","Ascorbic acid (vitamin C), plain",Ascorbic acid (Vitamin C),Oral:,100 mg/mL Syrup in 30 mL *Primary Health Care,A11GA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS","Ascorbic acid (vitamin C), plain",Ascorbic acid (Vitamin C),Inj.:,250 mg/mL in 2 mL Ampul (IV) ,A11GA01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,Asparaginase,Inj.:,"10,000 IU Lyophilized powder Vial (IV) ",L01XX02
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Aspirin,Oral:,80 mg Tablet *Primary Health Care,B01AC06
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Aspirin,Oral:,100 mg Tablet *Primary Health Care,B01AC06
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Aspirin,Oral:,300 mg Tablet ,B01AC06
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Aspirin,Oral:,325 mg Tablet ,B01AC06
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Atenolol,Oral:,50 mg Tablet *Primary Health Care,C07AB03
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Atenolol,Oral:,100 mg Tablet *Primary Health Care,C07AB03
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",HMG CoA reductase inhibitors,Atorvastatin,Oral:,10 mg (as Calcium) Tablet *Primary Health Care,C10AA05
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",HMG CoA reductase inhibitors,Atorvastatin,Oral:,20 mg (as Calcium) Tablet *Primary Health Care,C10AA05
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",HMG CoA reductase inhibitors,Atorvastatin,Oral:,40 mg (as Calcium) Tablet *Primary Health Care,C10AA05
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",HMG CoA reductase inhibitors,Atorvastatin,Oral:,80 mg (as Calcium) Tablet *Primary Health Care,C10AA05
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",Other quaternary ammonium compounds,Atracurium,Inj.:,10 mg/mL (as Besilate) in 2.5 mL Ampul (IV) ,M03AC04
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",Other quaternary ammonium compounds,Atracurium,Inj.:,10 mg/mL (as Besilate) in 5 mL Ampul (IV) ,M03AC05
SENSORY ORGANS,OPHTHALMOLOGICALS,MYDRIATICS AND CYCLOPLEGICS,Anticholinergics,Atropine,Oral:,600 mcg (equiv. to 500 mcg atropine) (as Sulfate) Tablet *Primary Health Care,S01FA01
SENSORY ORGANS,OPHTHALMOLOGICALS,MYDRIATICS AND CYCLOPLEGICS,Anticholinergics,Atropine,Inj.:,"500 mcg/mL (as Sulfate) in 1 mL Ampul (IM, IV, SC) ",S01FA01
SENSORY ORGANS,OPHTHALMOLOGICALS,MYDRIATICS AND CYCLOPLEGICS,Anticholinergics,Atropine,Inj.:,"600 mcg/mL (as Sulfate) in 1 mL Ampul (IM, IV, SC) ",S01FA01
SENSORY ORGANS,OPHTHALMOLOGICALS,MYDRIATICS AND CYCLOPLEGICS,Anticholinergics,Atropine,Inj.:,"1 mg/mL (as Sulfate) in 1 mL Ampul (IM, IV, SC) *Primary Health Care",S01FA01
SENSORY ORGANS,OPHTHALMOLOGICALS,MYDRIATICS AND CYCLOPLEGICS,Anticholinergics,Atropine,Ophthalmic:,1% (as Sulfate) Solution in 5 mL (Ophthalmic drops) ,S01FA01
SENSORY ORGANS,OPHTHALMOLOGICALS,MYDRIATICS AND CYCLOPLEGICS,Anticholinergics,Atropine,Ophthalmic:,1% (as Sulfate) Solution in 10 mL (Ophthalmic drops) ,S01FA01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants,Azathioprine,Oral:,50 mg Tablet ,L04AX01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Azithromycin,Oral:,250 mg (as Base*/dihydrate) Capsule *Primary Health Care,J01FA10
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Azithromycin,Oral:,250 mg (as Base*/dihydrate/monohydrate) Tablet *Primary Health Care,J01FA10
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Azithromycin,Oral:,500 mg (as Base*/dihydrate/monohydrate) Tablet *Primary Health Care,J01FA10
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Azithromycin,Oral:,200 mg/5 mL (as Base*/dihydrate/monohydrate) Powder for suspension in 15 mL *Primary Health Care,J01FA10
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Azithromycin,Oral:,200 mg/5 mL (as Base*/dihydrate/monohydrate) Powder for suspension in 60 mL *Primary Health Care,J01FA10
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Azithromycin,Inj.:,500 mg (as Base*/dihydrate) Powder Vial (IV infusion) ,J01FA10
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Monobactams,Aztreonam *Reserve antimicrobial,Inj.:,1 g Powder for injection ,J01DF01
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,ANTIBIOTICS FOR TOPICAL USE,Other antibiotics for topical use,Bacitracin + Neomycin + Polymixin B,Topical:,"200 IU + 3 mg (as Sulfate) + 4000 IU (as Sulfate) per g, Ointment in 10 g Tube ",D06AX05
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",Other centrally acting agents,Baclofen,Oral:,10 mg Tablet ,M03BX01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions affecting the electrolyte balance,Balanced Multiple Maintenance Solution + Dextrose,Inj.:,"in 250 mL Bottle/Bag (IV infusion) (Infants) with 5% Dextrose composed of:
Dextrose = 50 g/L
Na+ = 25-30 mmol/L
K+ = 20-25 mmol/L
Mg++ = 1.35-1.65 mmol/L
Cl- = 22 mmol/L
Acetate = 23 mmol/L  *Primary Health Care",B05BB02
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions affecting the electrolyte balance,Balanced Multiple Maintenance Solution + Dextrose,Inj.:,"in 500 mL Bottle/Bag (IV infusion) (Infants) with 5% Dextrose composed of:
Dextrose = 50 g/L
Na+ = 25-30 mmol/L
K+ = 20-25 mmol/L
Mg++ = 1.35-1.65 mmol/L
Cl- = 22 mmol/L
Acetate = 23 mmol/L  *Primary Health Care",B05BB02
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions affecting the electrolyte balance,Balanced Multiple Maintenance Solution + Dextrose,Inj.:,"with 5% Dextrose, in 1 L Bottle/Bag (IV infusion) (Children & Adults) composed of:
Dextrose = 50 g/L
Na+ = 40-50 mmol/L
K+ = 13-30 mmol/L
Mg++ = 1.65 mmol/L
Cl- = 40 mmol/L
Acetate = 16 mmol/L *Primary Health Care",B05BB02
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions affecting the electrolyte balance,Balanced Multiple Replacement Solution,Inj.:,"in 500 mL Bottle/Bag (IV infusion) composed of:
Na+ = 140-145 mmol/L
K+ = 4-5 mmol/L
Mg++ = 1-1.65 mmol/L
Cl- = 98-127 mmol/L
Acetate = 24-50 mmol/L
Dextrose = 50 g/L (5%) *Primary Health Care",B05BB02
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions affecting the electrolyte balance,Balanced Multiple Replacement Solution,Inj.:,"in 1 L Bottle/Bag (IV infusion) composed of:
Na+ = 140-145 mmol/L
K+ = 4-5 mmol/L
Mg++ = 1-1.65 mmol/L
Cl- = 98-127 mmol/L
Acetate = 24-50 mmol/L
Dextrose = 50 g/L (5%) *Primary Health Care",B05BB02
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions affecting the electrolyte balance,Balanced Multiple Replacement Solution (pH 7.4),Inj.:,"in 500 mL Bottle/Bag (IV infusion) composed of:
Na+ = 140 mmol/L
K+ = 5 mmol/L
Mg++ = 3 mmol/L
Cl- = 98 mmol/L
Acetate = 50 mmol/L ",B05BB02
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions affecting the electrolyte balance,Balanced Multiple Replacement Solution (pH 7.4),Inj.:,"in 1 L Bottle/Bag (IV infusion) composed of:
Na+ = 140 mmol/L
K+ = 5 mmol/L
Mg++ = 3 mmol/L
Cl- = 98 mmol/L
Acetate = 50 mmol/L ",B05BB02
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, NON-IODINATED",Barium sulfate containing X-ray contrast media,Barium,Oral:,"(as Sulfate) Powder in 340 g Pouch, LDPE bag USP Grade suspended in water ",V08BA01
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, NON-IODINATED",Barium sulfate containing X-ray contrast media,Barium,Oral:,"(as Sulfate) Powder in 454 g Pouch, LDPE bag USP Grade suspended in water ",V08BA01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,Basiliximab,Inj.:,20 mg Vial (IV infusion) ,L04AC02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,BCG Vaccine,Inj.:,100 mcg/0.1 mL Freeze dried powder in 1 mL Vial (ID) *Primary Health Care,L03AX03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,BCG Vaccine,Inj.:,100 mcg/0.1 mL Freeze dried powder in 1.5 mL Vial (ID) *Primary Health Care,L03AX03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,BCG Vaccine,Inj.:,100 mcg/0.1 mL Freeze dried powder in 2 mL Vial (ID) *Primary Health Care,L03AX03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Other immunostimulants,BCG Vaccine,Inj.:,500 mcg/mL Vial + Diluent in ampul (ID) 20 doses *Primary Health Care,L03AX03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Other drugs for treatment of tuberculosis,Bedaquiline,Oral:,100 mg (as Fumarate) Tablet ,J04AK05
DERMATOLOGICALS,ANTI-ACNE PREPARATIONS,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,Peroxides,Benzoyl peroxide,Topical:,5% Gel in 20 g Tube ,D10AE01
DERMATOLOGICALS,ANTI-ACNE PREPARATIONS,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,Peroxides,Benzoyl peroxide,Topical:,25% Lotion in 60 mL Bottle ,D10AE01
DERMATOLOGICALS,ANTI-ACNE PREPARATIONS,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,Peroxides,Benzoyl peroxide,Topical:,25% Lotion in 120 mL Bottle ,D10AE01
RESPIRATORY SYSTEM,OTHER RESPIRATORY SYSTEM PRODUCTS,OTHER RESPIRATORY SYSTEM PRODUCTS,Lung surfactants,Beractant,Inj.:,25 mg/mL Suspension in 4 mL Vial (Intratracheal administration) ,R07AA 
RESPIRATORY SYSTEM,OTHER RESPIRATORY SYSTEM PRODUCTS,OTHER RESPIRATORY SYSTEM PRODUCTS,Lung surfactants,Beractant,Inj.:,25 mg/mL Suspension in 8 mL Vial (Intratracheal administration) ,R07AA 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,ANTIVERTIGO PREPARATIONS,Antivertigo preparations,Betahistine,Oral:,8 mg (as Hydrochloride/Dihydrochloride) Tablet *Primary Health Care,N07CA01
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,ANTIVERTIGO PREPARATIONS,Antivertigo preparations,Betahistine,Oral:,16 mg (as Hydrochloride/Dihydrochloride) Tablet *Primary Health Care,N07CA01
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,ANTIVERTIGO PREPARATIONS,Antivertigo preparations,Betahistine,Oral:,24 mg (as Hydrochloride/Dihydrochloride) Tablet ,N07CA01
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, OTHER COMBINATIONS","Corticosteroids, potent, other combinations",Betamethasone,Topical:,0.05% (as Dipropionate) Cream/Ointment in 5 g Tube ,D07XC01
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, OTHER COMBINATIONS","Corticosteroids, potent, other combinations",Betamethasone,Topical:,0.05% (as Dipropionate) Cream/Ointment in 10 g Tube ,D07XC01
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, OTHER COMBINATIONS","Corticosteroids, potent, other combinations",Betamethasone,Topical:,0.1% (as Valerate) Cream/Ointment in 5 g Tube ,D07XC01
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Betaxolol,Ophthalmic:,0.25% (as Hydrochloride) Solution/Suspension in 5 mL drops ,C07AB05
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Betaxolol,Ophthalmic:,0.5% (as Hydrochloride) Solution/Suspension in 5 mL drops ,C07AB05
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Betaxolol,Ophthalmic:,0.5% (as Hydrochloride) Solution in 10 mL drops ,C07AB05
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens,Bicalutamide,Oral:,50 mg Tablet/Film-coated tablet ,L02BB03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens,Bicalutamide,Oral:,150 mg Tablet/Film-coated tablet ,L02BB03
NERVOUS SYSTEM,ANTI-PARKINSON DRUGS,ANTICHOLINERGIC AGENTS,Tertiary amines,Biperiden,Oral:,2 mg (as Hydrochloride) Tablet *Primary Health Care,N04AA02
NERVOUS SYSTEM,ANTI-PARKINSON DRUGS,ANTICHOLINERGIC AGENTS,Tertiary amines,Biperiden,Inj.:,"5 mg/mL (as Lactate) in 1 mL Ampul (IM, IV) ",N04AA02
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",Biphasic Isophane Human Insulin (Recombinant DNA),Inj.:,100 IU/mL (as 70% isophane suspension + 30% soluble insulin) in 5 mL Vial (SC) *Primary Health Care,A10AD01
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",Biphasic Isophane Human Insulin (Recombinant DNA),Inj.:,100 IU/mL (as 70% isophane suspension + 30% soluble insulin) in 10 mL Vial (SC) *Primary Health Care,A10AD01
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",Biphasic Isophane Human Insulin (Recombinant DNA),Inj.:,100 IU/mL (as 70% isophane suspension + 30% soluble insulin) in 3 mL Disposable syringe (SC) *Primary Health Care,A10AD01
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",Biphasic Isophane Human Insulin (Recombinant DNA),Inj.:,100 IU/mL (as 70% isophane suspension + 30% soluble insulin) in 3 mL Glass cartridge (SC) *Primary Health Care,A10AD01
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Enemas,Bisacodyl,Oral:,5 mg Tablet *Primary Health Care,A06AG02
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Enemas,Bisacodyl,Oral:,5 mg Modified Release (MR) tablet *Primary Health Care,A06AG02
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Enemas,Bisacodyl,Rectal:,5 mg Suppository (children) *Primary Health Care,A06AG02
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Enemas,Bisacodyl,Rectal:,10 mg Suppository (adult) *Primary Health Care,A06AG02
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Bisoprolol,Oral:,2.5 mg (as Fumarate) Tablet ,C07AB07
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Bisoprolol,Oral:,5 mg (as Fumarate) Tablet ,C07AB07
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Other cytotoxic antibiotics,Bleomycin,Inj.:,"15 IU (as Sulfate) Powder Ampul/Vial (IM, IV) ",L01DC01
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Sympathomimetics in glaucoma therapy,Brimonidine,Ophthalmic:,0.15% (as Tartrate) Ophthalmic solution in 5 mL Bottle ,S01EA05
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Carbonic anhydrase inhibitors,Brinzolamide,Ophthalmic:,1% Ophthalmic suspension in 5 mL Bottle ,S01EC04
NERVOUS SYSTEM,PSYCHOLEPTICS,ANXIOLYTICS,Benzodiazepine derivatives,Bromazepam,Oral:,1.5 mg Tablet ,N05BA08
GENITO URINARY SYSTEM AND SEX HORMONES,OTHER GYNECOLOGICALS,OTHER GYNECOLOGICALS,Prolactine inhibitors,Bromocriptine,Oral:,2.5 mg (as Mesilate) Tablet ,G02CB01
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Budesonide,Inhalation:,"100 mcg/dose x 200 doses, DPI with appropriate accompanying dispenser  ",R03BA02
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Budesonide,Inhalation:,"200 mcg/dose x 100 doses, DPI with appropriate accompanying dispenser  ",R03BA02
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Budesonide,Inhalation:,"200 mcg/dose x 120 actuations, MDI with appropriate accompanying dispenser  ",R03BA02
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Budesonide,Inhalation:,250 mcg/mL in 2 mL Unit dose ,R03BA02
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Budesonide + Formoterol,Inhalation:,"80 mcg + 4.5 mcg (as Fumarate dihydrate) x 60 doses, DPI with appropriate accompanying dispenser  ",R03AK07
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Budesonide + Formoterol,Inhalation:,"160 mcg + 4.5 mcg (as Fumarate dihydrate) x 60 doses, DPI with appropriate accompanying dispenser  ",R03AK07
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Budesonide + Formoterol,Inhalation:,"320 mcg + 9 mcg (as Fumarate dihydrate) x 60 doses, DPI with appropriate accompanying dispenser  ",R03AK07
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Budesonide + Formoterol,Inhalation:,"80 mcg + 4.5 mcg (as Fumarate dihydrate) x 120 doses, MDI with appropriate accompanying dispenser  ",R03AK07
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Budesonide + Formoterol,Inhalation:,"160 mcg + 4.5 mcg (as Fumarate dihydrate) x 120 doses, MDI with appropriate accompanying dispenser  ",R03AK07
CARDIOVASCULAR SYSTEM,DIURETICS,HIGH-CEILING DIURETICS,"Sulfonamides, plain",Bumetanide,Oral:,1 mg Tablet ,C03CA02
CARDIOVASCULAR SYSTEM,DIURETICS,HIGH-CEILING DIURETICS,"Sulfonamides, plain",Bumetanide,Inj.:,"500 mcg/mL in 4 mL Ampul (IM, IV) ",C03CA02
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 5 mL Vial ,N01BB01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 10 mL Vial ,N01BB01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 20 mL Vial ,N01BB01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 5 mL Ampul/Vial (local infiltration) ,N01BB01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 10 mL Ampul/Vial (local infiltration) ,N01BB01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 20 mL Ampul/Vial (local infiltration) ,N01BB01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 50 mL Ampul/Vial (local infiltration) ,N01BB01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Bupivacaine,Inj.:,"0.5% (as Hydrochloride) with 8% dextrose, in 4 mL Ampul (spinal) ",N01BB01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 5 mL Ampul (isobaric) (spinal) ,N01BB01
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",Other cough suppressants,Butamirate,Oral:,50 mg (as Citrate) Modified Release (MR) tablet *Primary Health Care,R05DB13
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",Other cough suppressants,Butamirate,Oral:,7.5 mg/5 mL (as Citrate) Syrup in 120 mL *Primary Health Care,R05DB13
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Morphinan derivatives,Butorphanol,Inj.:,"2 mg/mL in 1 mL Ampul/Vial (IM, IV) ",N02AF01
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Morphinan derivatives,Butorphanol,Inj.:,"2 mg/mL in 2 mL Ampul/Vial (IM, IV) ",N02AF01
DERMATOLOGICALS,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.","ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",Other antipruritics,Calamine,Topical:,8% Lotion in 60 mL (plain) *Primary Health Care,D04AX 
DERMATOLOGICALS,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.","ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",Other antipruritics,Calamine,Topical:,8% Lotion in 120 mL (plain) *Primary Health Care,D04AX 
DERMATOLOGICALS,ANTIPSORIATICS,ANTIPSORIATICS FOR TOPICAL USE,Other antipsoriatics for topical use,Calcipotriol,Topical:,50 mcg/g Ointment in 30 g Tube/Bottle ,D05AX02
DERMATOLOGICALS,ANTIPSORIATICS,ANTIPSORIATICS FOR TOPICAL USE,Other antipsoriatics for topical use,Calcipotriol + Betamethasone,Topical:,"50 mcg (as Hydrate) + 500 mcg (as Dipropionate) per g, Ointment in 30 g Tube ",D05AX52
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",Vitamin D and analogues,Calcitriol,Oral:,0.25 mcg Capsule ,A11CC04
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium,Oral:,(equiv. to 500 mg elemental calcium) (as Lactate) Tablet ,A12AA05 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium,Oral:,(equiv. to 500 mg elemental calcium) (as Carbonate) Tablet/Chewable tablet *Primary Health Care,A12AA04 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium,Oral:,(equiv. to 600 mg elemental calcium) (as Carbonate) Tablet/Chewable tablet *Primary Health Care,A12AA04 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium,Oral:,(as Chloride) Powder USP Grade ,A12AA07 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium,Inj.:,10% (as Gluconate) Solution in 10 mL Ampul (IV) ,A12AA03 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium,Inj.:,10% (as Gluconate) in 10 mL Ampul/Vial (IV) *Primary Health Care,A12AA03 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium,Inj.:,10% (as Gluconate) in 20 mL Bottle (IV) *Primary Health Care,A12AA03 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium,Inj.:,10% (as Gluconate) in 25 mL Bottle (IV) *Primary Health Care,A12AA03 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Detoxifying agents for antineoplastic treatment,Calcium (Leucovorin Calcium),Inj.:,"10 mg/mL (as Folinate) in 5 mL Ampul/Vial (IM, IV) ",V03AF03
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Detoxifying agents for antineoplastic treatment,Calcium (Leucovorin Calcium),Inj.:,"10 mg/mL (as Folinate) in 50 mg Vial (IM, IV) ",V03AF03
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium + Cholecalciferol/Vitamin D3,Oral:,(equiv. to 500 mg elemental calcium) (as Carbonate) + 400 IU *Primary Health Care,A12AX
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,CALCIUM,Calcium,Calcium + Cholecalciferol/Vitamin D3,Oral:,(equiv. to 600 mg elemental calcium) (as Carbonate) + 400 IU *Primary Health Care,A12AX
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Contact laxatives,Calcium Sennosides,Oral:,8.77 mg (equiv. to standardized senna concentrate) Tablet ,A06AB56
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Contact laxatives,Calcium Sennosides,Oral:,17.54 mg (equiv. to standardized senna concentrate) Tablet ,A06AB56
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Capecitabine,Oral:,150 mg Tablet ,L01BC06
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Capecitabine,Oral:,500 mg Tablet ,L01BC06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Antibiotics,Capreomycin,Inj.:,"1 g Powder for injection (IM, IV) ",J04AB30
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ACE INHIBITORS, PLAIN","ACE inhibitors, plain",Captopril,Oral:,25 mg Tablet *Primary Health Care,C09AA01
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ACE INHIBITORS, PLAIN","ACE inhibitors, plain",Captopril,Oral:,50 mg Tablet ,C09AA01
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,PARASYMPATHOMIMETICS,Choline esters,Carbachol,Ophthalmic:,0.01% Intraocular solution in 1.5 mL Vial ,N07AB01
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Carboxamide derivatives,Carbamazepine,Oral:,200 mg Tablet *Primary Health Care,N03AF01
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Carboxamide derivatives,Carbamazepine,Oral:,200 mg Modified Release (MR) tablet *Primary Health Care,N03AF01
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Carboxamide derivatives,Carbamazepine,Oral:,400 mg Modified Release (MR) tablet *Primary Health Care,N03AF01
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Carboxamide derivatives,Carbamazepine,Oral:,100 mg/5 mL Syrup in 120 mL *Primary Health Care,N03AF01
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,POSTERIOR PITUITARY LOBE HORMONES,Oxytocin and analogues,Carbetocin,Inj.:,100 mcg/mL Solution for injection in 1 mL Ampul/Vial (IV) ,H01BB03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,Carboplatin,Inj.:,150 mg Powder Vial (IV) ,L01XA02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,Carboplatin,Inj.:,450 mg Powder Vial (IV) ,L01XA02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,Carboplatin,Inj.:,10 mg/mL in 15 mL Vial (IV) ,L01XA02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,Carboplatin,Inj.:,10 mg/mL in 45 mL Vial (IV) ,L01XA02
GENITO URINARY SYSTEM AND SEX HORMONES,OTHER GYNECOLOGICALS,UTEROTONICS,Prostaglandins,Carboprost,Inj.:,125 mcg/0.5 mL Solution for injection in 0.5 mL Ampul/Vial ,G02AD04
GENITO URINARY SYSTEM AND SEX HORMONES,OTHER GYNECOLOGICALS,UTEROTONICS,Prostaglandins,Carboprost,Inj.:,250 mcg/mL Solution for injection in 1 mL Ampul/Vial ,G02AD04
SENSORY ORGANS,OPHTHALMOLOGICALS,OTHER OPHTHALMOLOGICALS,Other ophthalmologicals,Carboxymethylcellulose,Ophthalmic:,0.5% Solution in 0.4 mL Solution for eye drops ,S01XA20
SENSORY ORGANS,OPHTHALMOLOGICALS,OTHER OPHTHALMOLOGICALS,Other ophthalmologicals,Carboxymethylcellulose,Ophthalmic:,0.5% Solution in 15 mL Solution for eye drops Drops ,S01XA20
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,Alpha and beta blocking agents,Carvedilol,Oral:,6.25 mg Tablet ,C07AG02
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,Alpha and beta blocking agents,Carvedilol,Oral:,25 mg Tablet ,C07AG02
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Contact laxatives,Castor Oil,Oral:,USP Grade ,A06AB05
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,First-generation cephalosporins,Cefalexin,Oral:,500 mg (as Monohydrate) Capsule *Primary Health Care,J01DB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,First-generation cephalosporins,Cefalexin,Oral:,100 mg/mL (as Monohydrate) Granules/Powder for drops in 10 mL *Primary Health Care,J01DB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,First-generation cephalosporins,Cefalexin,Oral:,125 mg/5 mL (as Monohydrate) Granules/Powder for suspension/syrup in 30 mL *Primary Health Care,J01DB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,First-generation cephalosporins,Cefalexin,Oral:,250 mg/5 mL (as Monohydrate) Granules/Powder for suspension/syrup in 60 mL *Primary Health Care,J01DB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,First-generation cephalosporins,Cefazolin,Inj.:,"500 mg (as Sodium) Vial (IM, IV) ",J01DB04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,First-generation cephalosporins,Cefazolin,Inj.:,"1 g (as Sodium) Vial (IM, IV) ",J01DB04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Fourth-generation cephalosporins,Cefepime *Reserve antimicrobial,Inj.:,"500 mg (as Hydrochloride) Vial (IM, IV) ",J01DE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Fourth-generation cephalosporins,Cefepime *Reserve antimicrobial,Inj.:,"1 g (as Hydrochloride) Vial (IM, IV) ",J01DE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Fourth-generation cephalosporins,Cefepime *Reserve antimicrobial,Inj.:,"2 g (as Hydrochloride) Vial (IM, IV) ",J01DE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Cefixime,Oral:,200 mg Capsule *Primary Health Care,J01DD08
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Cefixime,Oral:,400 mg Capsule ,J01DD08
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Cefixime,Oral:,20 mg/mL in 10 mL (drops) *Primary Health Care,J01DD08
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Cefixime,Oral:,100 mg/5 mL Granules for Suspension in 60 mL *Primary Health Care,J01DD08
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Cefotaxime,Inj.:,"250 mg (as Sodium) Vial + 2 mL diluent (IM, IV) ",J01DD01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Cefotaxime,Inj.:,"500 mg (as Sodium) Vial + 2 mL diluent (IM, IV) ",J01DD01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Second-generation cephalosporins,Cefoxitin,Inj.:,"1 g (as Sodium) Vial (IM, IV) ",J01DC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Second-generation cephalosporins,Cefoxitin,Inj.:,1 g (as Sodium) Powder for injection + 4% dextrose solution for injection (IV infusion) ,J01DC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Ceftazidime (Ceftaxidime),Inj.:,"250 mg (as Pentahydrate) Vial (IM, IV) ",J01DD02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Ceftazidime (Ceftaxidime),Inj.:,"500 mg (as Pentahydrate) Vial (IM, IV) ",J01DD02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Ceftazidime (Ceftaxidime),Inj.:,"1 g (as Pentahydrate) Vial (IM, IV) ",J01DD02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Ceftazidime (Ceftaxidime),Inj.:,2 g (as Pentahydrate) Vial (IV infusion) ,J01DD02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Ceftriaxone,Inj.:,250 mg (as Sodium/Disodium) Vial + 2 mL 1% solution of lidocaine (IM) *Primary Health Care,J01DD04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Ceftriaxone,Inj.:,500 mg (as Sodium/Disodium) Vial + 2 mL 1% solution of lidocaine (IM) *Primary Health Care,J01DD04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Ceftriaxone,Inj.:,250 mg (as Sodium/Disodium) Vial + 5 mL diluent (IV) *Primary Health Care,J01DD04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Ceftriaxone,Inj.:,1 g (as Sodium/Disodium) Vial + 3.5 mL 1% solution of lidocaine (IM) *Primary Health Care,J01DD04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Third-generation cephalosporins,Ceftriaxone,Inj.:,1 g (as Sodium/Disodium) Vial + 10 mL diluent (IV) ,J01DD04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Second-generation cephalosporins,Cefuroxime,Oral:,500 mg (as Axetil) Tablet *Primary Health Care,J01DC02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Second-generation cephalosporins,Cefuroxime,Oral:,125 mg/5 mL (as Axetil) Granules for Suspension in 70 mL *Primary Health Care,J01DC02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Second-generation cephalosporins,Cefuroxime,Oral:,250 mg/5 mL Granules for Suspension in 50 mL in 120 mL Bottle *Primary Health Care,J01DC02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Second-generation cephalosporins,Cefuroxime,Inj.:,"250 mg Vial (IM,IV) ",J01DC02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Second-generation cephalosporins,Cefuroxime,Inj.:,"750 mg Vial (IM,IV) ",J01DC02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Second-generation cephalosporins,Cefuroxime,Inj.:,1.5 g (as Sodium) Vial (IV infusion) ,J01DC02
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Coxibs,Celecoxib,Oral:,100 mg Capsule *Primary Health Care,M01AH01
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Coxibs,Celecoxib,Oral:,200 mg Capsule *Primary Health Care,M01AH01
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Coxibs,Celecoxib,Oral:,400 mg Capsule *Primary Health Care,M01AH01
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Piperazine derivatives,Cetirizine,Oral:,10 mg (as Dihydrochloride) Tablet *Primary Health Care,R06AE07
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Piperazine derivatives,Cetirizine,Oral:,2.5 mg/mL (as Dihydrochloride) Syrup in 10 mL Drops ,R06AE07
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Piperazine derivatives,Cetirizine,Oral:,10 mg/mL (as Dihydrochloride) in 10 mL Drops ,R06AE07
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Piperazine derivatives,Cetirizine,Oral:,1 mg/mL (as Dihydrochloride) Solution in 30 mL *Primary Health Care,R06AE07
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Piperazine derivatives,Cetirizine,Oral:,1 mg/mL (as Dihydrochloride) Solution in 60 mL *Primary Health Care,R06AE07
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Piperazine derivatives,Cetirizine,Oral:,5 mg/ 5mL (as Dihydrochloride) Syrup in 30 mL *Primary Health Care,R06AE07
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,Chlorambucil,Oral:,2 mg Tablet ,L01AA02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMPHENICOLS,Amphenicols,Chloramphenicol,Oral:,500 mg Capsule *Primary Health Care,J01BA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMPHENICOLS,Amphenicols,Chloramphenicol,Oral:,125 mg/5 mL (as Palmitate) Suspension in 60 mL *Primary Health Care,J01BA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMPHENICOLS,Amphenicols,Chloramphenicol,Inj.:,1 g (as Sodium succinate) Vial (IV; IM if recommended by manufacturer) ,J01BA01
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,0.12% (as Gluconate) Solution in 50 mL ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,0.12% (as Gluconate) Solution in 120 mL ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,0.12% (as Gluconate) Solution in 380 mL ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,0.12% (as Gluconate) Solution in 500 mL ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,0.12% (as Gluconate) Solution in 4 L ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,0.12% (as Gluconate) Solution in 5 L ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,4% (as Gluconate) Solution in 50 mL ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,4% (as Gluconate) Solution in 120 mL ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,4% (as Gluconate) Solution in 380 mL ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,4% (as Gluconate) Solution in 500 mL ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,4% (as Gluconate) Solution in 4 L ,D08AC02
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Biguanides and amidines,Chlorhexedine,,4% (as Gluconate) Solution in 5 L ,D08AC02
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Aminoquinolines,Chloroquine,Oral:,250 mg (150 mg base) (as Phosphate/Diphosphate) Tablet *Primary Health Care,P01BA01
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Aminoquinolines,Chloroquine,Inj.:,"50 mg/mL (as Phosphate/Diphosphate) in 20 mL Vial (IM,IV) ",P01BA01
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Substituted alkylamines,Chlorphenamine (Chlorpheniramine),Oral:,4 mg (as Maleate) Tablet ,R06AB04
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Substituted alkylamines,Chlorphenamine (Chlorpheniramine),Oral:,2.5 mg/5 mL (as Maleate) Syrup in 60 mL ,R06AB04
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Substituted alkylamines,Chlorphenamine (Chlorpheniramine),Inj.:,"10 mg/mL (as Maleate) in 1 mL (IM,IV) ",R06AB04
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Phenothiazines with aliphatic side-chain,Chlorpromazine,Oral:,100 mg (as Hydrochloride) Tablet *Primary Health Care,N05AA01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Phenothiazines with aliphatic side-chain,Chlorpromazine,Oral:,200 mg (as Hydrochloride) Tablet *Primary Health Care,N05AA01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Phenothiazines with aliphatic side-chain,Chlorpromazine,Oral:,50 mg (as Hydrochloride) Tablet *Primary Health Care,N05AA01 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Phenothiazines with aliphatic side-chain,Chlorpromazine,Inj.:,25 mg/mL (as Hydrochloride) in 1 mL Ampul *Primary Health Care,N05AA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,Ciclosporin,Oral:,25 mg Capsule ,L04AD01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,Ciclosporin,Oral:,50 mg Capsule ,L04AD01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,Ciclosporin,Oral:,100 mg Capsule ,L04AD01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,Ciclosporin,Oral:,100 mg/mL Solution in 50 mL ,L04AD01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,Ciclosporin,Ophthalmic:,0.05% Ophthalmic emulsion in 0.4 mL Bottle ,L04AD01
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Cilostazol,Oral:,50 mg Tablet ,B01AC23
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Cilostazol,Oral:,100 mg Tablet ,B01AC23
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Cilostazol,Oral:,50 mg (20% w/w) Powder in 0.25 g Sachet ,B01AC23
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Cilostazol,Oral:,100 mg (20% w/w) Powder in 0.5 g Sachet ,B01AC23
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,ANTIVERTIGO PREPARATIONS,Antivertigo preparations,Cinnarizine,Oral:,25 mg Tablet ,N07CA02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Ciprofloxacin,Oral:,250 mg (as Hydrochloride) Tablet *Primary Health Care,J01MA02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Ciprofloxacin,Oral:,500 mg (as Hydrochloride) Tablet *Primary Health Care,J01MA02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Ciprofloxacin,Inj.:,2 mg/mL (as Lactate) in 100 mL Vial + (IV infusion) ,J01MA02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Ciprofloxacin,Inj.:,400 mg/200 mL + (IV infusion) ,J01MA02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,Cisplatin,Inj.:,1 mg/mL in 10 mL Vial + (IV) ,L01XA01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,Cisplatin,Inj.:,1 mg/mL in 50 mL Vial + (IV) ,L01XA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Clarithromycin,Oral:,250 mg Tablet (Base) *Primary Health Care,J01FA09
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Clarithromycin,Oral:,500 mg Tablet (Base) *Primary Health Care,J01FA09
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Clarithromycin,Oral:,125 mg/5 mL Granules/Powder for suspension in 50 mL *Primary Health Care,J01FA09
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Clarithromycin,Oral:,250 mg/5 mL Granules/Powder for suspension in 50 mL *Primary Health Care,J01FA09
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Lincosamides,Clindamycin,Oral:,150 mg (as Hydrochloride) Capsule *Primary Health Care,J01FF01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Lincosamides,Clindamycin,Oral:,300 mg (as Hydrochloride) Capsule *Primary Health Care,J01FF01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Lincosamides,Clindamycin,Oral:,75 mg/5 mL (as Palmitate hydrochloride) Granules for suspension in 60 mL *Primary Health Care,J01FF01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Lincosamides,Clindamycin,Inj.:,"150 mg/mL (as Phosphate) in 2 mL Ampul/Vial (IM, IV) ",J01FF01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Lincosamides,Clindamycin,Inj.:,"150 mg/mL (as Phosphate) in 4 mL Ampul (IM, IV) ",J01FF01
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, very potent (group IV)",Clobetasol,Topical:,0.05% (as Propionate) Cream/Ointment in 5 g Tube ,D07AD01
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, very potent (group IV)",Clobetasol,Topical:,0.05% (as Propionate) Cream/Ointment in 15 g Tube ,D07AD01
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, very potent (group IV)",Clobetasol,Topical:,0.05% (as Propionate) Shampoo in 25 mL Bottle ,D07AD01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF LEPRA,Drugs for treatment of lepra,Clofazimine,Oral:,50 mg Capsule *Primary Health Care,J04BA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF LEPRA,Drugs for treatment of lepra,Clofazimine,Oral:,100 mg Capsule *Primary Health Care,J04BA01
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,GONADOTROPINS AND OTHER OVULATION STIMULANTS,"Ovulation stimulants, synthetic",Clomifene,Oral:,50 mg (as Citrate) Tablet ,G03GB02
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Benzodiazepine derivatives,Clonazepam,Oral:,500 mcg Tablet ,N03AE01
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Benzodiazepine derivatives,Clonazepam,Oral:,2 mg Tablet ,N03AE01
CARDIOVASCULAR SYSTEM,ANTIHYPERTENSIVES,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",Imidazoline receptor agonists,Clonidine,Oral:,75 mcg (as Hydrochloride) Tablet *Primary Health Care,C02AC01
CARDIOVASCULAR SYSTEM,ANTIHYPERTENSIVES,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",Imidazoline receptor agonists,Clonidine,Oral:,150 mcg (as Hydrochloride) Tablet ,C02AC01
CARDIOVASCULAR SYSTEM,ANTIHYPERTENSIVES,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",Imidazoline receptor agonists,Clonidine,,150 mcg/mL (as Hydrochloride) in 1 mL Ampul (IV) ,C02AC01
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Clopidogrel,Oral:,75 mg Tablet *Primary Health Care,B01AC04
GENITO URINARY SYSTEM AND SEX HORMONES,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",Imidazole derivatives,Clotrimazole,Topical:,1% (10 mg/g) Cream in 3 g Aluminum collapsible tube *Primary Health Care,G01AF02
GENITO URINARY SYSTEM AND SEX HORMONES,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",Imidazole derivatives,Clotrimazole,Topical:,1% (10 mg/g) Cream in 10 g Aluminum collapsible tube *Primary Health Care,G01AF02
GENITO URINARY SYSTEM AND SEX HORMONES,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",Imidazole derivatives,Clotrimazole,Topical:,1% (10 mg/g) Cream in 20 g Aluminum collapsible tube *Primary Health Care,G01AF02
GENITO URINARY SYSTEM AND SEX HORMONES,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",Imidazole derivatives,Clotrimazole,Topical:,2% (20 mg/g) Cream in 30 g Aluminum collapsible tube *Primary Health Care,G01AF02
GENITO URINARY SYSTEM AND SEX HORMONES,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",Imidazole derivatives,Clotrimazole,Vaginal:,1% Cream in 10 g Aluminum collapsible tube *Primary Health Care,G01AF02
GENITO URINARY SYSTEM AND SEX HORMONES,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",Imidazole derivatives,Clotrimazole,Otic:,1% Solution *Primary Health Care,G01AF02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase resistant penicillins,Cloxacillin,Oral:,500 mg (as Sodium) Capsule *Primary Health Care,J01CF02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase resistant penicillins,Cloxacillin,Oral:,250 mg/5 mL (as Sodium) Powder for solution in 60 mL *Primary Health Care,J01CF02
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines",Clozapine,Oral:,25 mg Tablet (Requires hematologic monitoring) *Primary Health Care,N05AH02
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines",Clozapine,Oral:,100 mg Tablet (Requires hematologic monitoring) *Primary Health Care,N05AH02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Cobra Antivenin,Inj.:,800 MU/4.8 mL in 1 mL Ampul (IV infusion) *Primary Health Care,J06AA03
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Cobra Antivenin,Inj.:,800 IU/mL in 5 mL Ampul (IV infusion) ,J06AA03
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",Opium alkaloids and derivatives,Codeine + A1,Oral:,30 mg (as Phosphate) Modified Release (MR) capsule ,R05DA04
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",Opium alkaloids and derivatives,Codeine + A1,Oral:,10 mg/5 mL Suspension in 60 mL ,R05DA04
MUSCULO-SKELETAL SYSTEM,ANTIGOUT PREPARATIONS,ANTIGOUT PREPARATIONS,Preparations with no effect on uric acid metabolism,Colchicine,Oral:,500 mcg Tablet ,M04AC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Polymyxins,Colistin *Reserve antimicrobial,Inj.:,"2,000,000 IU Lyophilized powder for injection (IV infusion) ",J01XB01
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Combined Glucose-Amino Acid Solutions,,"in 100 mL composed of:
Concentration - Variable
Glucose (Sorbitol) = 25-50 g
Protein = 20-30 g
Calories = 300-450 Kcal
Electrolytes = Variable ",B05BA10
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Combined Glucose-Amino Acid Solutions,,"in 500 mL composed of:
Concentration - Variable
Glucose (Sorbitol) = 25-50 g
Protein = 20-30 g
Calories = 300-450 Kcal
Electrolytes = Variable ",B05BA10
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,ESTROGENS,"Natural and semisynthetic estrogens, plain",Conjugated Estrogen,Oral:,625 mcg Tablet ,G03CA57
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,ESTROGENS,"Natural and semisynthetic estrogens, plain",Conjugated Estrogen,Oral:,1.25 mg Tablet ,G03CA57
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES","Other ectoparasiticides, incl. scabicides",Crotamiton,Topical:,10% Lotion in 60 mL ,P03AX 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,Cyclophosphamide,Inj.:,200 mg Powder Vial (IV) ,L01AA01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,Cyclophosphamide,Inj.:,500 mg Powder Vial (IV) ,L01AA01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,Cyclophosphamide,Inj.:,1 g Powder Vial (IV) ,L01AA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Antibiotics,Cycloserine,Oral:,250 mg Capsule ,J04AB01
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,ANTIANDROGENS,"Antiandrogens, plain",Cyproterone,Oral:,50 mg (as Acetate) Tablet ,G03HA01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Cytarabine,Inj.:,"20 mg/mL in 5 mL Ampul (IM, SC, Intrathecal) ",L01BC01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Cytarabine,Inj.:,100 mg/mL Solution for injection in 1 mL ,L01BC01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Cytarabine,Inj.:,100 mg/mL Solution for injection in 5 mL ,L01BC01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Cytarabine,Inj.:,100 mg/mL Solution for injection in 10 mL ,L01BC01
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Direct thrombin inhibitors,Dabigatran,Oral:,110 mg Capsule ,B01AE07 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Direct thrombin inhibitors,Dabigatran,Oral:,150 mg Capsule ,B01AE07 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Other alkylating agents,Dacarbazine,Inj.:,"100 mg Powder Vial (IV,IV infusion) ",L01AX04
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Other alkylating agents,Dacarbazine,Inj.:,"200 mg Powder Vial (IV,IV infusion) ",L01AX04
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Antivirals for treatment of HCV infections,Daclatasvir,Oral:,60 mg Tablet ,J05AP07
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Actinomycines,Dactinomycin,Inj.:,500 mcg Powder Vial (IV) ,L01DA01
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,Antigonadotropins and similar agents,Danazol,Oral:,200 mg Capsule ,G03XA01
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",Dantrolene and derivatives,Dantrolene,Oral:,25 mg (as Sodium) Capsule ,M03CA01
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",Dantrolene and derivatives,Dantrolene,Oral:,50 mg (as Sodium) Capsule ,M03CA01
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",Dantrolene and derivatives,Dantrolene,Inj.:,20 mg  (as Sodium) Vial with mannitol 3 g (IV) ,M03CA01
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Sodium-glucose co-transporter 2 (SGLT2) inhibitors,Dapagliflozin,Oral:,10 mg Film-coated tablet ,A10BK01 
GENITO URINARY SYSTEM AND SEX HORMONES,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",Other antiinfectives and antiseptics,Dapivirine,VAGIN,25 mg vaginal delivery system (vaginal ring),G01AX17
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF LEPRA,Drugs for treatment of lepra,Dapsone,Oral:,100 mg Tablet *Primary Health Care,J04BA02
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Iron chelating agents,Deferasirox,Oral:,125 mg Dispersible tablet ,V03AC03
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Iron chelating agents,Deferasirox,Oral:,250 mg Dispersible tablet ,V03AC03
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Iron chelating agents,Deferasirox,Oral:,90 mg Film-coated tablet ,V03AC03 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Iron chelating agents,Deferasirox,Oral:,180 mg Film-coated tablet ,V03AC03 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Iron chelating agents,Deferiprone,Oral:,500 mg Tablet ,V03AC02
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Iron chelating agents,Deferoxamine,Inj.:,"500 mg (as Mesilate) Vial (IM, IV infusion, SC) ",V03AC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Other drugs for treatment of tuberculosis,Delamanid,Oral:,50 mg Film-coated tablet ,J04AK06
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Halogenated hydrocarbons,Desflurane,Inhalation:,in 240 mL Bottle ,N01AB07
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,POSTERIOR PITUITARY LOBE HORMONES,Vasopressin and analogues,Desmopressin,Oral:,100 mcg (as Acetate) Tablet ,H01BA02
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,POSTERIOR PITUITARY LOBE HORMONES,Vasopressin and analogues,Desmopressin,Oral:,200 mcg (as Acetate) Tablet ,H01BA02
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,POSTERIOR PITUITARY LOBE HORMONES,Vasopressin and analogues,Desmopressin,Inj.:,"15 mcg/mL (as Acetate) in 1 mL Ampul (IM, SC) ",H01BA02
SENSORY ORGANS,OTOLOGICALS,CORTICOSTEROIDS,Corticosteroids,Dexamethasone,Oral:,500 mcg Tablet *Primary Health Care,S02BA06
SENSORY ORGANS,OTOLOGICALS,CORTICOSTEROIDS,Corticosteroids,Dexamethasone,Oral:,750 mcg Tablet ,S02BA06
SENSORY ORGANS,OTOLOGICALS,CORTICOSTEROIDS,Corticosteroids,Dexamethasone,Oral:,3 mg Tablet ,S02BA06
SENSORY ORGANS,OTOLOGICALS,CORTICOSTEROIDS,Corticosteroids,Dexamethasone,Oral:,4 mg Tablet *Primary Health Care,S02BA06
SENSORY ORGANS,OTOLOGICALS,CORTICOSTEROIDS,Corticosteroids,Dexamethasone,Inj.:,"4 mg/mL (as Sodium phosphate) in 1 mL Ampul/Vial (IM, IV) ",S02BA06
SENSORY ORGANS,OTOLOGICALS,CORTICOSTEROIDS,Corticosteroids,Dexamethasone,Inj.:,"4 mg/mL (as Sodium phosphate) in 2 mL Ampul/Vial (IM, IV) ",S02BA06
SENSORY ORGANS,OTOLOGICALS,CORTICOSTEROIDS,Corticosteroids,Dexamethasone,Inj.:,"5 mg/mL (as Sodium phosphate) Solution for IV infusion in 1 mL Ampul (IM,IV) *Primary Health Care",S02BA06
SENSORY ORGANS,OTOLOGICALS,CORTICOSTEROIDS,Corticosteroids,Dexamethasone,Ophthalmic:,0.1% Suspension for eye drops in 5 mL ,S02BA06
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,"Dextran, High Molecular Weight",Inj.:,"6% (as Dextran 70) in 0.9% Sodium chloride, in 500 mL (IV infusion) ",B05AA05
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,"Dextran, High Molecular Weight",Inj.:,"6% (as Dextran 70) in 5% Dextrose, in 500 mL (IV infusion) ",B05AA05
RESPIRATORY SYSTEM,COUGH AND COLD PREPARATIONS,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",Opium alkaloids and derivatives,Dextromethorphan,Oral:,10 mg (as Hydrobromide) Tablet ,R05DA09
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in 0.3% Sodium chloride, in 250 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 51 mmol/L
Cl- = 51 mmol/L ",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in 0.3% Sodium chloride, in 500 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 51 mmol/L
Cl- = 51 mmol/L ",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in 0.3% Sodium chloride, in 1 L Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 51 mmol/L
Cl- = 51 mmol/L ",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in 0.45% Sodium chloride, in 250 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 77 mmol/L
Cl- = 77 mmol/L ",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in 0.45% Sodium chloride, in 500 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 77 mmol/L
Cl- = 77 mmol/L ",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in 0.45% Sodium chloride, in 1 L Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 77 mmol/L
Cl- = 77 mmol/L ",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in 0.9% Sodium chloride, in 250 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 154 mmol/L
Cl- = 154 mmol/L *Primary Health Care",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in 0.9% Sodium chloride, in 500 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 154 mmol/L
Cl- = 154 mmol/L *Primary Health Care",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in 0.9% Sodium chloride, in 1 L Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 154 mmol/L
Cl- = 154 mmol/L *Primary Health Care",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in Lactated ringers in 250 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22-1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in Lactated ringers in 500 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22-1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,"5% in Lactated ringers in 1 L Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22-1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,5% in Water in 250 mL Bottle/Bag (IV infusion and as vehicle for IV medications) *Primary Health Care,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,5% in Water in 500 mL Bottle/Bag (IV infusion and as vehicle for IV medications) ,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,5% in Water in 1 L Bottle/Bag (IV infusion and as vehicle for IV medications) ,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,,10% in Water in 250 mL Bottle/Bag (IV infusion) ,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,10% in Water in 500 mL Bottle/Bag (IV infusion) ,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,10% in Water in 1 L Bottle/Bag (IV infusion) ,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Dextrose,Inj.:,10% in Water in 3 mL Ampul (As solvent) ,V06DC01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANXIOLYTICS,Benzodiazepine derivatives,Diazepam,Oral:,5 mg Tablet *Primary Health Care,N05BA01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANXIOLYTICS,Benzodiazepine derivatives,Diazepam,Inj.:,"5 mg/mL in 2 mL Ampul (IM,IV) *Primary Health Care",N05BA01
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Acetic acid derivatives and related substances,Diclofenac,Oral:,25 mg (as Sodium/Potassium) Tablet/Capsule ,M01AB05
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Acetic acid derivatives and related substances,Diclofenac,Oral:,50 mg (as Sodium/Potassium) Tablet/Capsule ,M01AB05
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Acetic acid derivatives and related substances,Diclofenac,Oral:,50 mg (as Sodium) Enteric-coated/Modified Release (MR) tablet ,M01AB05
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Acetic acid derivatives and related substances,Diclofenac,Oral:,100 mg (as Sodium/Potassium) Modified Release (MR) tablet/Capsule ,M01AB05
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Acetic acid derivatives and related substances,Diclofenac,Inj.:,"25 mg/mL (as Sodium) in 3 mL Ampul (IM, IV) ",M01AB05
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,"Synthetic anticholinergics, esters with tertiary amino group",Dicycloverine (Dicyclomine),Oral:,10 mg (as Hydrochloride) Tablet *Primary Health Care,A03AA07
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,"Synthetic anticholinergics, esters with tertiary amino group",Dicycloverine (Dicyclomine),Oral:,10 mg/5 mL (as Hydrochloride) Syrup in 60 mL *Primary Health Care,A03AA07
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Piperazine and derivatives,Diethylcarbamazine,Oral:,50 mg Tablet *Primary Health Care,P02CB02
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Piperazine and derivatives,Diethylcarbamazine,Oral:,100 mg Tablet ,P02CB02
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC GLYCOSIDES,Digitalis glycosides,Digoxin,Oral:,250 mcg Tablet *Primary Health Care,C01AA05
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC GLYCOSIDES,Digitalis glycosides,Digoxin,Oral:,50 mcg/mL Elixir in 60 mL ,C01AA05
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC GLYCOSIDES,Digitalis glycosides,Digoxin,Inj.:,"250 mcg/mL in 2 mL Ampul (IM, IV) ",C01AA05
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,Dichloroacetamide derivatives,Diloxanide,Oral:,500 mg (as Furoate) Tablet ,P01AC01
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,Dichloroacetamide derivatives,Diloxanide,Oral:,125 mg/5 mL (as Furoate) Syrup/Suspension in 30 mL ,P01AC01
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,Dichloroacetamide derivatives,Diloxanide,Oral:,125 mg/5 mL (as Furoate) Syrup/Suspension in 60 mL ,P01AC01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,60 mg (as Hydrochloride) Tablet *Primary Health Care,C08DB01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,60 mg (as Hydrochloride) Modified Release (MR) capsule *Primary Health Care,C08DB01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,120 mg (as Hydrochloride) Modified Release (MR) capsule *Primary Health Care,C08DB01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,180 mg (as Hydrochloride) Modified Release (MR) capsule *Primary Health Care,C08DB01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,240 mg (as Hydrochloride) Modified Release (MR) capsule ,C08DB01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,120 mg (as Hydrochloride) Modified Release (MR) tablet *Primary Health Care,C08DB01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,180 mg (as Hydrochloride) Modified Release (MR) tablet *Primary Health Care,C08DB01
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,30 mg (as Hydrochloride) Tablet *Primary Health Care,C08DB01 
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,90 mg (as Hydrochloride) Modified Release (MR) capsule *Primary Health Care,C08DB01 
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Benzothiazepine derivatives,Diltiazem,Oral:,90 mg (as Hydrochloride) Modified Release (MR) tablet *Primary Health Care,C08DB01 
VARIOUS,CONTRAST MEDIA,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,Paramagnetic contrast media,Dimeglumine Gadopentate,Inj.:,469 mg/mL Aqueous solution in 5 mL Vial ,V08CA01
VARIOUS,CONTRAST MEDIA,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,Paramagnetic contrast media,Dimeglumine Gadopentate,Inj.:,469 mg/mL Aqueous solution in 10 mL Vial ,V08CA01
VARIOUS,CONTRAST MEDIA,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,Paramagnetic contrast media,Dimeglumine Gadopentate,Inj.:,469 mg/mL Aqueous solution in 20 mL Vial ,V08CA01
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Dimercaprol,Inj.:,"50 mg/mL in Oil, in 2 mL Ampul (IM) ",V03AB09
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Dimercaptopropane-sulfonate (DMPS),Inj.:,100 mg/mL in 1 mL Ampul (IM) ,V03AB 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Dimercaptopropane-sulfonate (DMPS),Inj.:,100 mg/mL in 10 mL Vial (IM) ,V03AB 
DERMATOLOGICALS,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.","ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",Antihistamines for topical use,Diphenhydramine,Oral:,25 mg (as Hydrochloride) Capsule *Primary Health Care,D04AA32
DERMATOLOGICALS,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.","ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",Antihistamines for topical use,Diphenhydramine,Oral:,50 mg (as Hydrochloride) Capsule *Primary Health Care,D04AA32
DERMATOLOGICALS,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.","ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",Antihistamines for topical use,Diphenhydramine,Oral:,12.5 mg/mL (as Hydrochloride) Syrup in 30 mL *Primary Health Care,D04AA32
DERMATOLOGICALS,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.","ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",Antihistamines for topical use,Diphenhydramine,Oral:,12.5 mg/mL (as Hydrochloride) Syrup in 60 mL *Primary Health Care,D04AA32
DERMATOLOGICALS,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.","ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",Antihistamines for topical use,Diphenhydramine,Inj.:,"50 mg/mL (as Hydrochloride) in 1 mL Ampul (IM,IV) *Primary Health Care",D04AA32
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,"BACTERIAL AND VIRAL VACCINES, COMBINED","Bacterial and viral vaccines, combined",Diphtheria + Tetanus + Pertussis  + Hepatitis B recombinant + Hemophilus Influenza Type B Vaccine,Inj.:,0.5 mL Suspension for injection Vial (IM) ,J07CA11
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Diphtheria vaccines,Diphtheria + Tetanus Toxoids (DT) Vaccine,Inj.:,"30 IU + 40 IU per 0.5 mL, Ampul (IM) ",J07AF01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Diphtheria vaccines,Diphtheria + Tetanus Toxoids (Td) Vaccine,Inj.:,"≥ 2 IU + ≥ 40 IU per 0.5 mL, Ampul (IM) ",J07AF01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Diphtheria vaccines,Diphtheria + Tetanus Toxoids (Td) Vaccine,Inj.:,"≥ 2 IU + ≥ 40 IU per 0.5 mL, Multidose vial (IM)(10 doses per vial) ",J07AF01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pertussis vaccines,Diphtheria + Tetanus Toxoids + Acellular Pertussis (DTaP) Vaccine,Inj.:,0.5 mL Pre-filled syringe (IM) ,J07AJ52
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Haemophilus influenzae B vaccines,Diphtheria + Tetanus Toxoids + Acellular Pertussis + Haemophilus Influenzae Type B (DTaP + Hib) Vaccine,Inj.:,0.5 mL Pre-filled syringe (IM) ,J07AG52
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pertussis vaccines,Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,0.5 mL Ampul (IM) *Primary Health Care,J07AJ51
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pertussis vaccines,Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,0.5 mL Pre-filled syringe (IM) *Primary Health Care,J07AJ51
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pertussis vaccines,Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,in 0.5 mL Vial (IM) *Primary Health Care,J07AJ51
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pertussis vaccines,Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,in 5 mL Vial (IM) *Primary Health Care,J07AJ51
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pertussis vaccines,Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,in 7.5 mL Vial (IM) *Primary Health Care,J07AJ51
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pertussis vaccines,Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,in 10 mL Vial (IM) *Primary Health Care,J07AJ51
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,"BACTERIAL AND VIRAL VACCINES, COMBINED","Bacterial and viral vaccines, combined",Diphtheria + Tetanus Toxoids + Pertussis + Haemophilus Influenzae Type B (DTP + Hib) Vaccine,Inj.:,"10 mcg (as Hib) Freeze-dried powder Vial + 0.5 mL DTP diluent in pre-filled syringe (IM, SC) ",J07CA11
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,"BACTERIAL AND VIRAL VACCINES, COMBINED","Bacterial and viral vaccines, combined",Diphtheria + Tetanus Toxoids + Pertussis + Hepatitis B (Recombinant) Vaccine,Inj.:,"0.5 mL Vial (IM, SC) ",J07CA05
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,"BACTERIAL AND VIRAL VACCINES, COMBINED","Bacterial and viral vaccines, combined",Diphtheria + Tetanus Toxoids + Pertussis + Inactivated Polio Vaccine (DTP + IPV) Vaccine,Inj.:,"0.5 mL Monodose vial (IM, SC) ",J07CA02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,"BACTERIAL AND VIRAL VACCINES, COMBINED","Bacterial and viral vaccines, combined",Diphtheria + Tetanus Toxoids + Pertussis + Inactivated Polio Vaccine (DTP + IPV) Vaccine,Inj.:,"0.5 mL Pre-filled syringe (IM, SC) ",J07CA02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,"BACTERIAL AND VIRAL VACCINES, COMBINED","Bacterial and viral vaccines, combined",Diphtheria + Tetanus Toxoids + Pertussis + Inactivated Polio Vaccine + Haemophilus Influenzae Type B (DTP + IPV + Hib) Vaccine,Inj.:,"0.5 mL Pre-filled syringe (IM, SC) ",J07CA06
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Diphtheria Antitoxin,Inj.:,"10,000 IU in 5 mL (IM) ",J06AA01
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Diphtheria Antitoxin,Inj.:,"10,000 IU in 10 mL (IM) ",J06AA01
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Diphtheria Antitoxin,Inj.:,"20,000 IU in 5 mL (IM) ",J06AA01
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNE SERA,Immune sera,Diphtheria Antitoxin,Inj.:,"20,000 IU in 10 mL (IM) ",J06AA01
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin,Dipyridamole,Oral:,25 mg Tablet (Preferably used in combination with aspirin) ,B01AC07
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Dobutamine,Inj.:,50 mg/mL (as Hydrochloride) in 5 mL Ampul (Concentrate) (IV infusion) ,C01CA07
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Dobutamine,Inj.:,2 mg/mL (as Hydrochloride) + 250 mL D5W (pre-mixed) (IV) ,C01CA07
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Docetaxel,Inj.:,10 mg/mL Solution for infusion in 2 mL Vial (IV infusion) ,L01CD02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Docetaxel,Inj.:,10 mg/mL Solution for infusion in 8 mL Vial (IV infusion) ,L01CD02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Docetaxel,Inj.:,20 mg/0.5 mL (as Anhydrous) in 0.5 mL Vial (IV infusion) ,L01CD02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Docetaxel,Inj.:,40 mg/mL (as Anhydrous) in 2 mL Vial (IV infusion) ,L01CD02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Docetaxel,Inj.:,20 mg/mL (as Trihydrate) Solution for IV infusion in 1 mL Vial (Concentrate) ,L01CD02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Docetaxel,Inj.:,80 mg/4 mL (as Trihydrate) Solution for IV infusion in 4 mL Vial (Concentrate) ,L01CD02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Integrase inhibitors,Dolutegravir,Oral:,50 mg Tablet ,J05AJ03
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,PROPULSIVES,Propulsives,Domperidone,Oral:,10 mg Tablet ,A03FA03
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,PROPULSIVES,Propulsives,Domperidone,Oral:,1 mg/mL Suspension in 60 mL ,A03FA03
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTI-DEMENTIA DRUGS,Anticholinesterases,Donepezil,Oral:,5 mg Tablet/Orodispersible tablet (ODT) ,N06DA02
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTI-DEMENTIA DRUGS,Anticholinesterases,Donepezil,Oral:,10 mg Tablet/Orodispersible tablet (ODT) ,N06DA02
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTI-DEMENTIA,Anticholinesterases,Donepezil Hydrochloride,Oral:,23 mg film-coated tablet,N06DA02
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Dopamine,Inj.:,40 mg/mL (as Hydrochloride) in 5 mL Ampul/Vial (IV) *Primary Health Care,C01CA04
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Dopamine,Inj.:,800 mcg/mL (as Hydrochloride) + 250 mL D5W (pre-mixed) (IV) *Primary Health Care,C01CA04
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Dopamine,Inj.:,1.6 mg/mL (as Hydrochloride) + 250 mL D5W (pre-mixed) (IV) ,C01CA04
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Dopamine,Inj.:,80 mg/mL in 5 mL Vial (IV) *Primary Health Care,C01CA04 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Carbonic anhydrase inhibitors,Dorzolamide,Ophthalmic:,2% (as Hydrochloride) Ophthalmic solution in 5 mL Vial (drops) ,S01EC03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,Doxorubicin,Inj.:,10 mg (as Hydrochloride) Powder Vial (IV) ,L01DB01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,Doxorubicin,Inj.:,50 mg (as Hydrochloride) Powder Vial (IV) ,L01DB01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,Doxorubicin,Inj.:,2 mg/mL (as Hydrochloride) in 5 mL Vial (IV) ,L01DB01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,Doxorubicin,Inj.:,2 mg/mL (as Hydrochloride) in 25 mL Vial (IV) ,L01DB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,TETRACYCLINES,Tetracyclines,Doxycycline,Oral:,100 mg (as Hyclate) Capsule *Primary Health Care,J01AA02
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,PROGESTOGENS,Pregnadien derivatives,Dydrogesterone,Oral:,10 mg Tablet ,G03DB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Non-nucleoside reverse transcriptase inhibitors,Efavirenz,Oral:,50 mg Tablet/Capsule ,J05AG03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Non-nucleoside reverse transcriptase inhibitors,Efavirenz,Oral:,100 mg Tablet/Capsule ,J05AG03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Non-nucleoside reverse transcriptase inhibitors,Efavirenz,Oral:,200 mg Tablet/Capsule ,J05AG03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Non-nucleoside reverse transcriptase inhibitors,Efavirenz,Oral:,600 mg Tablet/Capsule ,J05AG03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Emtricitabine + Tenofovir,Oral:,200 mg + 300 mg (as Disoproxil fumarate) Tablet ,J05AR08
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ACE INHIBITORS, PLAIN","ACE inhibitors, plain",Enalapril,Oral:,5 mg (as Maleate) Tablet *Primary Health Care,C09AA02
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ACE INHIBITORS, PLAIN","ACE inhibitors, plain",Enalapril,Oral:,20 mg (as Maleate) Tablet *Primary Health Care,C09AA02
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ACE INHIBITORS, COMBINATIONS",ACE inhibitors and diuretics,Enalapril + Hydrochlorothiazide,Oral:,20 mg + 12.5 mg Tablet *Primary Health Care,C09BA02
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Heparin group,Enoxaparin,Inj.:,100 mg/mL (as Sodium) in 0.2 mL Pre-filled syringe (SC) ,B01AB05
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Heparin group,Enoxaparin,Inj.:,100 mg/mL (as Sodium) in 0.4 mL Pre-filled syringe (SC) ,B01AB05
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Heparin group,Enoxaparin,Inj.:,100 mg/mL (as Sodium) in 0.6 mL Pre-filled syringe (SC) ,B01AB05
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Entecavir,Oral:,500 mcg Tablet/Film-coated tablet ,J05AF10
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Entecavir,Oral:,1 mg/mL Tablet/Film-coated tablet ,J05AF10
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Entecavir,Oral:,0.05 mg/mL Solution ,J05AF10
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,"Fat/carbohydrates/proteins/minerals/vitamins, combinations",Enteral Nutrition - Adult Polymeric,Oral/Tube feed:,"in 100 mL-1 L composed of:
Calories = 100-475 Kcal
Dilution = 1:1-2:1
Carbohydrates = 13.9-59 g
Protein = 3.8-19.9 g
Fat = 3.4-21.5 g
mOsm/kg = 270-730
Sodium = 75-402 mg
Potassium = 370-580 mg
Calcium = 80-500 mg 
Magnesium = 25-500 mg
Fiber = 0-1.5 g
Phosphorus = 47-307 mg ",V06DB
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,"Fat/carbohydrates/proteins/minerals/vitamins, combinations",Enteral Nutrition - Disease Specific,Oral/Tube feed:,"in 50-500 mL composed of:
Calories = 100-1000 Kcal
Dilution = 1:1-2:1
Carbohydrates = 10.4-156 g
Protein = 5.5-88 g
Fat = 3.3-108 g
mOsm/kg = 230-635
Sodium = 80-2400 mg
Potassium = 172-5600 mg
Calcium = 80-500 mg 
Magnesium = 25-500 mg
Phosphorus = 50-1789 mg
50-500 g ",V06DB
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,"Fat/carbohydrates/proteins/minerals/vitamins, combinations",Enteral Nutrition - Fiber Containing,Oral/Tube feed:,"in 500 mL composed of:
Calories = 100-1048 Kcal
Dilution = 1:1-2:1
Carbohydrates = 13.8-148 g
Protein = 3.8-40 g
Fat = 3.4-34.7 g
mOsm/kg = 270-375
Sodium = 46.5-930 mg
Potassium = 78.5-1570 mg
Phosphorus = 63-720 mg
Fiber = 2.0-10.6 g
100-400 g ",V06DB
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,"Fat/carbohydrates/proteins/minerals/vitamins, combinations",Enteral Nutrition - Modular,Oral:,"in 280-400 g Composed of:
Calories = 9.5-380 Kcal
Dilution = 0
Carbohydrates = 0.67-94 g
Protein = 5-23 g
Fat = 0.6 g
mOsm/kg = 900
Sodium = 15-110 mg
Potassium = 10-66 mg 
Phosphorus = 5-30 mg ",V06DB
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,"Fat/carbohydrates/proteins/minerals/vitamins, combinations",Enteral Nutrition - Pediatric Polymeric,Oral:,"in 100 g composed of:
Calories = 445-511 Kcal
Dilution = 1:1
Carbohydrates = 14.9-62.2 g
Protein = 13.4-54.3 g
Fat = 16.2-26 g
mOsm/kg = 308-345
Sodium = 120-250 mg
Potassium = 400-750 mg 
Phosphorus = 150-760 mg ",V06DB
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,"Fat/carbohydrates/proteins/minerals/vitamins, combinations",Enteral Nutrition - Semi-elemental,Oral:,"in 100 mL-1 L composed of:
Calories = 100-1300 Kcal
Dilution = 1:1-1:5:1
Carbohydrates = 13.8-172.2 g
Protein = 3.0-66.6 g
Fat = 3.9-37.4 g
mOsm/kg = 375-575
Sodium = 66-1040 mg
Potassium = 135-1730 mg 
Phosphorus = 22-867 mg
76-450 g ",V06DB
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",Other centrally acting agents,Eperisone hydrochloride,Oral:,50 mg Tablet ,M03BX09
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,ADRENERGICS FOR SYSTEMIC USE,Alpha- and beta-adrenoreceptor agonists,Ephedrine,Inj.:,30 mg/mL Solution for injection in 1 mL Ampul ,R03CA02
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,ADRENERGICS FOR SYSTEMIC USE,Alpha- and beta-adrenoreceptor agonists,Ephedrine,Inj.:,"50 mg/mL (as Sulfate) in 1 mL Ampul (IM,IV) ",R03CA02
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Epinephrine (Adrenaline),Inj.:,"1 mg/mL (as Hydrochloride) in 1 mL Ampul (IV, IM, SC) *Primary Health Care",C01CA24
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Epinephrine (Adrenaline),Inj.:,"0.3 mg in 0.3 mL Pre-loaded injection pen, auto-injector (IM preload) ",C01CA24
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,Epirubicin,Inj.:,10 mg (as Hydrochloride) Powder Vial (IV) ,L01DB03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,Epirubicin,Inj.:,50 mg (as Hydrochloride) Powder Vial (IV) ,L01DB03
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,OTHER ANTIANEMIC PREPARATIONS,Other antianemic preparations,Epoetin Alfa (Recombinant human erythropoietin),Inj.:,"2000 IU/0.5 mL Pre-filled syringe (IV,SC) ",B03XA01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,OTHER ANTIANEMIC PREPARATIONS,Other antianemic preparations,Epoetin Alfa (Recombinant human erythropoietin),Inj.:,"4000 IU/0.4 mL Pre-filled syringe (IV,SC) ",B03XA01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,OTHER ANTIANEMIC PREPARATIONS,Other antianemic preparations,Epoetin Alfa (Recombinant human erythropoietin),Inj.:,"4000 IU/mL in 1 mL Vial (IV,SC) ",B03XA01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,OTHER ANTIANEMIC PREPARATIONS,Other antianemic preparations,Epoetin Alfa (Recombinant human erythropoietin),Inj.:,"10,000 IU/mL Pre-filled syringe (IV,SC) ",B03XA01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,OTHER ANTIANEMIC PREPARATIONS,Other antianemic preparations,Epoetin Alfa (Recombinant Human Erythropoietin),IV/SC:,4000 IU/mL Solution for injection in 1 mL Pre-filled syringe ,B03XA01 
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,OTHER ANTIANEMIC PREPARATIONS,Other antianemic preparations,Epoetin Beta (Recombinant human erythropoietin),Inj.:,"2000 IU/0.3 mL Pre-filled syringe + needle (IV,SC) ",B03XA01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,OTHER ANTIANEMIC PREPARATIONS,Other antianemic preparations,Epoetin Beta (Recombinant human erythropoietin),Inj.:,"5000 IU/0.3 mL Pre-filled syringe + needle (IV,SC) ",B03XA01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,OTHER ANTIANEMIC PREPARATIONS,Other antianemic preparations,Epoetin Beta (Recombinant human erythropoietin),Inj.:,"10,000 IU/0.6 mL Pre-filled syringe (IV,SC) ",B03XA01
NERVOUS SYSTEM,ANALGESICS,ANTIMIGRAINE PREPARATIONS,Ergot alkaloids,Ergotamine,Oral:,1 mg (as Tartrate) Tablet ,N02CA02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Carbapenems,Ertapenem *Reserve antimicrobial,Inj.:,"1 g (as Sodium) Powder Vial (IM, IV) ",J01DH03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Erythromycin,Oral:,500 mg (as Stearate) Tablet *Primary Health Care,J01FA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Erythromycin,Oral:,200 mg/5 mL (as Ethyl succinate) Granules/Powder for suspension in 60 mL *Primary Health Care,J01FA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Erythromycin,Oral:,400 mg/5 mL (as Ethyl succinate) Granules/Powder for suspension in 50 mL ,J01FA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Erythromycin,Oral:,400 mg/5 mL (as Ethyl succinate) Granules/Powder for suspension in 60 mL ,J01FA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Erythromycin,Ophthalmic:,0.5% Ophthalmic ointment in 3.5 g Tube *Primary Health Care,J01FA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides,Erythromycin,Ophthalmic:,0.5% Ophthalmic ointment in 5 g Tube ,J01FA01
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTIDEPRESSANTS,Selective serotonin reuptake inhibitors,Escitalopram,Oral:,10 mg (as Oxalate) Tablet *Primary Health Care,N06AB10
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Esmolol,Inj.:,10 mg/mL (as Hydrochloride) in 10 mL Vial (IV) ,C07AB09
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Esmolol,Inj.:,100 mg/mL (as Hydrochloride) in 10 mL Vial (IV) ,C07AB09
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Other drugs for treatment of tuberculosis,Ethambutol,Oral:,100 mg (as Hydrochloride) Tablet (Pediatric) ,J04AK02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Other drugs for treatment of tuberculosis,Ethambutol,Oral:,200 mg (as Hydrochloride) Tablet *Primary Health Care,J04AK02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Other drugs for treatment of tuberculosis,Ethambutol,Oral:,400 mg (as Hydrochloride) Tablet *Primary Health Care,J04AK02
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,"Progestogens and estrogens, fixed combinations",Ethinylestradiol + Desogestrel,Oral:,30 mcg + 150 mcg Tablet ,G03AA09
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,"Progestogens and estrogens, fixed combinations",Ethinylestradiol + Levonorgestrel,Oral:,30 mcg + 150 mcg Tablet *Primary Health Care,G03AA07
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,"Progestogens and estrogens, fixed combinations",Ethinylestradiol + Norethisterone,Oral:,35 mcg + 400 mcg (as Acetate) Tablet ,G03AA05
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,"Progestogens and estrogens, fixed combinations",Ethinylestradiol + Norgestrel,Oral:,30 mcg + 300 mcg Tablet ,G03AA06
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,Progestogens,Etonogestrel,Subdermal:,68 mg Implant ,G03AC08
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Podophyllotoxin derivatives,Etoposide,Inj.:,20 mg/mL in 5 mL Ampul/Vial (IV) ,L01CB01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Podophyllotoxin derivatives,Etoposide,Inj.:,20 mg/mL in 10 mL Vial (IV) ,L01CB01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Podophyllotoxin derivatives,Etoposide,Inj.:,100 mg Powder Vial (IV) ,L01CB01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mammalian target of rapamycin (mTOR) kinase inhibitors,Everolimus,Oral:,250 mcg Tablet ,L01EG02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mammalian target of rapamycin (mTOR) kinase inhibitors,Everolimus,Oral:,500 mcg Tablet ,L01EG02
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,VITAMIN K AND OTHER HEMOSTATICS,Blood coagulation factors,Factor IX Complex Concentrate,Inj.:,"100 IU/mL Lyophilized powder in 5 mL Vial (IV) (Coagulation Factors II, VII, IX, X) ",B02BD04
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,VITAMIN K AND OTHER HEMOSTATICS,Blood coagulation factors,Factor IX Complex Concentrate,Inj.:,"100 IU/mL Lyophilized powder in 10 mL Vial (IV) (Coagulation Factors II, VII, IX, X) ",B02BD04
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,VITAMIN K AND OTHER HEMOSTATICS,Blood coagulation factors,Factor IX Complex Concentrate,Inj.:,"500 IU Vial + Diluent (IV) (Coagulation Factors II, VII, IX, X) ",B02BD04
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,VITAMIN K AND OTHER HEMOSTATICS,Blood coagulation factors,Factor VIII Concentrate,Inj.:,100 IU/g Lyophilized powder Vial + Diluent (IV) ,B02BD02
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),H2-receptor antagonists,Famotidine,Oral:,20 mg Tablet ,A02BA03
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),H2-receptor antagonists,Famotidine,Inj.:,20 mg Powder/Lyophilized powder for injection Ampul/Vial ,A02BA03
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,Dihydropyridine derivatives,Felodipine,Oral:,5 mg Modified-release tablet ,C08CA02
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,Dihydropyridine derivatives,Felodipine,Oral:,10 mg Modified-release tablet ,C08CA02
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",Fibrates,Fenofibrate,Oral:,200 mg Capsule *Primary Health Care,C10AB05
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",Fibrates,Fenofibrate,Oral:,160 mg Tablet *Primary Health Care,C10AB05
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",Fibrates,Fenofibrate,Oral:,200 mg Tablet *Primary Health Care,C10AB05 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Phenylpiperidine derivatives,Fentanyl,Oral:,100 mcg (as Citrate) Sublingual tablet ,N02AB03
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Phenylpiperidine derivatives,Fentanyl,Oral:,200 mcg (as Citrate) Sublingual tablet ,N02AB03
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Phenylpiperidine derivatives,Fentanyl,Oral:,300 mcg (as Citrate) Sublingual tablet ,N02AB03
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Phenylpiperidine derivatives,Fentanyl,Oral:,400 mcg (as Citrate) Sublingual tablet ,N02AB03
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Phenylpiperidine derivatives,Fentanyl,Inj.:,50 mcg/mL (as Citrate) in 2 mL Ampul (IV) ,N02AB03
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Phenylpiperidine derivatives,Fentanyl,Inj.:,50 mcg/mL (as Citrate) in 10 mL Ampul (IV) ,N02AB03
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,IRON PREPARATIONS,"Iron bivalent, oral preparations",Ferrous Salt,Oral:,"(equiv. to 60 mg elemental iron) Tablet 
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate, desicated = 32%) *Primary Health Care",B03AA07
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,IRON PREPARATIONS,"Iron bivalent, oral preparations",Ferrous Salt,Oral:,"(equiv. to 15 mg elemental iron per 0.6 mL) Solution in 15 mL (Drops)
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate, desicated = 32%) *Primary Health Care",B03AA07
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,IRON PREPARATIONS,"Iron bivalent, oral preparations",Ferrous Salt,Oral:,"(equiv. to 15 mg elemental iron per 0.6 mL) Solution in 30 mL (Drops)
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate , dessicated = 32%) *Primary Health Care",B03AA07
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,IRON PREPARATIONS,"Iron bivalent, oral preparations",Ferrous Salt,Oral:,"(equiv. to 30 mg elemental iron per 5 mL) Solution 
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate , dessicated = 32%) *Primary Health Care",B03AA07
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,IRON PREPARATIONS,"Iron bivalent, oral preparations",Ferrous Salt,Oral:,"Syrup in 60 mL 
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate , dessicated = 32%) *Primary Health Care",B03AA07
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,IRON PREPARATIONS,Iron in combination with folic acid,Ferrous Salt + Folic Acid,Oral:,60 mg (elemental iron) + 400 mcg Tablet/Capsule/Film-coated tablet *Primary Health Care,B03AD03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,Filgrastim,IV/SC:,300 mcg/0.9 mL Solution in 0.9 mL Pre-filled syringe ,L03AA02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,Filgrastim (G-CSF),Inj.:,"150 mcg/0.6 mL Vial (IV, SC) ",L03AA02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,Filgrastim (G-CSF),Inj.:,"300 mcg/0.5 mL Solution for injection Pre-filled syringe (IV, SC) ",L03AA02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,Filgrastim (G-CSF),Inj.:,"300 mcg/mL Vial (IV, SC) ",L03AA02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Colony stimulating factors,Filgrastim (G-CSF),Inj.:,"300 mcg/1.2 mL Vial (IV, SC) ",L03AA02
GENITO URINARY SYSTEM AND SEX HORMONES,UROLOGICALS,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,Testosterone-5-alpha reductase inhibitors,Finasteride,Oral:,5 mg Tablet *Primary Health Care,G04CB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Triazole and tetrazole derivatives,Fluconazole,Oral:,50 mg Capsule ,J02AC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Triazole and tetrazole derivatives,Fluconazole,Oral:,150 mg Capsule ,J02AC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Triazole and tetrazole derivatives,Fluconazole,Oral:,200 mg Capsule ,J02AC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Triazole and tetrazole derivatives,Fluconazole,Inj.:,2 mg/mL in 100 mL Vial (IV infusion) ,J02AC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Other antimycotics for systemic use,Flucytosine (5-fluoroyctosine),Oral:,250 mg Tablet ,J02AX01
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Flumazenil,Inj.:,"100 mcg/mL in 5 mL Ampul (Slow IV, IV infusion) ",V03AB25
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,ANTIVERTIGO PREPARATIONS,Antivertigo preparations,Flunarizine,Oral:,5 mg (as Hydrochloride) Capsule ,N07CA03
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, potent (group III)",Fluocinonide,Topical:,0.05% Cream/Ointment in 5 g Tube ,D07AC08
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, potent (group III)",Fluocinonide,Topical:,0.05% Cream/Ointment in 15 g Tube ,D07AC08
SENSORY ORGANS,OPHTHALMOLOGICALS,DIAGNOSTIC AGENTS,Colouring agents,Fluorescein,Inj.:,10% (100 mg/mL) (as Sodium) in 5 mL Ampul (IV) ,S01JA01
SENSORY ORGANS,OPHTHALMOLOGICALS,DIAGNOSTIC AGENTS,Colouring agents,Fluorescein,Ophthalmic:,1 mg (as Sodium) Strip ,S01JA01
SENSORY ORGANS,OPHTHALMOLOGICALS,DIAGNOSTIC AGENTS,Colouring agents,Fluorescein,Ophthalmic:,9 mg (as Sodium) Strip ,S01JA01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Fluorouracil,Inj.:,50 mg/mL in 10 mL Ampul/Vial (IV) (IV infusion) ,L01BC02
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTIDEPRESSANTS,Selective serotonin reuptake inhibitors,Fluoxetine,Oral:,20 mg Dispersible tablet/Capsule *Primary Health Care,N06AB03
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Thioxanthene derivatives,Flupentixol,Inj.:,20 mg/mL (as Decanoate) in 1 mL Ampul (IM) ,N05AF01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Thioxanthene derivatives,Flupentixol,Inj.:,20 mg/mL (as Decanoate) in 10 mL Vial (IM) ,N05AF01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Phenothiazines with piperazine structure,Fluphenazine,Inj.:,25 mg/mL (as Decanoate) in 1 mL Ampul (IM) *Primary Health Care,N05AB02
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Phenothiazines with piperazine structure,Fluphenazine,Inj.:,25 mg/mL (as Decanoate) in 10 mL Vial (IM) *Primary Health Care,N05AB02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens,Flutamide,Oral:,250 mg Tablet ,L02BB01
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Fluticasone,Inhalation:,"0.05% (as Propionate) per dose x 120 doses, Solution (Nasal aqueous solution) ",R03BA05
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Fluticasone,Inhalation:,50 mcg/dose (as Propionate) DPI with appropriate accompanying dispenser ,R03BA05
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Fluticasone,Inhalation:,250 mcg/dose (as Propionate) DPI with appropriate accompanying dispenser ,R03BA05
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Fluticasone,Inhalation:,"50 mcg/dose (as Propionate) x 60 doses, MDI with appropriate accompanying dispenser ",R03BA05
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Fluticasone,Inhalation:,"50 mcg/dose (as Propionate) x 120 doses, MDI with appropriate accompanying dispenser ",R03BA05
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Fluticasone,Inhalation:,"125 mcg/dose (as Propionate) x 60 doses, MDI with appropriate accompanying dispenser ",R03BA05
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Fluticasone,Inhalation:,"125 mcg/dose (as Propionate) x 120 doses, MDI with appropriate accompanying dispenser ",R03BA05
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Glucocorticoids,Fluticasone,Inhalation:,250 mcg/mL (as Propionate) in 2 mL (Unit dose) (For nebulization) ,R03BA05
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Formoterol,Inhalation:,"50 mcg (as Propionate) + 5 mcg (as Fumarate dihydrate) x 120 actuations, MDI ",R03AK11
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Formoterol,Inhalation:,"125 mcg (as Propionate) + 5 mcg (as Fumarate dihydrate) x 120 actuations, MDI ",R03AK11
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Formoterol,Inhalation:,"250 mcg (as Propionate) + 10 mcg (as Fumarate dihydrate) x 120 actuations, MDI ",R03AK11
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Salmeterol,Inhalation:,"100 mcg (as Propionate) + 50 mcg (as Xinafoate) x 28 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Salmeterol,Inhalation:,"100 mcg (as Propionate) + 50 mcg (as Xinafoate) x 60 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Salmeterol,Inhalation:,"250 mcg (as Propionate) + 50 mcg (as Xinafoate) x 28 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Salmeterol,Inhalation:,"250 mcg (as Propionate) + 50 mcg (as Xinafoate) x 60 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Salmeterol,Inhalation:,"500 mcg (as Propionate) + 50 mcg (as Xinafoate) x 28 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Salmeterol,Inhalation:,"500 mcg (as Propionate) + 50 mcg (as Xinafoate) x 60 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Salmeterol,Inhalation:,"50 mcg (as Propionate) + 25 mcg (as Xinafoate) x 120 actuations, MDI with dose counter ",R03AK06
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Salmeterol,Inhalation:,"125 mcg (as Propionate) + 25 mcg (as Xinafoate) x 120 actuations, MDI ",R03AK06
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS","Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",Fluticasone + Salmeterol,Inhalation:,"250 mcg (as Propionate) + 25 mcg (as Xinafoate) x 120 actuations, MDI ",R03AK06
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,VITAMIN B12 AND FOLIC ACID,Folic acid and derivatives,Folic Acid,Oral:,400 mcg Tablet/Capsule *Primary Health Care,B03BB01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,VITAMIN B12 AND FOLIC ACID,Folic acid and derivatives,Folic Acid,Oral:,800 mcg Tablet/Capsule *Primary Health Care,B03BB01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,VITAMIN B12 AND FOLIC ACID,Folic acid and derivatives,Folic Acid,Oral:,1 mg Tablet/Capsule *Primary Health Care,B03BB01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,VITAMIN B12 AND FOLIC ACID,Folic acid and derivatives,Folic Acid,Oral:,5 mg Tablet/Capsule *Primary Health Care,B03BB01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,VITAMIN B12 AND FOLIC ACID,Folic acid and derivatives,Folic Acid,Oral:,2.5 mg/mL Syrup (Pediatric drops) *Primary Health Care,B03BB01
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,VITAMIN B12 AND FOLIC ACID,Folic acid and derivatives,Folic Acid,Oral:,5 mg/5 mL Syrup *Primary Health Care,B03BB01
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Fomepizole (4-methylprazole),Inj.:,1 g/mL in 1.5 mL Vial (IV) ,V03AB34
BLOOD AND BLOOD FORMING ORGANS, ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Other antithrombotic agents,Fondaparinux,Inj.:,2.5 mg/0.5 mL (as Sodium) Solution ,B01AX05
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Selective beta-2-adrenoreceptor agonists,Formoterol,Inhalation:,12 mcg DPI with appropriate accompanying dispenser ,R03AC13
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Other antibacterials,Fosfomycin,Oral:,3 g Granules for Suspension ,J01XX01
CARDIOVASCULAR SYSTEM,DIURETICS,HIGH-CEILING DIURETICS,"Sulfonamides, plain",Furosemide,Oral:,20 mg Tablet ,C03CA01
CARDIOVASCULAR SYSTEM,DIURETICS,HIGH-CEILING DIURETICS,"Sulfonamides, plain",Furosemide,Oral:,40 mg Tablet *Primary Health Care,C03CA01
CARDIOVASCULAR SYSTEM,DIURETICS,HIGH-CEILING DIURETICS,"Sulfonamides, plain",Furosemide,Inj.:,"10 mg/mL in 2 mL Ampul (IM, IV) *Primary Health Care",C03CA01
CARDIOVASCULAR SYSTEM,DIURETICS,HIGH-CEILING DIURETICS,"Sulfonamides, plain",Furosemide,Inj.:,10 mg/mL in 25 mL Ampul (IV infusion) ,C03CA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Steroid antibacterials,Fusidic Acid/Fusidate Sodium,Topical:,2% Cream in 5 g Tube *Primary Health Care,J01XC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Steroid antibacterials,Fusidic Acid/Fusidate Sodium,Topical:,2% Ointment in 15 g Tube *Primary Health Care,J01XC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Steroid antibacterials,Fusidic Acid/Fusidate Sodium,Ophthalmic:,1% (as Sulfate) Suspension in 5 g Tube (Eye drops) ,J01XC01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Gabapentinoids,Gabapentin,Oral:,100 mg Capsule *Primary Health Care,N02BF01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Gabapentinoids,Gabapentin,Oral:,300 mg Capsule *Primary Health Care,N02BF01
VARIOUS,CONTRAST MEDIA,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,Paramagnetic contrast media,Gadobutrol,Inj.:,1 mmol/mL Solution for injection in 15 mL Vial ,V08CA09
VARIOUS,CONTRAST MEDIA,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,Paramagnetic contrast media,Gadobutrol,Inj.:,1 mmol/mL Solution for injection in 5 mL Pre-filled syringe ,V08CA09
VARIOUS,CONTRAST MEDIA, MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,Paramagnetic contrast media,Gadoteric Acid,Inj.:,0.5 mmol/mL Solution for injection in 10 mL Vial ,V08CA02
VARIOUS,CONTRAST MEDIA, MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,Paramagnetic contrast media,Gadoteric Acid,Inj.:,0.5 mmol/mL Solution for injection in 15 mL Vial ,V08CA02
VARIOUS,CONTRAST MEDIA, MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,Paramagnetic contrast media,Gadoteric Acid,Inj.:,0.5 mmol/mL Solution for injection in 20 mL Vial ,V08CA02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Ganciclovir,Ophthalmic:,0.15% Gel in 5 g Tube ,J05AB06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Ganciclovir,Inj.:,500 mg (as Sodium) Vial (IV infusion) ,J05AB06
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Gemcitabine,Inj.:,200 mg (as Hydrochloride) Vial (IV infusion) ,L01BC05
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Gemcitabine,Inj.:,1 g (as Hydrochloride) Vial (IV infusion) ,L01BC05
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Gentamicin,Inj.:,"10 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) *Primary Health Care",J01GB03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Gentamicin,Inj.:,"40 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) *Primary Health Care",J01GB03
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Sulfonylureas,Gliclazide,Oral:,30 mg Modified Release (MR) tablet *Primary Health Care,A10BB09
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Sulfonylureas,Gliclazide,Oral:,60 mg Modified Release (MR) tablet ,A10BB09
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Sulfonylureas,Gliclazide,Oral:,80 mg Tablet *Primary Health Care,A10BB09
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PANCREATIC HORMONES,GLYCOGENOLYTIC HORMONES,Glycogenolytic hormones,Glucagon,Inj.:,"1 mg (as Hydrochloride) Lyophilized powder + Solvent (IM, IV, SC) ",H04AA01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Glucose (Dextrose),Inj.:,50% in 50 mL Vial (IV) *Primary Health Care,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Glucose (Dextrose),Inj.:,50% in 10 mL Ampul (IV) ,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Glucose (Dextrose),Inj.:,50% in 20 mL Ampul (IV) ,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Glucose (Dextrose),Inj.:,50% in 10 mL Vial (IV)(85 Kcal) ,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Glucose (Dextrose),Inj.:,50% in 20 mL Vial (IV)(85 Kcal) ,V06DC01
VARIOUS,GENERAL NUTRIENTS,OTHER NUTRIENTS,Carbohydrates,Glucose (Dextrose),Inj.:,50% in 50 mL Vial (IV)(85 Kcal) ,V06DC01
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Enemas,Glycerin (Glycerol),Oral:,USP Grade (Liquid) ,A06AG04
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Enemas,Glycerin (Glycerol),Rectal:,2 g Suppository ,A06AG04
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Enemas,Glycerin (Glycerol),Rectal:,2.5 g Suppository ,A06AG04
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Glyceryl trinitrate (Nitroglycerin),Inj.:,1 mg/mL in 10 mL Ampul (IV infusion) ,C01DA02
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Glyceryl trinitrate (Nitroglycerin),Inj.:,1 mg/mL in 25 mL Ampul (IV infusion) ,C01DA02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Gonadotropin releasing hormone analogues,Goserelin,Inj.:,3.6 mg (as Acetate) Depot solution Pre-filled syringe (SC) ,L02AE03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Gonadotropin releasing hormone analogues,Goserelin,Inj.:,10.8 mg (as Acetate) Depot solution Pre-filled syringe (SC) ,L02AE03
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Butyrophenone derivatives,Haloperidol,Oral:,2 mg Tablet *Primary Health Care,N05AD01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Butyrophenone derivatives,Haloperidol,Oral:,5 mg Tablet *Primary Health Care,N05AD01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Butyrophenone derivatives,Haloperidol,Oral:,10 mg Tablet *Primary Health Care,N05AD01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Butyrophenone derivatives,Haloperidol,Inj.:,5 mg/mL in 1 mL Ampul (IM) *Primary Health Care,N05AD01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Butyrophenone derivatives,Haloperidol,Inj.:,50 mg/mL (as Decanoate) in 1 mL Ampul (IM)(Oily) *Primary Health Care,N05AD01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Halogenated hydrocarbons,Halothane,Inhalation:,in 250 mL Bottle ,N01AB01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Haemophilus influenzae B vaccines,Hemophilus Influenzae type B Conjugated (Hib) Vaccine,Inj.:,10 mcg/0.5 mL in 1 Dose vial + 0.5 mL diluent with tetanus protein (IM) *Primary Health Care,J07AG01 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Haemophilus influenzae B vaccines,Hemophilus Influenzae type B Conjugated (Hib) Vaccine,Inj.:,10 mcg/0.5 mL Vial + 0.9% sodium chloride with diptheria CRM 197 protein (IM) *Primary Health Care,J07AG01 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Haemophilus influenzae B vaccines,Hemophilus Influenzae type B Conjugated (Hib) Vaccine,Inj.:,in 0.5 mL Vial + Meningococcal protein (IM) *Primary Health Care,J07AG01 
CARDIOVASCULAR SYSTEM,VASOPROTECTIVES,ANTIVARICOSE THERAPY,Heparins or heparinoids for topical use,Heparin,Inj.:,"1000 IU/mL (as Sodium) in 5 mL Vial (IV infusion, SC) (Bovine origin) (Unfractionated) ",C05BA03
CARDIOVASCULAR SYSTEM,VASOPROTECTIVES,ANTIVARICOSE THERAPY,Heparins or heparinoids for topical use,Heparin,Inj.:,"5000 IU/mL (as Sodium) in 5 mL Vial (IV infusion, SC) (Bovine origin) (Unfractionated) ",C05BA03
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Hepatitis vaccines,Hepatitis A Inactivated Vaccine,Inj.:,Viral antigen not less than 720 EU  in 0.5 mL Monodose vial (IM) (Junior) ,J07BC02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Hepatitis vaccines,Hepatitis A Inactivated Vaccine,Inj.:,Viral antigen not less than 1440 EU  in 1 mL Monodose vial (IM) (Adult) ,J07BC02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Hepatitis vaccines,Hepatitis A Inactivated Vaccine,Inj.:,80 units/0.5 mL Pre-filled syringe (IM) (Pediatric) (Single dose) (GBM strain) ,J07BC02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Hepatitis vaccines,Hepatitis A Inactivated Vaccine,Inj.:,160 units/0.5 mL Pre-filled syringe (IM) (Pediatric) (Single dose) (GBM strain) ,J07BC02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Hepatitis B Immunoglobulin,Inj.:,in 0.5 mL Vial (IM) (Human) ,J06BB04
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Hepatitis B Immunoglobulin,Inj.:,in 1 mL Vial (IM) (Human) ,J06BB04
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Hepatitis B Immunoglobulin,Inj.:,in 2 mL Vial (IM) (Human) ,J06BB04
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Hepatitis vaccines,Hepatitis B Vaccine,Inj.:,"10 mcg/0.5 mL Monodose vial (IM) (Pediatric) (Recombinant DNA)
(N.B.: Formulations of different manufacturers are of equal or similar immunogenicity. Follow strictly the recommended dose of each manufacturer) *Primary Health Care",J07BC01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Hepatitis vaccines,Hepatitis B Vaccine,Inj.:,"10 mcg/0.5 mL x 10 dose, in 5 mL Vial (IM) (Recombinant DNA)
(N.B.: Formulations of different manufacturers are of equal or similar immunogenicity. Follow strictly the recommended dose of each manufacturer) *Primary Health Care",J07BC01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Hepatitis vaccines,Hepatitis B Vaccine,Inj.:,"20 mcg/mL Monodose vial (IM) (Adult) (Recombinant DNA) (For more than 10 years old)
(N.B.: Formulations of different manufacturers are of equal or similar immunogenicity. Follow strictly the recommended dose of each manufacturer) *Primary Health Care",J07BC01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Hepatitis vaccines,Hepatitis B Vaccine,Inj.:,"20 mcg/mL x 10 dose, in 10 mL Vial (IM) (Adult) (Recombinant DNA)
(N.B.: Formulations of different manufacturers are of equal or similar immunogenicity. Follow strictly the recommended dose of each manufacturer) *Primary Health Care",J07BC01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Papillomavirus vaccines,Human Papillomavirus Vaccine,Inj.:,"Suspension in 0.5 mL Glass pre-filled syringe (IM) (Quadrivalent - Types 6, 11, 16, 18) (Recombinant) ",J07BM03
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Papillomavirus vaccines,Human Papillomavirus Vaccine,Inj.:,"in 0.5 mL Glass vial (IM) (Quadrivalent - Types 6, 11, 16, 18) (Recombinant) ",J07BM03
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Papillomavirus vaccines,Human Papillomavirus Vaccine,Inj.:,"Suspension in 0.5 mL Pre-filled syringe (Type 1 glass) with plunger stopper (rubber butyl) and sterile needle (Types 16 and 18) (Recombinant, AS04 Adjuvanted) ",J07BM03
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Papillomavirus vaccines,Human Papillomavirus Vaccine,Inj.:,"0.5 mL in 3 mL Monodose vial (Type 1 glass) (Types 16 and 18) (Recombinant, AS04 Adjuvanted) ",J07BM03
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Papillomavirus vaccines,Human Papillomavirus Vaccine,Inj.:,"1 mL in 3 mL Glass vial (Types 16 and 18) (Recombinant, AS04 Adjuvanted) ",J07BM03
CARDIOVASCULAR SYSTEM,ANTIHYPERTENSIVES,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",Hydrazinophthalazine derivatives,Hydralazine,Oral:,25 mg (as Hydrochloride) Tablet ,C02DB02
CARDIOVASCULAR SYSTEM,ANTIHYPERTENSIVES,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",Hydrazinophthalazine derivatives,Hydralazine,Oral:,50 mg (as Hydrochloride) Tablet ,C02DB02
CARDIOVASCULAR SYSTEM,ANTIHYPERTENSIVES,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",Hydrazinophthalazine derivatives,Hydralazine,Inj.:,"20 mg/mL (as Hydrochloride) in 1 mL Ampul (IM, IV) *Primary Health Care",C02DB02
CARDIOVASCULAR SYSTEM,DIURETICS,"LOW-CEILING DIURETICS, THIAZIDES","Thiazides, plain",Hydrochlorothiazide,Oral:,12.5 mg Tablet *Primary Health Care,C03AA03
CARDIOVASCULAR SYSTEM,DIURETICS,"LOW-CEILING DIURETICS, THIAZIDES","Thiazides, plain",Hydrochlorothiazide,Oral:,25 mg Tablet *Primary Health Care,C03AA03
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Oral:,5 mg Tablet *Primary Health Care,D07AA02
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Oral:,20 mg Tablet *Primary Health Care,D07AA02
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Inj.:,"50 mg/mL (as Sodium succinate) in 2 mL Vial (IM, IV) *Primary Health Care",D07AA02
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Inj.:,125 mg/mL (as Sodium succinate) in 2 mL Vial (IV) *Primary Health Care,D07AA02
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Inj.:,100 mg (as Sodium succinate) Powder Vial (IV) *Primary Health Care,D07AA02
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Inj.:,250 mg (as Sodium succinate) Powder Vial (IV) *Primary Health Care,D07AA02
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Topical:,1% Cream/Ointment in 5 g Tube *Primary Health Care,D07AA02
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Topical:,1% Cream/Ointment in 10 g Tube ,D07AA02
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Topical:,1% Lotion in 25 mL Bottle ,D07AA02
DERMATOLOGICALS,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","CORTICOSTEROIDS, PLAIN","Corticosteroids, weak (group I)",Hydrocortisone,Topical:,2.5% Lotion in 25 mL Bottle ,D07AA02
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Hydrocortisone,Inj.:,125 mg/mL (as Sodium succinate) in 4 mL Vial (IV) *Primary Health Care,H02AB09 
DERMATOLOGICALS,OTHER DERMATOLOGICAL PREPARATIONS,OTHER DERMATOLOGICAL PREPARATIONS,Other dermatologicals,Hydrogen Peroxide,Topical:,3% Solution in 60 mL ,D11AX25
DERMATOLOGICALS,OTHER DERMATOLOGICAL PREPARATIONS,OTHER DERMATOLOGICAL PREPARATIONS,Other dermatologicals,Hydrogen Peroxide,Topical:,3% Solution in 120 mL *Primary Health Care,D11AX25
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Aminoquinolines,Hydroxychloroquine,Oral:,200 mg (as Sulfate) Tablet ,P01BA02
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,Hydroxyethyl Starch,Inj.:,6%  Solution in 250 mL Bottle (IV infusion) ,B05AA07
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,Hydroxyethyl Starch,Inj.:,6% Solution in 500 mL Bottle (IV infusion) ,B05AA07
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents,Hydroxyurea,Oral:,500 mg Capsule ,L01XX05
NERVOUS SYSTEM,PSYCHOLEPTICS,ANXIOLYTICS,Diphenylmethane derivatives,Hydroxyzine,Oral:,25 mg (as Dihydrochloride) Tablet ,N05BB01
NERVOUS SYSTEM,PSYCHOLEPTICS,ANXIOLYTICS,Diphenylmethane derivatives,Hydroxyzine,Oral:,2 mg/mL (as Dihydrochloride) Syrup in 100 mL ,N05BB01
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,"BELLADONNA AND DERIVATIVES, PLAIN","Belladonna alkaloids, tertiary amines",Hyoscine ,Oral:,10 mg (as N-butyl bromide) Tablet *Primary Health Care,A03BA03
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,"BELLADONNA AND DERIVATIVES, PLAIN","Belladonna alkaloids, tertiary amines",Hyoscine ,Oral:,5 mg/5 mL (as N-butyl bromide) Syrup in 60 mL *Primary Health Care,A03BA03
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,"BELLADONNA AND DERIVATIVES, PLAIN","Belladonna alkaloids, tertiary amines",Hyoscine ,Inj.:,"20 mg/mL (as N-butyl bromide) in 1 mL Ampul (IM, IV, SC) *Primary Health Care",A03BA03
Not available,Not available,Not available,Not available,Hypertonic lactate,Inj.:,"Solution for IV infusion in 250 mL containing:

Sodium Lactate Solution (50%) = 28.250 g (equal with 14.125 Solution Lactate)
Potassium Chloride = 0.075 g
Calcium Chloride 2H20 (100%) = 0.05 g
Water for injection = q.s.

Composed of:
Na+ = 504.15 mmol/L
K+ = 40.2 mmol/L
Ca++ = 1.36 mmol/L
Cl- = 6.74 mmol/L
Lactate = 504.15 mmol/L ",Not available
Not available,Not available,Not available,Not available,Hypertonic Saline Solution ,,3% (For diagnosis of pulmonary tuberculosis) ,Not available
SENSORY ORGANS,OPHTHALMOLOGICALS,SURGICAL AIDS,Viscoelastic substances,Hypromellose,Ophthalmic:,5 mg/mL Solution in 10 mL (Eye drops) ,S01KA02
SENSORY ORGANS,OPHTHALMOLOGICALS,SURGICAL AIDS,Viscoelastic substances,Hypromellose,Ophthalmic:,5 mg/mL Solution in 15 mL (Eye drops) ,S01KA02
SENSORY ORGANS,OPHTHALMOLOGICALS,SURGICAL AIDS,Viscoelastic substances,Hypromellose,Ophthalmic:,10 mg/mL Solution in 10 mL (Eye drops) ,S01KA02
SENSORY ORGANS,OPHTHALMOLOGICALS,SURGICAL AIDS,Viscoelastic substances,Hypromellose,Ophthalmic:,10 mg/mL Solution in 15 mL (Eye drops) ,S01KA02
SENSORY ORGANS,OPHTHALMOLOGICALS,SURGICAL AIDS,Viscoelastic substances,Hypromellose,Ophthalmic:,0.3% Solution in 10 mL Bottle ,S01KA02
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Propionic acid derivatives,Ibuprofen,Oral:,200 mg Capsule *Primary Health Care,M01AE01
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Propionic acid derivatives,Ibuprofen,Oral:,400 mg Capsule *Primary Health Care,M01AE01
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Propionic acid derivatives,Ibuprofen,Oral:,100 mg/5 mL Syrup/Suspension in 60 mL *Primary Health Care,M01AE01
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Propionic acid derivatives,Ibuprofen,Oral:,200 mg/5 mL Suspension in 60 mL ,M01AE01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,Idarubicin,Inj.:,5 mg (as Hydrochloride) Powder Vial (IV) ,L01DB06
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,Ifosfamide,Inj.:,1 g Powder Vial (IV Infusion) ,L01AA06
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,Ifosfamide,Inj.:,2 g Powder Vial (IV Infusion) ,L01AA06
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors,Imatinib,Inj.:,100 mg (as Mesilate) Tablet ,L01EA01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors,Imatinib,Inj.:,400 mg (as Mesilate) Tablet ,L01EA01
ALIMENTARY TRACT AND METABOLISM,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,Enzymes,Imiglucerase,Inj.:,400 IU Powder in 20 mL Vial (IV Infusion) ,A16AB02
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,CHEMOTHERAPEUTICS FOR TOPICAL USE,Antivirals,Imiquinod,Topical:,5% Cream Aluminum foil sachet ,D06BB10
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIM)",Inj.:,160 mg/mL in 2 mL Vial (IM) ,J06BA01
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIM)",Inj.:,160 mg/mL in 5 mL Vial (IM) ,J06BA01
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIM)",Inj.:,160 mg/mL in 10 mL Vial (IM) ,J06BA01
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 10 mL Vial (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 20 mL Vial (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 50 mL Vial (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 100 mL Vial (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 200 mL Vial (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 1 g Bottle + 33 mL reconstitution fluid (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 1 g Bottle + 50 mL reconstitution fluid (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 2.5 g Bottle + 100 mL reconstitution fluid (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 5 g Bottle + 100 mL diluent vial (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,"Immunoglobulins, normal human","Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 10 g Bottle + 260 mL diluent vial (IV) ,J06BA02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,"BACTERIAL AND VIRAL VACCINES, COMBINED","Bacterial and viral vaccines, combined",Inactivated Polio Vaccine,Inj.:,"0.5 mL/dose Suspension for injection in 5 mL Multidose vial (IM, SC) (Types 1, 2, and 3) ",J07CA02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Poliomyelitis vaccines,Inactivated Poliomyelitis Vaccine,Inj.:,"0.5 mL/dose Suspension for injection Single dose/multidose vial (IM, SC) (Types 1, 2, and 3) *Primary Health Care",J07BF01
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids,Indacaterol + Glycopyrronium,Inhalation:,110 mcg (as Maleate) + 50 mcg (as Bromide) Powder in hard capsules ,R03AL12
CARDIOVASCULAR SYSTEM,DIURETICS,"LOW-CEILING DIURETICS, EXCL. THIAZIDES","Sulfonamides, plain",Indapamide,Oral:,1.5 mg Modified Release (MR) tablet ,C03BA11
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Influenza vaccines,Influenza Polyvalent Vaccine,Inj.:,"in 0.5 mL Vial + Pre-filled syringe diluent (IM)
(N.B.: Strains as recommended by WHO) *Primary Health Care",J07BB02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Influenza vaccines,Influenza Polyvalent Vaccine,Inj.:,"Suspension in 0.5 mL Pre-filled syringe/ampule (IM) (Adult)
(N.B.: Strains as recommended by WHO) *Primary Health Care",J07BB02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Influenza vaccines,Influenza Polyvalent Vaccine,Inj.:,"15 mcg/0.5 mL in 5 mL Multidose vial 
(N.B.: Strains as recommended by WHO) *Primary Health Care",J07BB02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Influenza vaccines,Influenza Polyvalent Vaccine,Inj.:,"7.5 mcg/ 0.25 mL Suspension for injection in 0.25 mL Single dose pre-filled glass syringe 
(N.B.: Strains as recommended by WHO) ",J07BB02
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, long-acting",Insulin Glargine,SC:,100 IU/mL in 10 mL Vial ,A10AE04 
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, long-acting",Insulin Glargine,SC:,100 IU/mL in 3 mL Pre-filled pen ,A10AE04 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,Interferon Alfa 2B,Inj.:,"3 million IU/mL Vial + Diluent (IM, SC) (Human) ",L03AB05
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,Interferon Alfa 2B,Inj.:,"5 million IU/mL Vial + Diluent (IM, SC) (Human) ",L03AB05
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,IRRIGATING SOLUTIONS,Other irrigating solutions,Intraocular Irrigation Solution (Balanced salt solution),Intraocular:,"in 15 mL composed of:
Sodium chloride = 0.64%
Potassium chloride = 0.075%
Calcium chloride = 0.048%
Magnesium chloride hexahydrate = 0.03%
Sodium acetate = 0.39%
Sodium citrate = 0.17%
Water for injection to make 100% ",B05CX10
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,IRRIGATING SOLUTIONS,Other irrigating solutions,Intraocular Irrigation Solution (Balanced salt solution),Intraocular:,"in 250 mL composed of:
Sodium chloride = 0.64%
Potassium chloride = 0.075%
Calcium chloride = 0.048%
Magnesium chloride hexahydrate = 0.03%
Sodium acetate = 0.39%
Sodium citrate = 0.17%
Water for injection to make 100% ",B05CX10
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,IRRIGATING SOLUTIONS,Other irrigating solutions,Intraocular Irrigation Solution (Balanced salt solution),Intraocular:,"in 500 mL composed of:
Sodium chloride = 0.64%
Potassium chloride = 0.075%
Calcium chloride = 0.048%
Magnesium chloride hexahydrate = 0.03%
Sodium acetate = 0.39%
Sodium citrate = 0.17%
Water for injection to make 100% ",B05CX10
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,THYROID PREPARATIONS,ANTITHYROID PREPARATIONS,Iodine,Topical:,1% Tincture ,H03C
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,THYROID PREPARATIONS,ANTITHYROID PREPARATIONS,Iodine,Topical:,2% Tincture ,H03C
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,THYROID PREPARATIONS,ANTITHYROID PREPARATIONS,Iodine,Topical:,2% Solution ,H03C
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,THYROID PREPARATIONS,ANTITHYROID PREPARATIONS,Iodine,Topical:,5% Solution ,H03C
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,THYROID PREPARATIONS,ANTITHYROID PREPARATIONS,Iodine + Potassium iodide (Lugol's Solution),Oral:,"5% + 10% Solution in 30 mL (Aqueous iodine solution, total iodine = 130 mg/mL) ",H03C
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iodixanol,Inj.:,652 mg/mL (equiv. to 320 mg iodine) Solution in 50 mL Vial ,V08AB09
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iodixanol,Inj.:,652 mg/mL (equiv. to 320 mg iodine) Solution in 100 mL Vial ,V08AB09
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iodixanol,Inj.:,550 mg/mL (equiv. to 270 mg iodine) Solution in 50 mL Vial ,V08AB09
Not available,Not available,Not available,Not available,Iodized Oil Fluid,Oral:,500 mg (equiv. to 200 mg elemental iodine) Softgel capsule (Only for DOH program) ,Not available
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iohexol,Inj.:,300 mg iodine/mL in 50 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB02
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iohexol,Inj.:,300 mg iodine/mL in 100 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB02
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iohexol,Inj.:,350 mg iodine/mL in 50 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB02
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iohexol,Inj.:,350 mg iodine/mL in 100 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB02
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iopamidol,Inj.:,612 mg/mL (equiv. to 300 mg iodine) in 50 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB04
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iopamidol,Inj.:,612 mg/mL (equiv. to 300 mg iodine) in 100 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB04
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iopamidol,Inj.:,755 mg/mL (equiv. to 370 mg iodine) in 50 mL Vial/bottle (Intravascular and other parenteral routes as appropriate) ,V08AB04
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iopamidol,Inj.:,755 mg/mL (equiv. to 370 mg iodine) in 100 mL Vial/bottle (Intravascular and other parenteral routes as appropriate) ,V08AB04
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iopromide,Inj.:,300 mg/mL (equiv. to 623 mg iodine) in 50 mL Vial ,V08AB05
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iopromide,Inj.:,300 mg/mL (equiv. to 623 mg iodine) in 100 mL Vial ,V08AB05
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iopromide,Inj.:,370 mg/mL (equiv. to 769 mg iodine) in 50 mL Vial ,V08AB05
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Iopromide,Inj.:,370 mg/mL (equiv. to 769 mg iodine) in 100 mL Vial ,V08AB05
VARIOUS,DIAGNOSTIC RADIOPHARMACEUTICALS,RENAL SYSTEM,Other renal system diagnostic radiopharmaceuticals,Iothalamate,Inj.:,600 mg /mL (as Meglumine) in 30 mL Vial (Usually IV) ,V09CX03
VARIOUS,DIAGNOSTIC RADIOPHARMACEUTICALS,RENAL SYSTEM,Other renal system diagnostic radiopharmaceuticals,Iothalamate,Inj.:,600 mg /mL (as Meglumine) in 50 mL Vial (Usually IV) ,V09CX03
VARIOUS,DIAGNOSTIC RADIOPHARMACEUTICALS,RENAL SYSTEM,Other renal system diagnostic radiopharmaceuticals,Iothalamate,Inj.:,600 mg /mL (as Meglumine) in 100 mL Vial (Usually IV) ,V09CX03
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Ioversol,Inj.:,636 mg/mL (equiv. to 300 mg/mL iodine) in 50 mL Vial ,V08AB07
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Ioversol,Inj.:,636 mg/mL (equiv. to 300 mg/mL iodine) in 100 mL Vial ,V08AB07
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Ioversol,Inj.:,741 mg/mL (equiv. to 350 mg/mL iodine) in 50 mL Vial ,V08AB07
VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media",Ioversol,Inj.:,741 mg/mL (equiv. to 350 mg/mL iodine) in 100 mL Vial ,V08AB07
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Anticholinergics,Ipratropium,Inhalation:,"20 mcg/dose (as Bromide) x 200 doses, MDI *Primary Health Care",R03BB01
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Anticholinergics,Ipratropium,Inhalation:,250 mcg/mL (as Bromide) Respiratory solution in 2 mL Unit dose (For nebulization) *Primary Health Care,R03BB01
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids,Ipratropium + Fenoterol,Inhalation:,"20 mcg (as Bromide) + 50 mcg (as Hydrobromide) x 10 mL doses, MDI ",R03AL01
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids,Ipratropium + Salbutamol,Inhalation:,"20 mcg (as Bromide) + 100 mcg x 200 doses, in 10 mL MDI *Primary Health Care",R03AL02
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids,Ipratropium + Salbutamol,Inhalation:,500 mcg (as Bromide anhydrous) + 2.5 mg (as Base) in 2.5 mL Unit dose (For nebulization) *Primary Health Care,R03AL02
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN","Angiotensin II receptor blockers (ARBs), plain",Irbesartan,Oral:,150 mg Tablet ,C09CA04
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN","Angiotensin II receptor blockers (ARBs), plain",Irbesartan,Oral:,300 mg Tablet ,C09CA04
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS","Angiotensin II receptor blockers (ARBs), other combinations",Irbesartan + Hydrochlorothiazide,Oral:,150 mg + 12.5 mg Tablet ,C09DX07
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Topoisomerase 1 (TOP1) inhibitors,Irinotecan,Inj.:,40 mg/2 mL (as Hydrochloride) Vial (IV infusion) ,L01CE02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Topoisomerase 1 (TOP1) inhibitors,Irinotecan,Inj.:,100 mg/5 mL (as Hydrochloride) Vial (IV infusion) ,L01CE02
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,IRON PREPARATIONS,Iron in other combinations,Iron sucrose,Inj.:,20 mg/mL in 5 mL Ampul ,B03AE04
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Halogenated hydrocarbons,Isoflurane,Inhalation:,in 100 mL Bottle ,N01AB06
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Halogenated hydrocarbons,Isoflurane,Inhalation:,in 250 mL Bottle ,N01AB06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Hydrazides,Isoniazid,Oral:,300 mg Tablet *Primary Health Care,J04AC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Hydrazides,Isoniazid,Oral:,400 mg Tablet *Primary Health Care,J04AC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Hydrazides,Isoniazid,Oral:,200 mg/5 mL Syrup in 120 mL *Primary Health Care,J04AC01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Combinations of drugs for treatment of tuberculosis,Isoniazid + Rifampicin,Oral:,50 mg + 75 mg Dispersible tablet (Fixed dose combination) (Pediatric) ,J04AM05
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Combinations of drugs for treatment of tuberculosis,Isoniazid + Rifampicin,Oral:,75 mg + 150 mg Tablet *Primary Health Care,J04AM05
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Combinations of drugs for treatment of tuberculosis,Isoniazid + Rifampicin + Ethambutol,Oral:,75 mg + 150 mg + 275 mg Tablet *Primary Health Care,J04AM06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Combinations of drugs for treatment of tuberculosis,Isoniazid + Rifampicin + Pyrazinamide,Oral:,50 mg + 75 mg + 150 mg Dispersible tablet (Fixed dose combination) (Pediatric) ,J04AM06
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Combinations of drugs for treatment of tuberculosis,Isoniazid + Rifampicin + Pyrazinamide + Ethambutol,Oral:,75 mg + 150 mg + 400 mg + 275 mg Tablet *Primary Health Care,J04AM06
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, fast-acting",Isophane Insulin Human,Inj.:,100 IU/mL in 3 mL Pre-filled syringe (SC) (Recombinant DNA) *Primary Health Care,A10AB30
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, fast-acting",Isophane Insulin Human,Inj.:,100 IU/mL in 5 mL Vial (SC) (Recombinant DNA) *Primary Health Care,A10AB30
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, fast-acting",Isophane Insulin Human,Inj.:,100 IU/mL in 10 mL Vial (SC) (Recombinant DNA) *Primary Health Care,A10AB30
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Isosorbide,Oral:,10 mg (as Dinitrate) Tablet *Primary Health Care,C01DA08
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Isosorbide,Oral:,20 mg (as Dinitrate) Tablet *Primary Health Care,C01DA08
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Isosorbide,Oral:,20 mg (as Dinitrate) Modified Release (MR) tablet/Capsule *Primary Health Care,C01DA08
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Isosorbide,Sublingual:,5 mg (as Dinitrate) Sublingual (SL) tablet *Primary Health Care,C01DA08
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Isosorbide,Inj.:,1 mg/mL (as Dinitrate) in 10 mL Ampul (IV) ,C01DA08
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Isosorbide,Oral:,40 mg (as 5-Mononitrate) Tablet ,C01DA08
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Isosorbide,Oral:,30 mg (as 5-Mononitrate) Modified Release (MR) tablet/Capsule *Primary Health Care,C01DA08
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Organic nitrates,Isosorbide,Oral:,60 mg (as 5-Mononitrate) Modified Release (MR) tablet/Capsule *Primary Health Care,C01DA08
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions affecting the electrolyte balance,Isotonic electrolyte solution for IV infusion,Inj.:,"in 1 L composed of:
Sodium chloride = 6.80 g
Potassium chloride = 0.30 g
Calcium chloride dihydrate = 0.37 g
Magnesium chloride hexahydrate = 0.20 g
Sodium acetate trihydrate = 3.27 g
Malic acid = 0.67 g ",B05BB01
CARDIOVASCULAR SYSTEM,PERIPHERAL VASODILATORS,PERIPHERAL VASODILATORS,2-amino-1-phenylethanol derivatives,Isoxsuprine,Oral:,10 mg (as Hydrochloride) Tablet ,C04AA01
CARDIOVASCULAR SYSTEM,PERIPHERAL VASODILATORS,PERIPHERAL VASODILATORS,2-amino-1-phenylethanol derivatives,Isoxsuprine,Oral:,40 mg (as Hydrochloride) Tablet ,C04AA01
CARDIOVASCULAR SYSTEM,PERIPHERAL VASODILATORS,PERIPHERAL VASODILATORS,2-amino-1-phenylethanol derivatives,Isoxsuprine,Inj.:,"5 mg/mL (as Hydrochloride) in 2 mL Ampul (IM, IV infusion) ",C04AA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Triazole and tetrazole derivatives,Itraconazole,Oral:,100 mg Capsule ,J02AC02
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Avermectines,Ivermectin,Oral:,3 mg Tablet ,P02CF01
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Avermectines,Ivermectin,Oral:,6 mg Tablet ,P02CF01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Other aminoglycosides,Kanamycin,Inj.:,1 g (as Sulfate) Vial (IM) ,J01GB04
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Other general anesthetics,Ketamine,Inj.:,"50 mg/mL (as Hydrochloride) Vial (IM, IV) ",N01AX03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Imidazole derivatives,Ketoconazole,Topical:,2% (20 mg/g) Cream in 3.5 g Aluminum collapsible tube ,J02AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Imidazole derivatives,Ketoconazole,Topical:,2% (20 mg/g) Cream in 15 g Aluminum collapsible tube ,J02AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Imidazole derivatives,Ketoconazole,Topical:,2% (20 mg/g) Shampoo in 6 mL Foil sachet *Primary Health Care,J02AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Imidazole derivatives,Ketoconazole,Topical:,2% (20 mg/g) Shampoo in 10 mL Bottle *Primary Health Care,J02AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Imidazole derivatives,Ketoconazole,Topical:,2% (20 mg/g) Shampoo in 60 mL Bottle *Primary Health Care,J02AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Imidazole derivatives,Ketoconazole,Topical:,2% (20 mg/g) Shampoo in 100 mL Bottle *Primary Health Care,J02AB02 
MUSCULO-SKELETAL SYSTEM,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,"Antiinflammatory preparations, non-steroids for topical use",Ketoprofen,Oral:,100 mg Tablet ,M02AA10
MUSCULO-SKELETAL SYSTEM,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,"Antiinflammatory preparations, non-steroids for topical use",Ketoprofen,Inj.:,50 mg/mL in 2 mL Ampul (IM) ,M02AA10
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIINFLAMMATORY AGENTS,"Antiinflammatory agents, non-steroids",Ketorolac,Inj.:,"30 mg/mL (as Tromethamol) in 1 mL Ampul (IM, IV) ",S01BC05
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTION ADDITIVES,Electrolyte solutions,Lactated Ringer's solution (Ringer's Lactate),Inj.:,"in 500 mL Bottle/Bag (IV infusion) composed of:
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22 - 1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",B05XA30
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTION ADDITIVES,Electrolyte solutions,Lactated Ringer's solution (Ringer's Lactate),Inj.:,"in 1 L Bottle/Bag (IV infusion) composed of:
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22 - 1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",B05XA30
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Osmotically acting laxatives,Lactulose,Oral:,3.3 g/5 mL (3.35 g/5 mL) Syrup *Primary Health Care,A06AD11
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Osmotically acting laxatives,Lactulose,Oral:,3.3 g/5 mL (3.35 g/ 5 mL) Syrup in 120 mL *Primary Health Care,A06AD11 
Not Available,Not Available,Not Available,Not Available,Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,300 mg Tablet *Primary Health Care,Not Available
Not Available,Not Available,Not Available,Not Available,Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,600 mg Tablet *Primary Health Care,Not Available
Not Available,Not Available,Not Available,Not Available,Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,300 mg/5 mL Syrup in 60 mL *Primary Health Care,Not Available
Not Available,Not Available,Not Available,Not Available,Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,300 mg/5 mL Syrup in 120 mL *Primary Health Care,Not Available
Not Available,Not Available,Not Available,Not Available,Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,600 mg/5 mL Syrup in 60 mL ,Not Available
Not Available,Not Available,Not Available,Not Available,Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,600 mg/5 mL Syrup in 120 mL ,Not Available
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Lamivudine,Oral:,100 mg Tablet/Film-coated tablet ,J05AF05
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Lamivudine,Oral:,150 mg Tablet/Film-coated tablet ,J05AF05
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Lamivudine,Oral:,10 mg/mL Suspension in 240 mL Bottle ,J05AF05
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Lamivudine + Efavirenz + Tenofovir,Oral:,300 mg + 600 mg + 300 mg Tablet ,J05AR11
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Lamivudine + Tenofovir,Oral:,300 mg + 300 mg Tablet ,J05AR12
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Lamivudine + Zidovudine,Oral:,150 mg + 300 mg Tablet ,J05AR01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Lamivudine + Zidovudine + Nevirapine,Oral:,150 mg + 300 mg + 200 mg Tablet ,J05AR05
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Lamotrigine,Oral:,50 mg Tablet ,N03AX09
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Lamotrigine,Oral:,100 mg Tablet ,N03AX09
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS, DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Lansoprazole,Oral:,15 mg Capsule ,A02BC03
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS, DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Lansoprazole,Oral:,30 mg Capsule ,A02BC03
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS, DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Lansoprazole,Oral:,15 mg Modified Release (MR) tablet ,A02BC03
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS, DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Lansoprazole,Oral:,30 mg Modified Release (MR) tablet ,A02BC03
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Prostaglandin analogues,Latanoprost,Ophthalmic:,50 mcg/mL Solution in 2.5 mL (Eye drops) ,S01EE01
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Beta blocking agents,Latanoprost + Timolol,Ophthalmic:,50 mcg + 5 mcg/mL (as Maleate) Solution in 5 mL Bottle (Eye drops) ,S01ED51
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Aromatase inhibitors,Letrozole,Oral:,2.5 mg Tablet/Film-coated tablet ,L02BG04
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,ENDOCRINE THERAPY,Gonadotropin releasing hormone analogues,Leuprorelin,Inj.:,"3.75 mg/2 mL (as Acetate) Vial + Syringe (IM, SC) ",L02AE02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,ENDOCRINE THERAPY,Gonadotropin releasing hormone analogues,Leuprorelin,Inj.:,"1.88 mg (as Acetate) Single dose, Powder + Syringe (IM, SC) ",L02AE02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,ENDOCRINE THERAPY,Gonadotropin releasing hormone analogues,Leuprorelin,Inj.:,"3.75 mg (as Acetate) Single dose, Powder + Syringe (IM, SC) ",L02AE02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,ENDOCRINE THERAPY,Gonadotropin releasing hormone analogues,Leuprorelin,Inj.:,"11.25 mg (as Acetate) Depot solution Vial + Syringe (IM, SC) ",L02AE02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,ENDOCRINE THERAPY,Gonadotropin releasing hormone analogues,Leuprorelin,Inj.:,7.5 mg (as Acetate) Pre-filled syringe (SC) ,L02AE02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,ENDOCRINE THERAPY,Gonadotropin releasing hormone analogues,Leuprorelin,Inj.:,22.5 mg (as Acetate) Pre-filled syringe (SC) ,L02AE02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,ENDOCRINE THERAPY,Gonadotropin releasing hormone analogues,Leuprorelin,Inj.:,45 mg (as Acetate) Pre-filled syringe (SC) ,L02AE02
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Levetiracetam,Oral:,250 mg Film-coated tablet ,N03AX14 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Levetiracetam,Oral:,500 mg Film-coated tablet ,N03AX14 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Levetiracetam,Oral:,750 mg Film-coated tablet ,N03AX14 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Levetiracetam,Oral:,1 g Film-coated tablet ,N03AX14 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Levetiracetam,Inj.:,500 mg/5 mL (100 mg/mL) Solution in 5 mL Vial (IV infusion) (Concentrate) ,N03AX14 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Levetiracetam,Oral:,100 mg/mL Solution in 100 mL Bottle ,N03AX14 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Levetiracetam,Oral:,100 mg/mL Solution in 300 mL Bottle ,N03AX14 
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Levobupivacaine,Inj.:,5 mg/mL Solution in 10 mL Ampul ,N01BB10
NERVOUS SYSTEM,ANTI-PARKINSON DRUGS,DOPAMINERGIC AGENTS,Dopa and dopa derivatives,Levodopa + Carbidopa,Oral:,100 mg + 25 mg Tablet *Primary Health Care,N04BA02
NERVOUS SYSTEM,ANTI-PARKINSON DRUGS,DOPAMINERGIC AGENTS,Dopa and dopa derivatives,Levodopa + Carbidopa,Oral:,250 mg + 25 mg Tablet *Primary Health Care,N04BA02
NERVOUS SYSTEM,ANTI-PARKINSON DRUGS,DOPAMINERGIC AGENTS,Dopa and dopa derivatives,Levodopa + Carbidopa,Oral:,200 mg + 50 mg Extended Release (ER) tablet *Primary Health Care,N04BA02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Levofloxacin,Oral:,250 mg Tablet ,J01MA12 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Levofloxacin,Oral:,500 mg Tablet ,J01MA12 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Levofloxacin,Oral:,750 mg Tablet ,J01MA12 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Levofloxacin,Inj.:,5 mg/mL Solution in 100 mL Vial (IV infusion) ,J01MA12 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Levofloxacin,Inj.:,5 mg/mL Solution in 150 mL Vial (IV infusion) ,J01MA12 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Levofloxacin,Ophthalmic:,5 mg/mL (0.5% w/v) Solution (Eye drops) ,J01MA12 
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE`,Progestogens,Levonorgestrel,SC:,52 mg intrauterine (IUD) system,G03AC03
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE`,Progestogens,Levonorgestrel,SC:,75 mg subdermal implant,G03AC03
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,THYROID PREPARATIONS,Thyroid hormones,Levothyroxine,Oral:,50 mcg (as Sodium/anhydrous Sodium) Tablet *Primary Health Care,H03AA01
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,THYROID PREPARATIONS,Thyroid hormones,Levothyroxine,Oral:,100 mcg (as Sodium/anhydrous Sodium) Tablet *Primary Health Care,H03AA01
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,THYROID PREPARATIONS,Thyroid hormones,Levothyroxine,Oral:,150 mcg (as Sodium/anhydrous Sodium) Tablet *Primary Health Care,H03AA01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ib",Lidocaine,Inj.:,1% (as Hydrochloride) in 20 mL Ampul *Primary Health Care,C01BB01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ib",Lidocaine,Inj.:,"2% (20 mg/mL) (as Hydrochloride) in 2 mL Ampul/vial (IM, IV) ",C01BB01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ib",Lidocaine,Inj.:,"2% (20 mg/mL) (as Hydrochloride) in 5 mL Ampul/vial (IM, IV) ",C01BB01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ib",Lidocaine,Inj.:,"2% (20 mg/mL) (as Hydrochloride) in 20 mL Ampul/vial (IM, IV) ",C01BB01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ib",Lidocaine,Inj.:,"2% (20 mg/mL) (as Hydrochloride) in 50 mL Ampul/vial (IM, IV) ",C01BB01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ib",Lidocaine,Inj.:,"2% (as Hydrochloride) in 5 mL Vial (Epidural, local infiltration) *Primary Health Care",C01BB01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ib",Lidocaine,Inj.:,"2% (as Hydrochloride) in 50 mL Vial (Epidural, local infiltration) *Primary Health Care",C01BB01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ib",Lidocaine,Inj.:,2% (as Hydrochloride) in 1.8 mL Carpule + Epinephrine (local infiltration) *Primary Health Care,C01BB01
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ib",Lidocaine,Topical:,10% (as Hydrochloride) Solution in 50 mL Spray *Primary Health Care,C01BB01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Other antibacterials,Linezolid *Reserve antimicrobial,Oral:,600 mg Tablet/Film-coated tablet ,J01XX08
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Other antibacterials,Linezolid *Reserve antimicrobial,Inj.:,2 mg/mL (600 mg/300 mL) Solution for IV infusion ,J01XX08
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN","LIPID MODIFYING AGENTS, COMBINATIONS",Lipids,Inj.:,10% in 100 mL Bottle (IV infusion) ,C10BX 
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN","LIPID MODIFYING AGENTS, COMBINATIONS",Lipids,Inj.:,10% in 200 mL Bottle (IV infusion) ,C10BX 
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN","LIPID MODIFYING AGENTS, COMBINATIONS",Lipids,Inj.:,10% in 500 mL Bottle (IV infusion) ,C10BX 
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN","LIPID MODIFYING AGENTS, COMBINATIONS",Lipids,Inj.:,20% in 100 mL Bottle (IV infusion) ,C10BX 
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN","LIPID MODIFYING AGENTS, COMBINATIONS",Lipids,Inj.:,20% in 250 mL Bottle (IV infusion) ,C10BX 
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN","LIPID MODIFYING AGENTS, COMBINATIONS",Lipids,Inj.:,20% in 500 mL Bottle (IV infusion) ,C10BX 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Lithium,Lithium ,Oral:,450 mg (as Carbonate) Modified Release (MR) tablet *Primary Health Care,N05AN01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Poliomyelitis vaccines,Live Attenuated Bivalent Oral Polio Vaccine,Oral:,"2 mg 20 doses, in Vial (Types 1 and 3) *Primary Health Care",J07BF02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Measles vaccines,Live Attenuated Measles and Rubella (MR) Vaccine,Inj.:,"x 10 doses/vial, Multidose vial + 5 mL diluent (SC)(With vaccine vial monitor) ",J07BD53
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Measles vaccines,Live Attenuated Measles Vaccine,Inj.:,Monodose vial + 0.5 mL diluent (SC) *Primary Health Care,J07BD01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Measles vaccines,Live Attenuated Measles Vaccine,Inj.:,Multidose vial + 5 mL diluent (SC) *Primary Health Care,J07BD01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Measles vaccines,"Live Attenuated Measles, Mumps and Rubella (MMR) Vaccine",Inj.:,Monodose vial + 0.5 mL diluent (SC) *Primary Health Care,J07BD52
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Measles vaccines,"Live Attenuated Measles, Mumps and Rubella (MMR) Vaccine",Inj.:,Multidose vial + 5 mL diluent (SC) *Primary Health Care,J07BD52
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Mumps vaccines,Live Attenuated Mumps Vaccine,Inj.:,Monodose vial + 0.5 mL diluent (SC) ,J07BE01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Rubella vaccines,Live Attenuated Rubella Vaccine,Inj.:,Monodose vial + 0.5 mL diluent (SC) ,J07BJ01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Rubella vaccines,Live Attenuated Rubella Vaccine,Inj.:,Multidose vial + 5 mL diluent (SC) ,J07BJ01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Varicella zoster vaccines,Live Attenuated Varicella Vaccine,Inj.:,Not less than 2000 PFU Freeze-dried powder Monodose vial + 0.5 mL water for injection ampule) (SC only)(OKA strain varicella zoster virus) ,J07BK01
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",ANTIPROPULSIVES,Antipropulsives,Loperamide,Oral:,2 mg (as Hydrochloride) Capsule (N.B.: Not for infants and children less than 12 years old) *Primary Health Care,A07DA03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Lopinavir + Ritonavir,Oral:,200 mg + 50 mg Tablet/Capsule ,J05AR10 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Lopinavir + Ritonavir,Oral:,40 mg + 10 mg Oral pellets contained in capsule ,J05AR10 
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Other antihistamines for systemic use,Loratadine,Oral:,10 mg Tablet/Film-coated tablet *Primary Health Care,R06AX13
RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Other antihistamines for systemic use,Loratadine,Oral:,5 mg/5 mL Syrup in 30 mL *Primary Health Care,R06AX13
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN","Angiotensin II receptor blockers (ARBs), plain",Losartan,Oral:,50 mg (as Potassium) Tablet *Primary Health Care,C09CA01
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN","Angiotensin II receptor blockers (ARBs), plain",Losartan,Oral:,100 mg (as Potassium) Tablet *Primary Health Care,C09CA01
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",Angiotensin II receptor blockers (ARBs) and diuretics,Losartan + Hydrochlorothiazide,Oral:,50 mg + 12.5 mg Tablet *Primary Health Care,C09DA01
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,Progestogens,Lynestrenol,Oral:,500 mcg Tablet ,G03AC02
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Magnesium,Magnesium Sulfate,Inj.:,"250 mg/mL (as Heptahydrate) in 2 mL Ampul (IM, IV) *Primary Health Care",A12CC02 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Magnesium,Magnesium Sulfate,Inj.:,"250 mg/mL (as Heptahydrate) in 10 mL Ampul (IM, IV) *Primary Health Care",A12CC02 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Magnesium,Magnesium Sulfate,Inj.:,250 mg/mL (as Heptahydrate) in 10 mL Vial (IV) ,A12CC02 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Magnesium,Magnesium Sulfate,Inj.:,250 mg/mL (as Heptahydrate) in 20 mL Vial (IV) *Primary Health Care,A12CC02 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Magnesium,Magnesium Sulfate,Inj.:,250 mg/mL (as Heptahydrate) in 50 mL Vial (IV) ,A12CC02 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Magnesium,Magnesium Sulfate,Inj.:,"500 mg/mL (as Heptahydrate) in 2 mL Ampul (IM, IV) *Primary Health Care",A12CC02 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Magnesium,Magnesium Sulfate,Inj.:,"500 mg/mL (as Heptahydrate) in 10 mL Ampul (IM, IV) *Primary Health Care",A12CC02 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions producing osmotic diuresis,Mannitol,Inj.:,20% in 250 mL Bottle (IV) ,B05BC01 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions producing osmotic diuresis,Mannitol,Inj.:,20% in 500 mL Bottle (IV) ,B05BC01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Benzimidazole derivatives,Mebendazole,Oral:,100 mg Tablet /Capsule *Primary Health Care,P02CA01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Benzimidazole derivatives,Mebendazole,Oral:,500 mg Tablet /Chewable tablet *Primary Health Care,P02CA01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Benzimidazole derivatives,Mebendazole,Oral:,50 mg/mL Suspension in 10 mL ,P02CA01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Benzimidazole derivatives,Mebendazole,Oral:,100 mg/mL Suspension in 30 mL ,P02CA01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTINEMATODAL AGENTS,Benzimidazole derivatives,Mebendazole,Oral:,100 mg/mL Suspension in 60 mL ,P02CA01 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,"Synthetic anticholinergics, esters with tertiary amino group",Mebeverine,Oral:,100 mg (as Hydrochloride) Tablet ,A03AA04 
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,VITAMIN B12 AND FOLIC ACID,Vitamin B12 (cyanocobalamin and analogues),Mecobalamin,Oral:,500 mcg Tablet ,B03BA05 
BLOOD AND BLOOD FORMING ORGANS,ANTIANEMIC PREPARATIONS,VITAMIN B12 AND FOLIC ACID,Vitamin B12 (cyanocobalamin and analogues),Mecobalamin,Inj.:,"500 mcg/mL in 1 mL Ampul (IM, IV) ",B03BA05 
GENITO URINARY SYSTEM AND SEX HORMONES, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,Progestogens,Medroxyprogesterone,Oral:,5 mg (as Acetate) Tablet ,G03AC06 
GENITO URINARY SYSTEM AND SEX HORMONES, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,Progestogens,Medroxyprogesterone,Oral:,10 mg (as Acetate) Tablet ,G03AC06 
GENITO URINARY SYSTEM AND SEX HORMONES, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,Progestogens,Medroxyprogesterone,Inj.:,50 mg/mL (as Acetate) in 3 mL Vial with syringe (IM)(N.B.: Use 1 inch long needle) *Primary Health Care,G03AC06 
GENITO URINARY SYSTEM AND SEX HORMONES, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,Progestogens,Medroxyprogesterone,Inj.:,150 mg/mL (as Enanthate/Acetate) in 1 mL Vial ,G03AC06 
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Fenamates,Mefenamic Acid,Oral:,250 mg Tablet /Capsule *Primary Health Care,M01AG01 
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Fenamates,Mefenamic Acid,Oral:,500 mg Tablet /Capsule *Primary Health Care,M01AG01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Methanolquinolines,Mefloquine,Oral:,250 mg (as Hydrochloride) Tablet ,P01BC02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Progestogens,Megestrol,Oral:,40 mg (as Acetate) Tablet ,L02AB01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONES AND RELATED AGENTS,Progestogens,Megestrol,Oral:,160 mg (as Acetate) Tablet ,L02AB01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues,Melphalan,Oral:,2 mg Tablet ,L01AA03 
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTI-DEMENTIA DRUGS,Other anti-dementia drugs,Memantine,Oral:,5 mg Film-coated tablet ,N06DX01
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTI-DEMENTIA DRUGS,Other anti-dementia drugs,Memantine,Oral:,10 mg Film-coated tablet ,N06DX01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Meningococcal vaccines,Meningococcal polysaccharide (Neisseria meningitidis) Vaccine,Inj.:,"50 mcg/0.5 mL x 10 doses, Lyophilized powder Multidose vial + 5 mL diluent  (IM, SC)(Group A + C) *Primary Health Care",J07AH02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Meningococcal vaccines,Meningococcal polysaccharide (Neisseria meningitidis) Vaccine,Inj.:,"50 mcg/0.5 mL Lyophilized powder Single dose vial + 0.5 mL diluent  (IM, SC)(Group A + C) *Primary Health Care",J07AH02
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Meningococcal vaccines,Meningococcal polysaccharide (Neisseria meningitidis) Vaccine,Inj.:,"50 mcg/0.5 mL x 10 doses, Lyophilized powder Multidose vial + Diluent (IM, SC)(Serogroup A + Serogroup B + Serogroup Wl35 + Serogroup Y) *Primary Health Care",J07AH02
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Purine analogues,Mercaptopurine,Oral:,50 mg Tablet ,L01BB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Carbapenems,Meropenem *Reserve antimicrobial,Inj.:,500 mg (as Trihydrate) Powder Vial (IV) ,J01DH02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER BETA-LACTAM ANTIBACTERIALS,Carbapenems,Meropenem *Reserve antimicrobial,Inj.:,1 g (as Trihydrate) Powder Vial (IV) ,J01DH02
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFLAMMATORY AGENTS,Aminosalicylic acid and similar agents,Mesalazine,Oral:,500 mg Enteric-coated tablet ,A07EC02 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFLAMMATORY AGENTS,Aminosalicylic acid and similar agents,Mesalazine,Oral:,500 mg Enteric Modified Release (MR) tablet ,A07EC02 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFLAMMATORY AGENTS,Aminosalicylic acid and similar agents,Mesalazine,Rectal:,250 mg Suppository ,A07EC02 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFLAMMATORY AGENTS,Aminosalicylic acid and similar agents,Mesalazine,,Gastro-resistant Prolonged Release (PR) granules in 1.5 g Sachet ,A07EC02 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFLAMMATORY AGENTS,Aminosalicylic acid and similar agents,Mesalazine,Oral:,1 g Prolonged release tablet ,A07EC02 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFLAMMATORY AGENTS,Aminosalicylic acid and similar agents,Mesalazine,Oral:,2 g Prolonged release tablet ,A07EC02 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFLAMMATORY AGENTS,Aminosalicylic acid and similar agents,Mesalazine,Oral:,1 g Suppository ,A07EC02 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Detoxifying agents for antineoplastic treatment,Mesna (Sodium-2-mercaptoethanesulphonate),Inj.:,100 mg /mL in 4 mL Ampul (IV) ,V03AF01 
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Biguanides,Metformin,Oral:,500 mg (as Hydrochloride) Tablet/Film-coated tablet *Primary Health Care,A10BA02 
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Biguanides,Metformin,Oral:,850 mg (as Hydrochloride) Tablet *Primary Health Care,A10BA02 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,ANTITHYROID PREPARATIONS,Sulfur-containing imidazole derivatives,Methimazole/Thiamazole,Oral:,5 mg Tablet *Primary Health Care,H03BB02 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,ANTITHYROID PREPARATIONS,Sulfur-containing imidazole derivatives,Methimazole/Thiamazole,Oral:,10 mg Tablet *Primary Health Care,H03BB02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,Methotrexate,Oral:,2.5 mg (as Base/Sodium/Disodium) Tablet ,L01BA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,Methotrexate,Inj.:,"5 mg/mL (as Sodium) in 3 mL Vial (IM, IV) ",L01BA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,Methotrexate,Inj.:,"25 mg/mL (as Base) in 2 mL Ampul/Vial (IM, IV, Intrathecal) ",L01BA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,Methotrexate,Inj.:,"25 mg/mL (as Sodium) in 2 mL Vial (IM, IV, Intrathecal)(Preservative free) ",L01BA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,Methotrexate,Inj.:,"25 mg/mL (as Sodium) in 20 mL Vial (IM, IV, Intrathecal)(Preservative free) ",L01BA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,Methotrexate,Inj.:,100 mg/mL (as Base) in 10 mL Vial ,L01BA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Folic acid analogues,Methotrexate,Inj.:,"100 mg/mL (as Sodium) in 10 mL Vial (IM, IV, Intrathecal)(Preservative free) ",L01BA01 
CARDIOVASCULAR SYSTEM,ANTIHYPERTENSIVES,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",Methyldopa,Methyldopa,Oral:,250 mg Tablet *Primary Health Care,C02AB01 
VARIOUS,DIAGNOSTIC AGENTS,OTHER DIAGNOSTIC AGENTS,Tests for gastric secretion,Methylene Blue,Oral:,1% Solution ,V04CG05 
VARIOUS,DIAGNOSTIC AGENTS,OTHER DIAGNOSTIC AGENTS,Tests for gastric secretion,Methylene Blue,Inj.:,10 mg/ mL in 1 mL Ampul/Vial ,V04CG05 
VARIOUS,DIAGNOSTIC AGENTS,OTHER DIAGNOSTIC AGENTS,Tests for gastric secretion,Methylene Blue,Inj.:,10 mg/ mL in 10 mL Ampul/Vial ,V04CG05 
GENITO URINARY SYSTEM AND SEX HORMONES,OTHER GYNECOLOGICALS,UTEROTONICS,Ergot alkaloids,Methylergometrine/Methylergonovine,Inj.:,200 mcg/ mL (as Hydrogen maleate/Maleate) in 1 mL Ampul ,G02AB01 
NERVOUS SYSTEM,PSYCHOANALEPTICS,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",Centrally acting sympathomimetics,Methylphenidate,Oral:,10 mg Tablet ,N06BA04 
NERVOUS SYSTEM,PSYCHOANALEPTICS,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",Centrally acting sympathomimetics,Methylphenidate,Oral:,18 mg Modified Release (MR) tablet ,N06BA04 
NERVOUS SYSTEM,PSYCHOANALEPTICS,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",Centrally acting sympathomimetics,Methylphenidate,Oral:,27 mg Modified Release (MR) tablet ,N06BA04 
NERVOUS SYSTEM,PSYCHOANALEPTICS,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",Centrally acting sympathomimetics,Methylphenidate,Oral:,36 mg Modified Release (MR) tablet ,N06BA04 
NERVOUS SYSTEM,PSYCHOANALEPTICS,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",Centrally acting sympathomimetics,Methylphenidate,Oral:,20 mg Modified Release (MR) capsule ,N06BA04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Oral:,4mg Tablet *Primary Health Care,H02AB04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Oral:,16 mg Tablet *Primary Health Care,H02AB04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Inj.:,"125 mg/mL (as Sodium succinate) Powder in 2 mL Vial + Diluent (IM, IV, IV infusion) ",H02AB04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Inj.:,"40 mg (as Sodium succinate) Solution for injection Single dose vial (IM, IV) ",H02AB04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Inj.:,"500 mg (as Sodium succinate) in 7.7 mL Vial + Diluent (IM, IV, IV infusion) ",H02AB04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Inj.:,"1 g/16 mL (as Sodium succinate) Vial + Diluent (IM, IV, IV infusion) ",H02AB04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Inj.:,"125 mg (as Sodium succinate) Lyophilized powder Vial (IM, IV) ",H02AB04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Inj.:,"500 mg (as Sodium succinate) Lyophilized powder Vial (IM, IV) ",H02AB04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Inj.:,"1 g (as Sodium succinate) Lyophilized powder Vial (IM, IV) ",H02AB04 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Methylprednisolone,Inj.:,"500 mg/8 mL (as Sodium succinate) Powder Vial + Diluent (IM, IV, IV infusion) ",H02AB04 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,PROPULSIVES,Propulsives,Metoclopramide,Inj.:,10 mg (as Hydrochloride) Tablet *Primary Health Care,A03FA01 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,PROPULSIVES,Propulsives,Metoclopramide,Inj.:,5 mg/5 mL (as Base /Hydrochloride) Syrup in 60 mL *Primary Health Care,A03FA01 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,PROPULSIVES,Propulsives,Metoclopramide,Inj.:,"5 mg/mL (as Base /Hydrochloride) in 2 mL Ampul (IM, IV) ",A03FA01 
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Metoprolol,Oral:,50 mg (as Tartrate) Tablet *Primary Health Care,C07AB02 
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, selective",Metoprolol,Oral:,100 mg (as Tartrate) Tablet *Primary Health Care,C07AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Imidazole derivatives,Metronidazole,Oral:,250 mg Tablet *Primary Health Care,J01XD01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Imidazole derivatives,Metronidazole,Oral:,500 mg Tablet *Primary Health Care,J01XD01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Imidazole derivatives,Metronidazole,Oral:,125 mg/5 mL (as Base) Suspension in 60 mL *Primary Health Care,J01XD01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Imidazole derivatives,Metronidazole,Oral:,200 mg/5 mL (as Benzoate) Suspension in 60 mL *Primary Health Care,J01XD01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Imidazole derivatives,Metronidazole,Inj.:,5 mg/mL in 100 mL Vial (IV infusion) ,J01XD01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Other antimycotics for systemic use,Micafungin *Reserve antimicrobial,Inj.:,50 mg Lyophilized powder for infusion (IV infusion) ,J02AX05 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFECTIVES, Imidazole derivatives,Miconazole,Topical:,20 mg Oral gel in 3.5 g Aluminum collapsible tube ,A07AC01 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFECTIVES, Imidazole derivatives,Miconazole,Topical:,2% (20 mg/g) Cream in 5 g Aluminum collapsible tube ,A07AC01 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFECTIVES, Imidazole derivatives,Miconazole,Vaginal:,"1.2 g x 1, Suppository Casing strip ",A07AC01 
ALIMENTARY TRACT AND METABOLISM,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,Enzymes,Micronutrient Powder,,"in 1 g Sachet composed of:
Vitamin A = 400 ug RE
Vitamin C = 30 mg
Vitamin D = 5 ug
Vitamin E = 5 mg a-TE
Vitamin B1 = 0.5 mg
Vitamin B2 = 0.5 mg
Vitamin B6 = 0.5 mg
Vitamin B12 = 0.9 ug
Folic acid = 150 ug
Niacin = 6 mg
Iron = 10 mg
Zinc = 4.1 mg
Copper = 0.56 mg
Iodine = 90 ug S
Elenium = 17 ug *Primary Health Care",A16AB02 
NERVOUS SYSTEM,PSYCHOLEPTICS,HYPNOTICS AND SEDATIVES,Benzodiazepine derivatives,Midazolam,Inj.:,15 mg Tablet ,N05CD08
NERVOUS SYSTEM,PSYCHOLEPTICS,HYPNOTICS AND SEDATIVES,Benzodiazepine derivatives,Midazolam,Inj.:,"1 mg/mL in 5 mL Ampul (IM, IV) ",N05CD08
NERVOUS SYSTEM,PSYCHOLEPTICS,HYPNOTICS AND SEDATIVES,Benzodiazepine derivatives,Midazolam,Inj.:,"5 mg/mL in 1 mL Ampul (IM, IV) ",N05CD08
NERVOUS SYSTEM,PSYCHOLEPTICS,HYPNOTICS AND SEDATIVES,Benzodiazepine derivatives,Midazolam,Inj.:,"5 mg/mL in 2 mL Ampul (IM, IV) ",N05CD08
NERVOUS SYSTEM,PSYCHOLEPTICS,HYPNOTICS AND SEDATIVES,Benzodiazepine derivatives,Midazolam,Inj.:,"5 mg/mL in 3 mL Ampul (IM, IV) ",N05CD08
NERVOUS SYSTEM,PSYCHOLEPTICS,HYPNOTICS AND SEDATIVES,Benzodiazepine derivatives,Midazolam,Inj.:,"5 mg/mL in 5 mL Ampul (IM, IV) ",N05CD08
NERVOUS SYSTEM,PSYCHOLEPTICS,HYPNOTICS AND SEDATIVES,Benzodiazepine derivatives,Midazolam,Inj.:,"5 mg/mL in 10 mL Ampul (IM, IV) ",N05CD08
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,Mitoxantrone,Inj.:,2mg/ mL Solution in 5 mL ,L01DB07 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances,Mitoxantrone,Inj.:,2mg/ mL Solution in 10 mL ,L01DB07 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,Modified Fluid Gelatin (polymerisate of degraded succinylated gelatin),Inj.:,3% Solution in 500 mL Bottle (IV infusion) ,B05AA06
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,BLOOD AND RELATED PRODUCTS,Blood substitutes and plasma protein fractions,Modified Fluid Gelatin (polymerisate of degraded succinylated gelatin),Inj.:,4% Solution in 500 mL Bottle (IV infusion) ,B05AA06
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTION ADDITIVES,Electrolyte solutions,Monobasic potassium phosphate + Dibasic potassium phosphate (Potassium Phosphate),Inj.:,"224 mg (equiv. to 3 mmol phosphorus and 4.4 mEq K) + 236 mg (as anhydrous) per mL, in 5 mL Vial (IV) ",B05XA06
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Osmotically acting laxatives,Monobasic/Dibasic Sodium Phosphate,Oral:,48g/ 18g  Solution in 45 mL Bottle ,A06AD17 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Osmotically acting laxatives,Monobasic/Dibasic Sodium Phosphate,Rectal:,19g/ 7g Solution in 66 mL Bottle (Enema) ,A06AD17 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Osmotically acting laxatives,Monobasic/Dibasic Sodium Phosphate,Rectal:,19g/ 7g Solution in 133 mL Bottle (Enema) ,A06AD17 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Leukotriene receptor antagonists,Montelukast,Oral:,4 mg (as Sodium) Granules Sachet *Primary Health Care,R03DC03 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Leukotriene receptor antagonists,Montelukast,Oral:,4 mg (as Sodium) Chewable tablet *Primary Health Care,R03DC03 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Leukotriene receptor antagonists,Montelukast,Oral:,5 mg (as Sodium) Chewable tablet *Primary Health Care,R03DC03 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Leukotriene receptor antagonists,Montelukast,Oral:,10 mg (as Sodium) Tablet *Primary Health Care,R03DC03 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Morphine,Oral:,10 mg (as Sulfate) Tablet/Capsule ,N02AA01 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Morphine,Oral:,20 mg (as Sulfate) Tablet/Capsule ,N02AA01 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Morphine,Oral:,30 mg (as Sulfate) Tablet/Capsule ,N02AA01 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Morphine,Oral:,10 mg (as Sulfate) Modified Release (MR) tablet ,N02AA01 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Morphine,Oral:,30 mg (as Sulfate) Modified Release (MR) tablet ,N02AA01 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Morphine,Oral:,60 mg (as Sulfate) Modified Release (MR) tablet ,N02AA01 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Morphine,Inj.:,"10 mg/mL (as Sulfate) in 1 mL Ampul (IM, IV, SC) ",N02AA01 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Morphine,Inj.:,"16 mg/mL (as Sulfate) in 1 mL Ampul (IM, IV) ",N02AA01 
ANTIINFECTIVES FOR SYSTEMIC USE, ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Moxifloxacin,Oral:,400 mg Film-coated tablet ,J01MA14 
ANTIINFECTIVES FOR SYSTEMIC USE, ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Moxifloxacin,Ophthalmic:,5 mg/mL (0.5% w/v) (as Hydrochloride) Sterile Ophthalmic Solution in 5 mL ,J01MA14 
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"MULTIVITAMINS, COMBINATIONS",Multivitamins with minerals,Multivitamins,Oral:,"per 1 mL, (Infants)(Drops) composed of:
Vitamin A = 325 - 380 mcg
Vitamin B1 = 0.2 - 0.4 mg
Vitamin B2 = 0.3 - 0.4 mg
Vitamin B6 = 0.3 - 0.6 mg
Vitamin B12 = 0.3 - 0.4 mcg
Vitamin C = 30 mg
Vitamin D = 200 - 400 IU (5 - 10 mcg)
Vitamin E = 3 - 4 mg
Folic acid = 20 - 65 mcg
Niacin = 1 - 5 mg *Primary Health Care",A11AB
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"MULTIVITAMINS, COMBINATIONS",Multivitamins with minerals,Multivitamins,Oral:,"per 5 mL, (Children)(Syrup) composed of:
Vitamin A = 350 - 400 mcg
Vitamin B1 = 0.5 - 1.0 mg
Vitamin B2 = 0.7 - 0.9 mg
Vitamin B6 = 0.9 - 1.6 mg
Vitamin B12 = 0.9 - 3.0 mcg
Vitamin C = 35 - 55 mg
Vitamin D = 200 - 400 IU (5 - 10 mcg)
Vitamin E = 5 - 7 mg
Folic acid = 40 - 300 mcg
Niacin = 5 - 18 mg *Primary Health Care",A11AB
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"MULTIVITAMINS, COMBINATIONS",Multivitamins with minerals,Multivitamins,Oral:,"Tablet/Capsule (Adult) composed of:
Vitamin A = 600 - 700 mcg (2000 - 2500 IU)
Vitamin B1 = 1.3 - 1.7 mg
Vitamin B2 = 0.7 - 1.3 mg
Vitamin B6 = 1.6 - 2.0 mg
Vitamin B12 = 2.0 - 6.0 mcg
Vitamin C = 60 - 80 mg
Vitamin D =  400 IU (10 mcg)
Vitamin E = 6 - 10 mg (15 - 30 IU)
Folic acid = 400 mcg
Niacin = 13 - 23 mg *Primary Health Care",A11AB
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,ANTIBIOTICS FOR TOPICAL USE,Other antibiotics for topical use,Mupirocin,Topical:,2% Cream in 5 g Sachet *Primary Health Care,D06AX09 
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,ANTIBIOTICS FOR TOPICAL USE,Other antibiotics for topical use,Mupirocin,Topical:,2% Cream in 15 g Tube *Primary Health Care,D06AX09 
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,ANTIBIOTICS FOR TOPICAL USE,Other antibiotics for topical use,Mupirocin,Topical:,2% Ointment in 5 g Tube *Primary Health Care,D06AX09 
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,ANTIBIOTICS FOR TOPICAL USE,Other antibiotics for topical use,Mupirocin,Topical:,2% Ointment in 15 g Tube *Primary Health Care,D06AX09 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,Mycophenolate Acid,Oral:,360 mg (as Mycophenolate Sodium) Tablet ,L04AA06 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants,Mycophenolate Mofetil,Oral:,500 mg Tablet ,L04AA 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,N-acetyl Penicillamine,Oral:,25 g/ bottle Crystal ,V03AB 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS, Morphinan derivatives,Nalbuphine,Inj.:,10 mg/mL (as Hydrochloride) in 1 mL Ampul ,N02AF02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Other quinolones,Nalidixic Acid,Oral:,500 mg Tablet ,J01MB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Other quinolones,Nalidixic Acid,Oral:,250 mg/5 mL Suspension in 60 mL ,J01MB02 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Peripheral opioid receptor antagonists,Naloxone,Inj.:,"400 mcg/mL (as Hydrochloride) in 1 mL Ampul (IM, IV, SC) ",A06AH04 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,DRUGS USED IN ADDICTIVE DISORDERS,Drugs used in alcohol dependence,Naltrexone,Oral:,50 mg (as Hydrochloride) Tablet ,N07BB04 
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Propionic acid derivatives,Naproxen,Oral:,250 mg (as Base) Tablet *Primary Health Care,M01AE02 
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Propionic acid derivatives,Naproxen,Oral:,275 mg (as Sodium) Tablet *Primary Health Care,M01AE02 
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Propionic acid derivatives,Naproxen,Oral:,500 mg (as Base) Tablet *Primary Health Care,M01AE02 
MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Propionic acid derivatives,Naproxen,Oral:,550 mg (as Sodium) Tablet *Primary Health Care,M01AE02 
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,ANTIBIOTICS FOR TOPICAL USE,Other antibiotics for topical use,Neomycin + Polymixin B + Fluocinolone Acetonide,Otic:,"3.5 mg (as Sulfate) + 10,000 units (as Sulfate) + 0.025% per mL, Otic drop solution in 5 mL *Primary Health Care",D06AX 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,PARASYMPATHOMIMETICS,Anticholinesterases,Neostigmine,Inj.:,500 mcg/mL in 10 mL Vial ,N07AA01
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,PARASYMPATHOMIMETICS,Anticholinesterases,Neostigmine,Inj.:,"500 mcg/mL Solution for injection in 1 mL Ampul (IM, IV, SC) ",N07AA01
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIINFLAMMATORY AGENTS,"Antiinflammatory agents, non-steroids",Nepafenac,Ophthalmic:,1 mg/mL Ophthalmic drop suspension in 5 mL ,S01BC10 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Non-nucleoside reverse transcriptase inhibitors,Nevirapine,Oral:,200 mg Tablet ,J05AG01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Non-nucleoside reverse transcriptase inhibitors,Nevirapine,Oral:,50 mg Dispersible tablet ,J05AG01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Non-nucleoside reverse transcriptase inhibitors,Nevirapine,Oral:,50 mg/5 mL Suspension in 240 mL ,J05AG01 
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,Dihydropyridine derivatives,Nicardipine,Inj.:,1 mg/mL (as Hydrochloride) in 2 mL Ampul (IV) *Primary Health Care,C08CA04
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,Dihydropyridine derivatives,Nicardipine,Inj.:,1 mg/mL (as Hydrochloride) in 10 mL Ampul (IV) *Primary Health Care,C08CA04
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,DRUGS USED IN ADDICTIVE DISORDERS,Drugs used in nicotine dependence,Nicotine,Oral:,1 mg Pastille *Primary Health Care,N07BA01 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,DRUGS USED IN ADDICTIVE DISORDERS,Drugs used in nicotine dependence,Nicotine,Oral:,2 mg Pastille *Primary Health Care,N07BA01 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,DRUGS USED IN ADDICTIVE DISORDERS,Drugs used in nicotine dependence,Nicotine,Oral:,1 mg Gum *Primary Health Care,N07BA01 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,DRUGS USED IN ADDICTIVE DISORDERS,Drugs used in nicotine dependence,Nicotine,Oral:,2 mg Gum *Primary Health Care,N07BA01 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,DRUGS USED IN ADDICTIVE DISORDERS,Drugs used in nicotine dependence,Nicotine transdermal therapeutic system,Patch:,7 mg Patch *Primary Health Care,N07BA01 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,DRUGS USED IN ADDICTIVE DISORDERS,Drugs used in nicotine dependence,Nicotine transdermal therapeutic system,Patch:,14 mg Patch *Primary Health Care,N07BA01 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,DRUGS USED IN ADDICTIVE DISORDERS,Drugs used in nicotine dependence,Nicotine transdermal therapeutic system,Patch:,21 mg Patch *Primary Health Care,N07BA01 
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,Dihydropyridine derivatives,Nifedipine,Oral:,10 mg Capsule (Restricted use for acute hypertensive emergencies in patients less than 18 years old with extreme caution due to rapid and prolonged fall in blood pressure) ,C08CA05 
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,Dihydropyridine derivatives,Nifedipine,Oral:,30 mg Modified Release (MR) tablet ,C08CA05 
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,Dihydropyridine derivatives,Nimodipine,Oral:,30 mg Tablet ,C08CA06 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Nitrofuran derivatives,Nitrofurantoin,Oral:,50 mg Capsule As Macrocrystals *Primary Health Care,J01XE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Nitrofuran derivatives,Nitrofurantoin,Oral:,100 mg Capsule As Macrocrystals *Primary Health Care,J01XE01
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Other general anesthetics,Nitrous Oxide,Inhalation:,Anesthetic gas ,N01AX13 
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Norepinephrine,Inj.:,1 mg/mL (as Bitartrate) in 2 mL Ampul (IV infusion) ,C01CA03
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Norepinephrine,Inj.:,1 mg/mL (as Bitartrate) in 4 mL Ampul (IV infusion) ,C01CA03
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Norepinephrine,Inj.:,1 mg/mL (as Bitartrate) Concentrate solution for IV infusion in 10 mL Ampul (IV infusion) ,C01CA03
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents,Norepinephrine,Inj.:,2 mg/mL (as Bitartrate) Solution for injection in 4 mL Ampul ,C01CA03
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,Progestogens,Norethisterone,Oral:,5 mg (as Acetate/Base) Tablet ,G03AC01
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR TOPICAL USE,Antibiotics,Nystatin,Oral:,"100,000 units/mL Suspension in 30 mL ",D01AA01 
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR TOPICAL USE,Antibiotics,Nystatin,Vaginal:,"100,000 units Tablet ",D01AA01 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,HYPOTHALAMIC HORMONES,Somatostatin and analogues,Octreotide,Inj.:,100 mcg/mL (as Acetate) in 1 mL Ampul (IV infusion) ,H01CB02 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,HYPOTHALAMIC HORMONES,Somatostatin and analogues,Octreotide,Inj.:,500 mcg/mL (as Acetate) in 1 mL Ampul (IV infusion) ,H01CB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Ofloxacin,Oral:,200 mg Tablet ,J01MA01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Ofloxacin,Ophthalmic:,0.3% Ophthalmic drop solution in 5 mL ,J01MA01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones,Ofloxacin,Otic:,0.3% Otic drop solution in 5 mL *Primary Health Care,J01MA01 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines",Olanzapine,Oral:,5 mg Tablet *Primary Health Care,N05AH03 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines",Olanzapine,Oral:,10 mg Tablet *Primary Health Care,N05AH03 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines",Olanzapine,Oral:,10 mg Orodispersible tablet (ODT) *Primary Health Care,N05AH03 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Selective beta-2-adrenoreceptor agonists,Olodaterol,Inhalation:,"2.5 mcg/puff (as Hydrochloride) x 60 puffs (equiv. to 30 medicinal doses), Solution for Inhalation Inhaler with 4 mL cartridge with 60 puffs ",R03AC19 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Omeprazole,Oral:,20 mg Capsule *Primary Health Care,A02BC01 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Omeprazole,Oral:,40 mg Capsule *Primary Health Care,A02BC01 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Omeprazole,Inj.:,40 mg Powder + 10 mL solvent (Ampule/Vial) (IV) ,A02BC01 
ALIMENTARY TRACT AND METABOLISM,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,Serotonin (5HT3) antagonists,Ondansetron,Oral:,8 mg (as Hydrochloridedihydrate) Tablet ,A04AA01 
ALIMENTARY TRACT AND METABOLISM,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,Serotonin (5HT3) antagonists,Ondansetron,Inj.:,"2 mg/mL in 2 mL Ampul (IM, IV) ",A04AA01 
ALIMENTARY TRACT AND METABOLISM,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,Serotonin (5HT3) antagonists,Ondansetron,Inj.:,"2 mg/mL in 4 mL Ampul (IM, IV) ",A04AA01 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",ELECTROLYTES WITH CARBOHYDRATES,Oral rehydration salt formulations,Oral Rehydration Salts (ORS 75-replacement),Oral:,"(L of water) composed of:
Sodium chloride = 2.6 g
Trisodium citrate dihydrate = 2.9 g
Potassium chloride = 1.5 g
Glucose anhydrous = 13.5 g
Total weight = 20.5 g
(WHO recommended)(N.B.: Reconstitute with clean potable water) *Primary Health Care",A07CA
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",ELECTROLYTES WITH CARBOHYDRATES,Oral rehydration salt formulations,Oral Rehydration Salts (ORS 75-replacement),Oral:,"(mmol/L) composed of:
Sodium = 75
Chloride = 65
Potassium = 20
Citrate = 10
Glucose anhydrous = 75
Total osmolarity = 245
(WHO recommended)(N.B.: Reconstitute with clean potable water) *Primary Health Care",A07CA
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Neuraminidase inhibitors,Oseltamivir,Oral:,75 mg (as Phosphate) Capsule *Primary Health Care,J05AH02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase resistant penicillins,Oxacillin,Inj.:,"250 mg (as Sodium) Vial (IM, IV) *Primary Health Care",J01CF04 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase resistant penicillins,Oxacillin,Inj.:,"500 mg (as Sodium) Vial (IM, IV) *Primary Health Care",J01CF04 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,Oxaliplatin,Inj.:,5 mg/mL Concentrate solution in 10 mL Vial (IV infusion) ,L01XA03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,Oxaliplatin,Inj.:,5 mg/mL Concentrate solution in 20 mL Vial (IV infusion) ,L01XA03
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Platinum compounds,Oxaliplatin,Inj.:,50 mg Powder Vial (IV infusion) ,L01XA03
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Carboxamide derivatives,Oxcarbazepine,Oral:,300 mg Tablet ,N03AF02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Carboxamide derivatives,Oxcarbazepine,Oral:,600 mg Tablet ,N03AF02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Carboxamide derivatives,Oxcarbazepine,Oral:,60 mg/mL Oral suspension in 100 mL ,N03AF02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Carboxamide derivatives,Oxcarbazepine,Oral:,60 mg/mL Oral suspension in 250 mL ,N03AF02 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone,Oral:,5 mg (as Hydrochloride) Capsule ,N02AA05
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone,Oral:,10 mg (as Hydrochloride) Tablet/Prolonged Release (PR) tablet/Controlled Release (CR) tablet ,N02AA05
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone,Oral:,20 mg (as Hydrochloride) Tablet/Prolonged Release (PR) tablet/Controlled Release (CR) tablet ,N02AA05
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone,Oral:,40 mg (as Hydrochloride) Tablet/Prolonged Release (PR) tablet/Controlled Release (CR) tablet ,N02AA05
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone,Oral:,80 mg (as Hydrochloride) Tablet/Prolonged Release (PR) tablet/Controlled Release (CR) tablet ,N02AA05
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone,Inj.:,10 mg/mL (as Hydrochloride) in 1 mL Ampul (IV infusion) ,N02AA05
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone,Inj.:,10 mg/mL (as Hydrochloride) in 2 mL Ampul (IV infusion) ,N02AA05
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone + Naloxone,Oral:,5 mg (as Hydrochloride) + 2.5 mg (as Hydrochloride) Prolonged Release (PR) tablet ,N02AA55
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone + Naloxone,Oral:,10 mg (as Hydrochloride) + 5 mg (as Hydrochloride) Prolonged Release (PR) tablet ,N02AA55
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone + Naloxone,Oral:,20 mg (as Hydrochloride) + 10 mg (as Hydrochloride) Prolonged Release (PR) tablet ,N02AA55
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Natural opium alkaloids,Oxycodone + Naloxone,Oral:,40 mg (as Hydrochloride) + 20 mg (as Hydrochloride) Prolonged Release (PR) tablet ,N02AA55
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Medical gases,Oxygen,Inhalation:,(Medicinal gas) ,V03AN01 
RESPIRATORY SYSTEM,NASAL PREPARATIONS,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,"Sympathomimetics, plain",Oxymetazoline,Nasal:,0.025% (as Hydrochloride) Solution in 10 mL Spray ,R01AA05 
RESPIRATORY SYSTEM,NASAL PREPARATIONS,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,"Sympathomimetics, plain",Oxymetazoline,Nasal:,0.05% (as Hydrochloride) Solution in 10 mL ,R01AA05 
RESPIRATORY SYSTEM,NASAL PREPARATIONS,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,"Sympathomimetics, plain",Oxymetazoline,Nasal:,0.05% (as Hydrochloride) Solution in 15 mL ,R01AA05 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,POSTERIOR PITUITARY LOBE HORMONES,Oxytocin and analogues,Oxytocin (Synthetic),Inj.:,"10 IU/mL in 1 mL Ampul (IM, IV) *Primary Health Care",H01BB02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Paclitaxel,Inj.:,"6 mg/mL in 5 mL Vial (IV,IV infusion) ",L01CD01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Paclitaxel,Inj.:,"6 mg/mL in 16.7 mL Vial (IV,IV infusion) ",L01CD01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Paclitaxel,Inj.:,"6 mg/mL in 17 mL Vial (IV,IV infusion) ",L01CD01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Paclitaxel,Inj.:,"6 mg/mL in 25 mL Vial (IV,IV infusion) ",L01CD01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Taxanes,Paclitaxel,Inj.:,"6 mg/mL in 43.4 mL Vial (IV,IV infusion) ",L01CD01 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Paliperidone,Inj.:,50 mg/0.5 mL Polonged Release (PR) suspension for injection (IM) ,N05AX13 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Paliperidone,Inj.:,75 mg/0.75 mL Polonged Release (PR) suspension for injection (IM) ,N05AX13 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Paliperidone,Inj.:,100 mg/mL Polonged Release (PR) suspension for injection (IM) ,N05AX13 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Paliperidone,Inj.:,150 mg/1.5 mL Polonged Release (PR) suspension for injection (IM) ,N05AX13 
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",Other quaternary ammonium compounds,Pancuronium,Inj.:,"2 mg/mL (as Bromide) in 2 mL Ampul (IM, IV) ",M03AC01 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Pantoprazole,Oral:,20 mg Tablet/Enteric coated tablet ,A02BC02 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Pantoprazole,Oral:,40 mg Tablet/Enteric coated tablet ,A02BC02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Aminosalicylic acid and derivatives,Para-amino salicylic acid,Oral:,4 g Enteric coated delayed release (DR) granules Sachet ,J04AA01 
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Oral:,300 mg Tablet *Primary Health Care,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Oral:,500 mg Tablet *Primary Health Care,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Oral:,100 mg/mL Drops in 15 mL (Alcohol-free) *Primary Health Care,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Oral:,120 mg/5 mL (125 mg/5 mL) Syrup/Suspension in 30 mL (Alcohol-free) ,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Oral:,120 mg/5 mL (125 mg/5 mL) Syrup/Suspension in 60 mL (Alcohol-free) *Primary Health Care,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Oral:,120 mg/5 mL (125 mg/5 mL) Syrup/Suspension in 120 mL (Alcohol-free) ,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Oral:,250 mg/5 mL Syrup/Suspension in 30 mL (Alcohol-free) ,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Oral:,250 mg/5 mL Syrup/Suspension in 60 mL (Alcohol-free) *Primary Health Care,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Oral:,250 mg/5 mL Syrup/Suspension in 120 mL (Alcohol-free) ,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Inj.:,"150 mg/mL Solution for injection in 2 mL Ampul (IM, IV) ",N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Inj.:,10 mg/mL Solution for infusion in 50 mL Vial (IV infusion) *Primary Health Care,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Inj.:,10 mg/mL Solution for infusion in 100 mL Vial (IV infusion) *Primary Health Care,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Rectal:,125 mg Suppository *Primary Health Care,N02BE01
NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Anilides,Paracetamol,Rectal:,250 mg Suppository *Primary Health Care,N02BE01
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,Interferons,Peginterferon Alfa 2A,Inj.:,135 mcg/0.5 mL Pre-filled syringe ,L03AB11 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase sensitive penicillins,Penicillin G Benzathine/Benzathine benzylpenicillin,Inj.:,"1,200,000 units Vial (IM) *Primary Health Care",J01CE08 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase sensitive penicillins,Penicillin G/benzylpenicillin Crystalline,Inj.:,"1,000,000 units (as Sodium) Vial (IM, IV) *Primary Health Care",J01CE01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase sensitive penicillins,Penicillin G/benzylpenicillin Crystalline,Inj.:,"5,000,000 units (as Sodium) Vial (IM, IV) *Primary Health Care",J01CE01 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,PERITONEAL DIALYTICS,"Isotonic solutions
Hypertonic solutions",Peritoneal Dialysis Solution,,"Sterile Solution in 2 L Bottle/Bag + 1.5% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,PERITONEAL DIALYTICS,"Isotonic solutions
Hypertonic solutions",Peritoneal Dialysis Solution,,"Sterile Solution in 5 L Bottle/Bag + 1.5% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,PERITONEAL DIALYTICS,"Isotonic solutions
Hypertonic solutions",Peritoneal Dialysis Solution,,"Sterile Solution in 2 L Bottle/Bag + 2.3% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,PERITONEAL DIALYTICS,"Isotonic solutions
Hypertonic solutions",Peritoneal Dialysis Solution,,"Sterile Solution in 5 L Bottle/Bag + 2.3% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,PERITONEAL DIALYTICS,"Isotonic solutions
Hypertonic solutions",Peritoneal Dialysis Solution,,"Sterile Solution in 2 L Bottle/Bag + 2.5% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,PERITONEAL DIALYTICS,"Isotonic solutions
Hypertonic solutions",Peritoneal Dialysis Solution,,"Sterile Solution in 5 L Bottle/Bag + 2.5% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,PERITONEAL DIALYTICS,"Isotonic solutions
Hypertonic solutions",Peritoneal Dialysis Solution,,"Sterile Solution in 2 L Bottle/Bag + 4.25% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,PERITONEAL DIALYTICS,"Isotonic solutions
Hypertonic solutions",Peritoneal Dialysis Solution,,"Sterile Solution in 5 L Bottle/Bag + 4.25% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES","Pyrethrines, incl. synthetic compounds",Permethrin,Topical:,1% Lotion in 125 mL Bottle *Primary Health Care,P03AC04 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES","Pyrethrines, incl. synthetic compounds",Permethrin,Topical:,5% Shampoo in 30 mL Bottle (Crème rinse) *Primary Health Care,P03AC04 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES","Pyrethrines, incl. synthetic compounds",Permethrin,Topical:,5% Shampoo in 60 mL Bottle (Crème rinse) *Primary Health Care,P03AC04 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES","Pyrethrines, incl. synthetic compounds",Permethrin,Topical:,1% Lotion in 30 mL Bottle *Primary Health Care,P03AC04 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS","ECTOPARASITICIDES, INCL. SCABICIDES","Pyrethrines, incl. synthetic compounds",Permethrin,Topical:,1% Lotion in 60 mL Bottle *Primary Health Care,P03AC04 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Phenylpiperidine derivatives,Pethidine/Meperidine,Inj.:,"50 mg/mL (as Hydrochloride) in 2 mL Ampul (IM, IV, SC) ",N02AB02 
DERMATOLOGICALS,EMOLLIENTS AND PROTECTIVES,EMOLLIENTS AND PROTECTIVES,Other emollients and protectives,Petrolatum/Petroleum,Topical:,Jelly in 25 g Jar USP Grade ,D02AX
DERMATOLOGICALS,EMOLLIENTS AND PROTECTIVES,EMOLLIENTS AND PROTECTIVES,Other emollients and protectives,Petrolatum/Petroleum,Topical:,Jelly in 100 g Jar USP Grade ,D02AX
DERMATOLOGICALS,EMOLLIENTS AND PROTECTIVES,EMOLLIENTS AND PROTECTIVES,Other emollients and protectives,Petrolatum/Petroleum,Topical:,Jelly in 200 g Jar USP Grade ,D02AX
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Barbiturates and derivatives,Phenobarbital,Oral:,15 mg Tablet ,N03AA02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Barbiturates and derivatives,Phenobarbital,Oral:,30 mg Tablet ,N03AA02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Barbiturates and derivatives,Phenobarbital,Oral:,60 mg Tablet ,N03AA02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Barbiturates and derivatives,Phenobarbital,Oral:,90 mg Tablet ,N03AA02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Barbiturates and derivatives,Phenobarbital,Inj.:,"120 mg/mL in 1 mL Ampul (IM, IV) ",N03AA02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Barbiturates and derivatives,Phenobarbital,Inj.:,"130 mg/mL (as Sodium) in 1 mL Ampul (IM, IV) ",N03AA02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase sensitive penicillins,Phenoxymethyl Penicillin/Penicillin V,Oral:,250 mg (as Potassium) Tablet/Capsule *Primary Health Care,J01CE02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase sensitive penicillins,Phenoxymethyl Penicillin/Penicillin V,Oral:,500 mg (as Potassium) Tablet/Capsule *Primary Health Care,J01CE02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",Beta-lactamase sensitive penicillins,Phenoxymethyl Penicillin/Penicillin V,Oral:,250 mg/5 mL (as Potassium) Granules/powder for syrup/suspension in 60 mL *Primary Health Care,J01CE02 
RESPIRATORY SYSTEM,NASAL PREPARATIONS,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,"Sympathomimetics, combinations excl. corticosteroids",Phenylephrine,Ophthalmic:,2.5% (as Hydrochloride) Ophthalmic drop solution in 5 mL ,R01AB01 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Hydantoin derivatives,Phenytoin,Oral:,100 mg (as Sodium) Tablet ,N03AB02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Hydantoin derivatives,Phenytoin,Oral:,30 mg/5 mL (as Sodium) Suspension in 120 mL ,N03AB02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Hydantoin derivatives,Phenytoin,Oral:,125 mg/5 mL (as Sodium) Suspension in 120 mL ,N03AB02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Hydantoin derivatives,Phenytoin,Inj.:,50 mg/ mL (as Sodium) in 2 mL Ampul (IV) ,N03AB02 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Hydantoin derivatives,Phenytoin,Inj.:,50 mg/ mL (as Sodium) in 5 mL Ampul (IV) ,N03AB02 
RESPIRATORY SYSTEM,OTHER RESPIRATORY SYSTEM PRODUCTS,OTHER RESPIRATORY SYSTEM PRODUCTS,Lung surfactants,Phospholipid fraction from bovine lung,Inj.:,45 mg/mL (54 mg/1.2 mL) Lyophilized powder for suspension (Intratracheal administration) ,R07AA02 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Physostigmine,Inj.:,"1 mg/mL (as Salicylate) in 2 mL Ampul (IM, IV) ",V03AB19 
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,VITAMIN K AND OTHER HEMOSTATICS,Vitamin K,Phytomenadione/Phytonadione/Vitamin K1,Oral/Inj.:,"2 mg/0.2 mL Ampul (IM, IV, PO)(Pediatric)(As mixed micelle) *Primary Health Care",B02BA01
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,VITAMIN K AND OTHER HEMOSTATICS,Vitamin K,Phytomenadione/Phytonadione/Vitamin K1,Inj.:,"10 mg/mL in 1 mL Ampul (IM, IV, SC)(As aqueous colloidal solution with benzyl alcohol) *Primary Health Care",B02BA01
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,VITAMIN K AND OTHER HEMOSTATICS,Vitamin K,Phytomenadione/Phytonadione/Vitamin K1,Inj.:,"10 mg/mL in 1 mL Ampul (IM, IV, SC)(As mixed micelle) *Primary Health Care",B02BA01
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Parasympathomimetics,Pilocarpine,Ophthalmic:,1% (as Hydrochloride) Ophthalmic drop solution in 10 mL ,S01EB01 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Parasympathomimetics,Pilocarpine,Ophthalmic:,1% (as Hydrochloride) Ophthalmic drop solution in 15 mL ,S01EB01 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Parasympathomimetics,Pilocarpine,Ophthalmic:,2% (as Hydrochloride) Ophthalmic drop solution in 10 mL ,S01EB01 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Parasympathomimetics,Pilocarpine,Ophthalmic:,2% (as Hydrochloride) Ophthalmic drop solution in 15 mL ,S01EB01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Piperacillin + Tazobactam,Inj.:,2 g + 250 mg (as Sodium) Vial (IV infusion) ,J01CR05
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS","Combinations of penicillins, incl. beta-lactamase inhibitors",Piperacillin + Tazobactam,Inj.:,4 g + 500 mg (as Sodium) Vial (IV infusion) ,J01CR05
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pneumococcal vaccines,Pneumococcal Conjugate Vaccine,Inj.:,10-valent (2 mL) Suspension for IM injection in 3 mL Multidose vial (IM) ,J07AL02 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pneumococcal vaccines,Pneumococcal Conjugate Vaccine,Inj.:,"13-valent 0.5 mL single dose, Suspension for IM injection in 0.5 mL Pre-filled syringe (IM) ",J07AL02 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pneumococcal vaccines,Pneumococcal Conjugate Vaccine,Inj.:,13-valent Suspension for IM injection in 2 mL Multidose vial (IM) ,J07AL02 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pneumococcal vaccines,Pneumococcal Polyvalent Vaccine,Inj.:,"25 mcg/0.5 mL Solution for injection in 0.5 mL Pre-filled syringe/Single dose vial (IM, SC)(Polysaccharide from each capsular type) ",J07AL01 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Pneumococcal vaccines,Pneumococcal Polyvalent Vaccine,Inj.:,"25 mcg/0.5 mL Solution for injection in 2.5 mL Multidose vial (IM, SC) ",J07AL01 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFECTIVES,Antibiotics,Polymyxin B *Reserve antimicrobial,Inj.:,"500,000 IU (as Sulfate) Powder for solution for injection in 5 mL Vial (Intrathecal, IM, IV) ",A07AA05 
RESPIRATORY SYSTEM,OTHER RESPIRATORY SYSTEM PRODUCTS,OTHER RESPIRATORY SYSTEM PRODUCTS,Lung surfactants,Poractant alfa,Inj.:,80 mg/mL Sterile Suspension in 1.5 mL Vial (Intratracheal/Intrabronchial) ,R07AA 
RESPIRATORY SYSTEM,OTHER RESPIRATORY SYSTEM PRODUCTS,OTHER RESPIRATORY SYSTEM PRODUCTS,Lung surfactants,Poractant alfa,Inj.:,80 mg/mL Sterile Suspension in 3 mL Vial (Intratracheal/Intrabronchial) ,R07AA 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium,Oral:,10 mEq (as Citrate) Tablet ,A12BA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium,Oral:,1620 mg (15 mEq) Tablet ,A12BA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium Chloride,Oral:,600 mg Tablet *Primary Health Care,A12BA01 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium Chloride,Oral:,750 mg (equiv. to approximately 10 mEq potassium) Durules *Primary Health Care,A12BA01 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium Chloride,Inj.:,1 mmol/mL (as Chloride) Syrup in 30 mL *Primary Health Care,A12BA01 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium Chloride,Inj.:,1 mmol/mL (as Chloride) Syrup in 60 mL *Primary Health Care,A12BA01 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium Chloride,Inj.:,2 mEq/mL in 2 mL Ampul (IV infusion) ,A12BA01 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium Chloride,Inj.:,2 mEq/mL in 5 mL Ampul (IV infusion) ,A12BA01 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium Chloride,Inj.:,2 mEq/mL in 10 mL Vial (IV infusion) ,A12BA01 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,POTASSIUM,Potassium,Potassium Chloride,Inj.:,2 mEq/mL in 20 mL Vial (IV infusion) ,A12BA01 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Oral antiseptic:,1% in 60 mL Bottle *Primary Health Care,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Oral antiseptic:,1% in 120 mL Bottle *Primary Health Care,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Oral antiseptic:,1% in 240 mL Bottle ,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Ointment in 5 g Tube *Primary Health Care,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Ointment in 15 g Tube *Primary Health Care,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Ointment in 30 g Tube ,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Paint in 10 mL Bottle *Primary Health Care,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Solution in 15 mL Bottle ,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Solution in 30 mL Bottle ,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Solution in 60 mL Bottle *Primary Health Care,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Solution in 120 mL Bottle *Primary Health Care,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Solution in 1 L Bottle ,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,10% Solution in 1 Gallon Bottle ,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,7.5% in 60 mL Bottle (Surgical skin cleanser) *Primary Health Care,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,7.5% in 120 mL Bottle (Surgical skin cleanser) *Primary Health Care,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,7.5% in 480 mL Bottle (Surgical skin cleanser) ,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,7.5% in 1 L Bottle (Surgical skin cleanser) ,D08AG02 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Iodine products,Povidone iodine,Topical:,7.5% in 1 Gallon Bottle (Surgical skin cleanser) ,D08AG02 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Pralidoxime Chloride,Inj.:,50 mg/mL in 20 mL Vial (IV) ,V03AB04 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTITREMATODALS,Quinoline derivatives and related substances,Praziquantel,Oral:,600 mg Tablet (Available under DOH program) *Primary Health Care,P02BA01 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Prednisolone,Oral:,15 mg/5 mL (as Sodium phosphate) Syrup in 60 mL ,H02AB06 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Prednisolone,Ophthalmic:,0.5% (as Acetate) Ophthalmic drop suspension in 5 mL ,H02AB06 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Prednisolone,Ophthalmic:,1% (as Acetate) Ophthalmic drop suspension in 5 mL ,H02AB06 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Prednisone,Oral:,5 mg Tablet *Primary Health Care,H02AB07 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Prednisone,Oral:,10 mg Tablet *Primary Health Care,H02AB07 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Prednisone,Oral:,20 mg Tablet *Primary Health Care,H02AB07 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",Glucocorticoids,Prednisone,Oral:,10 mg/5 mL Suspension in 60 mL *Primary Health Care,H02AB07 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Aminoquinolines,Primaquine,Oral:,26.3 mg (15 mg base) Tablet *Primary Health Care,P01BA03 
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Other general anesthetics,Propofol,Inj.:,10 mg/mL in 20 mL Ampul (IV) ,N01AX10
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Other general anesthetics,Propofol,Inj.:,10 mg/mL in 50 mL Pre-filled syringe (IV) ,N01AX10
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Other general anesthetics,Propofol,Inj.:,10 mg/mL in 20 mL Vial (IV) ,N01AX10
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Other general anesthetics,Propofol,Inj.:,10 mg/mL in 50 mL Vial (IV) ,N01AX10
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, non-selective",Propranolol,Oral:,10 mg (as Hydrochloride) Tablet ,C07AA05 
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, non-selective",Propranolol,Oral:,40 mg (as Hydrochloride) Tablet ,C07AA05 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",THYROID THERAPY,ANTITHYROID PREPARATIONS,Thiouracils,Propylthiouracyl,Oral:,50 mg Tablet ,H03BA02 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Protamine Sulfate,Inj.:,10 mg/mL in 5 mL Ampul (IV) ,V03AB14 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Protamine Sulfate,Inj.:,10 mg/mL in 25 mL Ampul (IV) ,V03AB14 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Thiocarbamide derivatives,Prothionamide,Oral:,250 mg Film-coated tablet ,J04AD01 
SENSORY ORGANS,OPHTHALMOLOGICALS,LOCAL ANESTHETICS,Local anesthetics,Proxymetacaine/Proparacaine,Ophthalmic:,0.5% (as Hydrochloride) Ophthalmic drop solution in 5 mL ,S01HA04 
SENSORY ORGANS,OPHTHALMOLOGICALS,LOCAL ANESTHETICS,Local anesthetics,Proxymetacaine/Proparacaine,Ophthalmic:,0.5% (as Hydrochloride) Ophthalmic drop solution in 15 mL ,S01HA04 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Other drugs for treatment of tuberculosis,Pyrazinamide,Oral:,500 mg Tablet *Primary Health Care,J04AK01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Other drugs for treatment of tuberculosis,Pyrazinamide,Oral:,250 mg/5 mL Suspension in 120 mL *Primary Health Care,J04AK01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Other drugs for treatment of tuberculosis,Pyrazinamide,Oral:,500 mg/5 mL Suspension in 120 mL *Primary Health Care,J04AK01 
NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,PARASYMPATHOMIMETICS,Anticholinesterases,Pyridostigmine,Oral:,60 mg (as Bromide) Tablet ,N07AA02 
ALIMENTARY TRACT AND METABOLISM,VITAMINS,OTHER PLAIN VITAMIN PREPARATIONS,Other plain vitamin preparations,Pyridoxine/Vitamin B6,Oral:,100 mg (as Hydrochloride) Tablet ,A11HA02
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Diaminopyrimidines,Pyrimethamine,Oral:,25 mg Tablet ,P01BD01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Diaminopyrimidines,Pyrimethamine,Oral:,75 mg Tablet ,P01BD01 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines",Quetiapine,Oral:,25 mg (as Fumarate) Tablet ,N05AH04 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines",Quetiapine,Oral:,100 mg (as Fumarate) Tablet ,N05AH04 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines",Quetiapine,Oral:,200 mg (as Fumarate) Tablet ,N05AH04 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines",Quetiapine,Oral:,300 mg (as Fumarate) Tablet ,N05AH04 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Methanolquinolines,Quinine,Oral:,325 mg Tablet ,P01BC01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Methanolquinolines,Quinine,Inj.:,300 mg (as Sulfate) Tablet ,P01BC01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Methanolquinolines,Quinine,Inj.:,300 mg/mL (as Dihydrochloride) in 1 mL Ampul (IV) ,P01BC01 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,ANTIMALARIALS,Methanolquinolines,Quinine,Inj.:,250 mg/mL (as Dihydrochloride) in 1 mL Ampul (IV) ,P01BC01 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Rabeprazole ,Oral:,10 mg (as Sodium) Tablet ,A02BC04
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Proton pump inhibitors,Rabeprazole ,Oral:,20 mg (as Sodium) Tablet ,A02BC04
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Rabies vaccines,"Rabies (Chick Embryo - purified, inactivated) Vaccine",Inj.:,"2.5 IU/mL Lyophilized powder in 1 Dose vial + 1 mL diluent (ID, IM) *Primary Health Care",J07BG01 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Rabies vaccines,Rabies (Vero Cell - purified) Vaccine,Inj.:,"2.5 IU/mL Lyophilized powder in 0.5 mL Vial + Diluent (ID, IM) *Primary Health Care",J07BG01 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Rabies vaccines,Rabies (Vero Cell - purified) Vaccine,Inj.:,2.5 IU/mL Suspension in 1 mL Vial (IM) *Primary Health Care,J07BG01 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 2 mL Vial (IM) *Primary Health Care,J06BB05 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 5 mL Vial (IM) *Primary Health Care,J06BB05 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 2 mL Ampul (IM) *Primary Health Care,J06BB05 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 5 mL Ampul (IM) *Primary Health Care,J06BB05 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 10 mL Ampul (IM) *Primary Health Care,J06BB05 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),H2-receptor antagonists,Ranitidine,Oral:,150 mg (as Hydrochloride) Tablet ,A02BA02 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),H2-receptor antagonists,Ranitidine,Oral:,300 mg (as Hydrochloride) Tablet ,A02BA02 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),H2-receptor antagonists,Ranitidine,Oral:,75 mg/5 mL (as Hydrochloride) Syrup in 60 mL ,A02BA02 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),H2-receptor antagonists,Ranitidine,Oral:,75 mg/5 mL (as Hydrochloride) Syrup in 150 mL ,A02BA02 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),H2-receptor antagonists,Ranitidine,Inj.:,"25 mg/mL (as Hydrochloride) in 2 mL Ampul/Vial (IM, IV, IV infusion) ",A02BA02 
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, intermediate-acting",Regular Insulin (Recombinant DNA human),Inj.:,"100 IU/mL in 3 mL Pre-filled syringe (IM, IV, SC) *Primary Health Care",A10AC01 
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, intermediate-acting",Regular Insulin (Recombinant DNA human),Inj.:,"100 IU/mL in 5 mL Vial (IM, IV, SC) *Primary Health Care",A10AC01 
ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,INSULINS AND ANALOGUES,"Insulins and analogues for injection, intermediate-acting",Regular Insulin (Recombinant DNA human),Inj.:,"100 IU/mL in 10 mL Vial (IM, IV, SC) *Primary Health Care",A10AC01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Remdesivir,IV:,100 mg Lyophilized powder ,J05AB16
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Opioid anesthetics,Remifentanil,Inj.:,1 mg Lyophilized powder Vial (IV infusion) ,N01AH06 
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Opioid anesthetics,Remifentanil,Inj.:,2 mg Lyophilized powder Vial (IV infusion) ,N01AH06 
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO","Vitamin A, plain",Retinol/Vitamin A,Oral:,"10,000 IU (as Palmitate) Soft gel capsule *Primary Health Care",A11CA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO","Vitamin A, plain",Retinol/Vitamin A,Oral:,"25,000 IU (as Palmitate) Soft gel capsule *Primary Health Care",A11CA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO","Vitamin A, plain",Retinol/Vitamin A,Oral:,"50,000 IU (as Palmitate) Soft gel capsule *Primary Health Care",A11CA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO","Vitamin A, plain",Retinol/Vitamin A,Oral:,"100,000 IU (as Palmitate) Soft gel capsule with nipple (Only for DOH program) *Primary Health Care",A11CA01
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO","Vitamin A, plain",Retinol/Vitamin A,Oral:,"200,000 IU (as Palmitate) Soft gel capsule with nipple (Only for DOH program) *Primary Health Care",A11CA01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Antivirals for treatment of HCV infections,Ribavirin,Oral:,200 mg Tablet ,J05AP01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Antivirals for treatment of HCV infections,Ribavirin,Oral:,500 mg Tablet ,J05AP01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Antivirals for treatment of HCV infections,Ribavirin,Oral:,600 mg Tablet ,J05AP01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Antibiotics,Rifabutin,Oral:,"150 mg Capsule (For HIV/AIDS patient on concomitant protease inhibitor therapy, in lieu of rifampicin) ",J04AB04 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Antibiotics,Rifampicin,Oral:,300 mg Tablet/Capsule *Primary Health Care,J04AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Antibiotics,Rifampicin,Oral:,450 mg Tablet/Capsule *Primary Health Care,J04AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Antibiotics,Rifampicin,Oral:,600 mg Tablet/Capsule *Primary Health Care,J04AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Antibiotics,Rifampicin,Oral:,200 mg/5 mL Suspension in 120 mL *Primary Health Care,J04AB02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOBACTERIALS,DRUGS FOR TREATMENT OF TUBERCULOSIS,Antibiotics,Rifapentine,Oral:,150 mg Film-coated tablet ,J04AB05 
ALIMENTARY TRACT AND METABOLISM,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",INTESTINAL ANTIINFECTIVES,Antibiotics,Rifaximin,Oral:,200 mg Tablet ,A07AA11 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Non-nucleoside reverse transcriptase inhibitors,Rilpivirine,Oral:,25 mg (as Hydrochloride) Tablet ,J05AG05 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Oral:,1 mg Tablet *Primary Health Care,N05AX08 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Oral:,2 mg Tablet *Primary Health Care,N05AX08 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Oral:,3 mg Tablet *Primary Health Care,N05AX08 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Oral:,4 mg Tablet *Primary Health Care,N05AX08 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Oral:,1 mg Orodispersible tablet (ODT) *Primary Health Care,N05AX08 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Oral:,2 mg Orodispersible tablet (ODT) *Primary Health Care,N05AX08 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Oral:,1 mg/mL Oral Solution in 100 mL *Primary Health Care,N05AX08 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Inj.:,25 mg Modified Release (MR) Powder for suspension Vial + 2 mL diluent in pre-filled syringe (IM) *Primary Health Care,N05AX08 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Inj.:,37.5 mg Modified Release (MR) Powder for suspension Vial + 2 mL diluent in pre-filled syringe (IM) *Primary Health Care,N05AX08 
NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics,Risperidone,Inj.:,50 mg Polonged Release (PR) suspension for injection + 2 mL diluent (IM)(This should not be administered to patients with dementia-related psychoses because of high risk of cardiovascular and infectiious related deaths.) ,N05AX08 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,CD20 (Clusters of Differentiation 20) inhibitors,Rituximab,Inj.:,10 mg/mL in 10 mL Vial (IV) ,L01FA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,CD20 (Clusters of Differentiation 20) inhibitors,Rituximab,Inj.:,10 mg/mL in 50 mL Vial (IV) ,L01FA01 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Direct factor Xa inhibitors,Rivaroxaban,Oral:,15 mg Film-coated tablet ,B01AF01 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Direct factor Xa inhibitors,Rivaroxaban,Oral:,20 mg Film-coated tablet ,B01AF01 
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTI-DEMENTIA DRUGS,Anticholinesterases,Rivastigmine,Oral:,1.5 mg (as Hydrogen tartrate) Capsule ,N06DA03 
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTI-DEMENTIA DRUGS,Anticholinesterases,Rivastigmine,Oral:,3 mg (as Hydrogen tartrate) Capsule ,N06DA03 
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTI-DEMENTIA DRUGS,Anticholinesterases,Rivastigmine,Oral:,6 mg (as Hydrogen tartrate) Capsule ,N06DA03 
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",Other quaternary ammonium compounds,Rocuronium,Inj.:,10 mg/mL (as Bromide) in 5 mL Ampul/Vial (IV) ,M03AC09 
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, LOCAL",Amides,Ropivacaine,Inj.:,10 mg/mL (as Hydrochloride) in 10 mL Ampul (IV) ,N01BB09 
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",HMG CoA reductase inhibitors,Rosuvastatin,Oral:,10 mg (as Calcium) Tablet *Primary Health Care,C10AA07 
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",HMG CoA reductase inhibitors,Rosuvastatin,Oral:,20 mg (as Calcium) Tablet *Primary Health Care,C10AA07 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Rota virus diarrhea vaccines,Rotavirus Vaccine,Oral:,"1.5 mL Suspension in Pre-filled glass syringe 

Contains:
Monovalent G1P[8] strain, Live, attenuated, containing NLT 10^6.0 cell culture infectious dose ",J07BH01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Rota virus diarrhea vaccines,Rotavirus Vaccine,Oral:,"1.5 mL Suspension in 3 mL ready-to-use plastic tube (sterile polyethylene squeezable tube with nozzle fitted with a tip seal and a tube cap (polypropylene)) 

Contains:
Monovalent G1P[8] strain, Live, attenuated, containing NLT 10^6.0 cell culture infectious dose ",J07BH01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Rota virus diarrhea vaccines,Rotavirus Vaccine,Oral:,"2 mL Solution in 2 mL single dose ready-to-use plastic tube (single dose plastic dosing tube in individual foil pouch per box) 

Contains:
Pentavalent G1, G2, G3, G4, and P1A[8] strains, live, attenuated, containing live reassortant rotaviruses - G1, G2, G3, G4 and P1A[8] with a minimum of 2.0-2.8 x 10^6 infectious units (IU) per reassortant dose ",J07BH01
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Rota virus diarrhea vaccines,Rotavirus Vaccine,Oral:,"2 mL Solution in 2 mL single dose ready-to-use plastic tube (single dose plastic dosing tube in individual foil pouch per box) 

Contains:
Pentavalent G1, G2, G3, G4, and P1A[8] strains, live, attenuated, containing live reassortant rotaviruses - G1, G2, G3, G4 and P1A[8] with a minimum of 2.0-2.8 x 10^6 infectious units (IU) per reassortant dose ",J07BH01
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS","Angiotensin II receptor blockers (ARBs), other combinations",Sacubitril + Valsartan,Oral:,24.3 mg + 25.7 mg Tablet (Restricted use for acute hypertensive emergencies in patients less than 18 years old with extreme caution due to rapid and prolonged fall in blood pressure) ,C09DX04 
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS","Angiotensin II receptor blockers (ARBs), other combinations",Sacubitril + Valsartan,Oral:,"48.6 ,g + 51.4 mg Tablet (Restricted use for acute hypertensive emergencies in patients less than 18 years old with extreme caution due to rapid and prolonged fall in blood pressure) ",C09DX04 
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS","Angiotensin II receptor blockers (ARBs), other combinations",Sacubitril + Valsartan,Oral:,97.2 mg + 102.8 mg Tablet (Restricted use for acute hypertensive emergencies in patients less than 18 years old with extreme caution due to rapid and prolonged fall in blood pressure) ,C09DX04 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Selective beta-2-adrenoreceptor agonists,Salbutamol,Oral:,2 mg/5 mL (as Sulfate) Syrup in 60 mL *Primary Health Care,R03AC02 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Selective beta-2-adrenoreceptor agonists,Salbutamol,Inhalation:,200 mcg/dose (as Sulfate) DPI with appropriate accompanying dispenser ,R03AC02 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Selective beta-2-adrenoreceptor agonists,Salbutamol,Inhalation:,"100 mcg/dose (as Sulfate) x 200 actuations, MDI *Primary Health Care",R03AC02 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Selective beta-2-adrenoreceptor agonists,Salbutamol,Inhalation:,"100 mcg/dose (as Sulfate) x 200 actuations, Breath actuated MDI *Primary Health Care",R03AC02 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Selective beta-2-adrenoreceptor agonists,Salbutamol,Inhalation:,1 mg/mL (as Sulfate) Respiratory solution in 2.5 mL Unit dose (For nebulization) *Primary Health Care,R03AC02 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS, INHALANTS",Selective beta-2-adrenoreceptor agonists,Salbutamol,Inhalation:,2 mg/mL (as Sulfate) Respiratory solution in 2.5 mL Unit dose (For nebulization) *Primary Health Care,R03AC02 
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR TOPICAL USE,Other antifungals for topical use,Salicylic Acid,Topical:,5% Solution in 30 mL ,D01AE12 
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR TOPICAL USE,Other antifungals for topical use,Salicylic Acid,Topical:,5% Solution in 60 mL ,D01AE12 
Not Available,Not Available,Not Available,Not Available,Sambong (Blumea balsamifera),Oral:,250 mg Tablet (Fam. Compositae) ,Not Available
Not Available,Not Available,Not Available,Not Available,Sambong (Blumea balsamifera),Oral:,500 mg Tablet (Fam. Compositae) ,Not Available
NERVOUS SYSTEM,ANTI-PARKINSON DRUGS,DOPAMINERGIC AGENTS,Monoamine oxidase B inhibitors,Selegiline,Oral:,5 mg (as Hydrochloride) Tablet ,N04BD01 
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR TOPICAL USE,Other antifungals for topical use,Selenium,Topical:,2.5% (as Sulfide) Lotion in 100 mL ,D01AE13 
NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTIDEPRESSANTS,Selective serotonin reuptake inhibitors,Sertraline,Oral:,50 mg (as Hydrochloride) Tablet *Primary Health Care,N06AB06 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Drugs for treatment of hyperkalemia and hyperphosphatemia,Sevelamer,Oral:,800 mg (as Carbonate) Tablet ,V03AE02 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Drugs for treatment of hyperkalemia and hyperphosphatemia,Sevelamer,Oral:,800 mg (as Carbonate) Powder for suspension ,V03AE02 
NERVOUS SYSTEM,ANESTHETICS," ANESTHETICS, GENERAL",Halogenated hydrocarbons,Sevoflurane,Inhalation:,in 250 mL Bottle ,N01AB08
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,CHEMOTHERAPEUTICS FOR TOPICAL USE,Sulfonamides,Silver Sulfadiazine,Topical:,1% Cream in 15 g Tube *Primary Health Care,D06BA01 
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,CHEMOTHERAPEUTICS FOR TOPICAL USE,Sulfonamides,Silver Sulfadiazine,Topical:,1% Cream in 25 g Tube *Primary Health Care,D06BA01 
DERMATOLOGICALS,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,CHEMOTHERAPEUTICS FOR TOPICAL USE,Sulfonamides,Silver Sulfadiazine,Topical:,Cream in 500 g Jar (Micronized) *Primary Health Care,D06BA01 
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",HMG CoA reductase inhibitors,Simvastatin,Oral:,20 mg Tablet *Primary Health Care,C10AA01 
CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",HMG CoA reductase inhibitors,Simvastatin,Oral:,40 mg Tablet *Primary Health Care,C10AA01 
SENSORY ORGANS,OPHTHALMOLOGICALS,OTHER OPHTHALMOLOGICALS,Other ophthalmologicals,Sirolimus,Oral:,0.5 mg Tablet ,S01XA23
SENSORY ORGANS,OPHTHALMOLOGICALS,OTHER OPHTHALMOLOGICALS,Other ophthalmologicals,Sirolimus,Oral:,1 mg Tablet ,S01XA23
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,IRRIGATING SOLUTIONS,Salt solutions,Sodium Bicarbonate,Oral:,325 mg Tablet ,B05CB04 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,IRRIGATING SOLUTIONS,Salt solutions,Sodium Bicarbonate,Oral:,650 mg Tablet ,B05CB04 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,IRRIGATING SOLUTIONS,Salt solutions,Sodium Bicarbonate,Inj.:,1 mEq/mL in 10 mL Vial (Pediatric) ,B05CB04 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,IRRIGATING SOLUTIONS,Salt solutions,Sodium Bicarbonate,Inj.:,1 mEq/mL in 20 mL Ampul/Vial (Adult)(IV infusion) ,B05CB04 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,IRRIGATING SOLUTIONS,Salt solutions,Sodium Bicarbonate,Inj.:,1 mEq/mL in 50 mL Ampul/Vial (Adult)(IV infusion) ,B05CB04 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,IRRIGATING SOLUTIONS,Salt solutions,Sodium Bicarbonate,Inj.:,1 mEq/mL in 100 mL Ampul/Vial (Adult)(IV infusion) ,B05CB04 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,HEMODIALYTICS AND HEMOFILTRATES,"Hemodialytics, concentrates",Sodium bicarbonate + Acid concentrates (Hemodialysis Solution),Inj.:,"650 g + Acid Concentrates (g/L) composed of:
Glucose = 0-49.5 g
Sodium chloride = 216.19-270.8 g
Potassium chloride = 5.25-6.7 g
Calcium chloride = 6.46-9.9 g
Magnesium chloride = 3.58-4.75 g
Glacial acetic acid = 8.1-8.46 g
Purified water = 1000 mL ",B05ZA
Not available,Not available,Not available,Not available,Sodium bicarbonate + Glutamic acid + Tartaric acid + Silicon resin (Gas Forming Agent),Oral:,470 mg + 70 mg + 420 mg + 25 mg Tablet ,Not available
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Sodium Calcium Edetate,Inj.:,200 mg/mL in 5 mL Ampul (IM) ,V03AB03
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 2 mL Ampul (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 2.5 mL Ampul (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 5 mL Ampul (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 10 mL Ampul (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 20 mL Ampul (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 50 mL Bottle/Bag (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 100 mL Bottle/Bag (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 200 mL Bottle/Bag (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 500 mL Bottle/Bag (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,Inj.:,0.9% in 1 L Bottle/Bag (IV infusion) *Primary Health Care,A12CA
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,Sodium,Sodium Chloride,,"0.9% in 1 L Bottle/Bag (For irrigation)Composed of:
Na+ = 154 mmol/L
Cl- = 154 mmol/L ",A12CA
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTION ADDITIVES,Electrolyte solutions,Sodium Chloride,Inj.:,2.5 mEq/mL in 20 mL Vial *Primary Health Care,B05XA03 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTION ADDITIVES,Electrolyte solutions,Sodium Chloride,Inj.:,2.5 mEq/mL in 50 mL Vial *Primary Health Care,B05XA03 
RESPIRATORY SYSTEM,NASAL PREPARATIONS,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,Other nasal preparations,Sodium Chloride + Potassium Chloride + Calcium Lactate Pentahydrate,,1.544 g/83.16 mg/63.13 mg per sachet powder for reconstitution,R01AX30
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Other antiseptics and disinfectants,Sodium Dichloroisocyanurate,,3.5 mg Tablet (2 mg free chlorine)(To be used for water purification) ,D08AX 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Other antiseptics and disinfectants,Sodium Dichloroisocyanurate,,8.68 mg Tablet (5 mg free chlorine)(To be used for water purification) ,D08AX 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Other antiseptics and disinfectants,Sodium Dichloroisocyanurate,,12.5 mg Tablet (8 mg free chlorine)(To be used for water purification) ,D08AX 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Other antiseptics and disinfectants,Sodium Dichloroisocyanurate,,17 mg Tablet (10 mg free chlorine)(To be used for water purification) ,D08AX 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Other antiseptics and disinfectants,Sodium Dichloroisocyanurate,,67 mg Tablet (40 mg free chlorine)(To be used for water purification) ,D08AX 
SENSORY ORGANS,OPHTHALMOLOGICALS,SURGICAL AIDS,Viscoelastic substances,Sodium Hyaluronate,Ophthalmic:,0.1% (1 mg/mL) Ophthalmic drop solution in 5 mL ,S01KA 
SENSORY ORGANS,OPHTHALMOLOGICALS,SURGICAL AIDS,Viscoelastic substances,Sodium Hyaluronate,Ophthalmic:,0.1% (1 mg/mL) Ophthalmic drop solution in 15 mL ,S01KA 
DERMATOLOGICALS,ANTISEPTICS AND DISINFECTANTS,ANTISEPTICS AND DISINFECTANTS,Other antiseptics and disinfectants,Sodium Hypochlorite,,Solution (1.25% available chlorine for water purification) ,D08AX07
VARIOUS,DIAGNOSTIC RADIOPHARMACEUTICALS,THYROID,Various thyroid diagnostic radiopharmaceuticals,Sodium Iodide,Oral:,Capsule (Radioactivity range of 0.8 - 100 mCi per capsule) ,V09FX03 
VARIOUS,DIAGNOSTIC RADIOPHARMACEUTICALS,THYROID,Various thyroid diagnostic radiopharmaceuticals,Sodium Iodide,Oral:,Capsule (Radioactivity range of 1.0 - 250 mCi per capsule) ,V09FX03 
VARIOUS,DIAGNOSTIC RADIOPHARMACEUTICALS,THYROID,Various thyroid diagnostic radiopharmaceuticals,Sodium Iodide,Oral:,Solution (Radioactivity range of 3.5 - 150 mCi per vial) ,V09FX03 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Sodium Nitrite,Inj.:,Powder (USP Grade) ,V03AB08 
CARDIOVASCULAR SYSTEM,ANTIHYPERTENSIVES,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON", Nitroferricyanide derivatives,Sodium Nitroprusside,Inj.:,50 mg Powder (IV infusion) ,C02DD01 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Osmotically acting laxatives,Sodium Sulfate,,Powder (USP Grade) ,A06AD13 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Sodium Thiosulfate,Inj.:,250 mg/mL in 50 mL Ampul (IV) ,V03AB 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Sodium Thiosulfate,,2.5% Solution ,V03AB 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Sodium Thiosulfate,,5% Solution ,V03AB 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Fatty acid derivatives,Sodium Valproate,Oral:,200 mg/5 mL Syrup in 100 mL Bottle *Primary Health Care,N03AG01 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Fatty acid derivatives,Sodium Valproate + Valproic Acid,Oral:,333 mg + 145 mg Controlled Release (CR) tablet *Primary Health Care,N03AG01 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Fatty acid derivatives,Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,250 mg Tablet *Primary Health Care,N03AG01
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Fatty acid derivatives,Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,500 mg Tablet *Primary Health Care,N03AG01
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Fatty acid derivatives,Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,250 mg Extended Release (ER) tablet *Primary Health Care,N03AG01
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Fatty acid derivatives,Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,500 mg Extended Release (ER) tablet *Primary Health Care,N03AG01
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Fatty acid derivatives,Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,500 mg (333 mg Sodium valproate + 145 mg Valproic acid) Controlled Release (CR) tablet *Primary Health Care,N03AG01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Antivirals for treatment of HCV infections,Sofosbuvir,Oral:,400 mg Tablet ,J05AP08 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Antivirals for treatment of HCV infections,Sofosbuvir + Ledipasvir,Oral:,400 mg + 90 mg Tablet ,J05AP51 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Antivirals for treatment of HCV infections,Sofosbuvir + Velpatasvir,Oral:,400 mg + 100 mg Tablet ,J05AP55 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,HYPOTHALAMIC HORMONES,Somatostatin and analogues,Somatostatin,Inj.:,"250 mcg Ampul/Vial (IV,IV infusion) ",H01CB01 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,HYPOTHALAMIC HORMONES,Somatostatin and analogues,Somatostatin,Inj.:,"3 mg Ampul/Vial (IV,IV infusion) ",H01CB01 
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTIONS,Solutions for parenteral nutrition,Soya bean oil + Medium chain triglycerides + Olive oil + Purified fish oil,Inj.:,20% (200 mg/mL) Emulsion for IV infusion in 250 mL ,B05BA02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Other antibacterials,Spectinomycin,Inj.:,2 g Vial (IM) ,J01XX04 
CARDIOVASCULAR SYSTEM,DIURETICS,ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS,Aldosterone antagonists,Spironolactone,Oral:,25 mg Tablet (K-sparer) ,C03DA01 
CARDIOVASCULAR SYSTEM,DIURETICS,ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS,Aldosterone antagonists,Spironolactone,Oral:,50 mg Tablet (K-sparer) ,C03DA01 
CARDIOVASCULAR SYSTEM,DIURETICS,ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS,Aldosterone antagonists,Spironolactone,Oral:,100 mg Tablet (K-sparer) ,C03DA01 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Contact laxatives,Standard Senna Concentrate,Oral:,187 mg Tablet ,A06AB06 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Contact laxatives,Standard Senna Concentrate,Oral:,374 mg Tablet ,A06AB06 
VARIOUS,ALL OTHER NON-THERAPEUTIC PRODUCTS,ALL OTHER NON-THERAPEUTIC PRODUCTS,"Solvents and diluting agents, incl. irrigating solutions",Sterile Water for Injection,Inj.:,in 2 mL Ampul (No preservative) *Primary Health Care,V07AB 
VARIOUS,ALL OTHER NON-THERAPEUTIC PRODUCTS,ALL OTHER NON-THERAPEUTIC PRODUCTS,"Solvents and diluting agents, incl. irrigating solutions",Sterile Water for Injection,Inj.:,in 5 mL Ampul (No preservative) *Primary Health Care,V07AB 
VARIOUS,ALL OTHER NON-THERAPEUTIC PRODUCTS,ALL OTHER NON-THERAPEUTIC PRODUCTS,"Solvents and diluting agents, incl. irrigating solutions",Sterile Water for Injection,Inj.:,in 10 mL Ampul (No preservative) *Primary Health Care,V07AB 
VARIOUS,ALL OTHER NON-THERAPEUTIC PRODUCTS,ALL OTHER NON-THERAPEUTIC PRODUCTS,"Solvents and diluting agents, incl. irrigating solutions",Sterile Water for Injection,Inj.:,in 20 mL Ampul (No preservative) *Primary Health Care,V07AB 
VARIOUS,ALL OTHER NON-THERAPEUTIC PRODUCTS,ALL OTHER NON-THERAPEUTIC PRODUCTS,"Solvents and diluting agents, incl. irrigating solutions",Sterile Water for Injection,Inj.:,in 50 mL Bottle/Bag (No preservative) *Primary Health Care,V07AB 
VARIOUS,ALL OTHER NON-THERAPEUTIC PRODUCTS,ALL OTHER NON-THERAPEUTIC PRODUCTS,"Solvents and diluting agents, incl. irrigating solutions",Sterile Water for Injection,Inj.:,in 100 mL Bottle/Bag (No preservative) *Primary Health Care,V07AB 
VARIOUS,ALL OTHER NON-THERAPEUTIC PRODUCTS,ALL OTHER NON-THERAPEUTIC PRODUCTS,"Solvents and diluting agents, incl. irrigating solutions",Sterile Water for Injection,Inj.:,in 500 mL Bottle/Bag (No preservative) *Primary Health Care,V07AB 
VARIOUS,ALL OTHER NON-THERAPEUTIC PRODUCTS,ALL OTHER NON-THERAPEUTIC PRODUCTS,"Solvents and diluting agents, incl. irrigating solutions",Sterile Water for Injection,Inj.:,in 1 L Bottle/Bag (No preservative) *Primary Health Care,V07AB 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Enzymes,Streptokinase,Inj.:,"1,500,000 IU Powder Vial (IV infusion) ",B01AD01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,AMINOGLYCOSIDE ANTIBACTERIALS,Streptomycins,Streptomycin,Inj.:,1 g (as Sulfate) Vial (IM) ,J01GA01 
VARIOUS,DIAGNOSTIC RADIOPHARMACEUTICALS,RENAL SYSTEM,Technetium (99mTc) compounds,Succimer/Dimercapto succinic acid (DMSA),Oral:,100 mg Capsule ,V09CA02 
VARIOUS,DIAGNOSTIC RADIOPHARMACEUTICALS,RENAL SYSTEM,Technetium (99mTc) compounds,Succimer/Dimercapto succinic acid (DMSA),Oral:,200 mg Capsule ,V09CA02 
ALIMENTARY TRACT AND METABOLISM,DRUGS FOR ACID RELATED DISORDERS,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),Sucralfate,Oral:,1 g Tablet ,A02BX02 
VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes,Sugammadex,Inj.:,100 mg/mL Solution for injection in 2 mL Vial (IV) ,V03AB35 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION,Corticosteroids and antiinfectives in combination,Sulfacetamide + Prednisolone,Ophthalmic:,10% + 0.25% (as Acetate) Ophthalmic drop suspension in 5 mL ,S01CA02 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,SULFONAMIDES AND TRIMETHOPRIM,"Combinations of sulfonamides and trimethoprim, incl. derivatives",Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,400 mg + 80 mg Tablet *Primary Health Care,J01EE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,SULFONAMIDES AND TRIMETHOPRIM,"Combinations of sulfonamides and trimethoprim, incl. derivatives",Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,400 mg + 80 mg Capsule *Primary Health Care,J01EE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,SULFONAMIDES AND TRIMETHOPRIM,"Combinations of sulfonamides and trimethoprim, incl. derivatives",Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,800 mg (as Sulfate) + 160 mg Tablet *Primary Health Care,J01EE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,SULFONAMIDES AND TRIMETHOPRIM,"Combinations of sulfonamides and trimethoprim, incl. derivatives",Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,200 mg + 40 mg/5 mL Suspension in 70 mL *Primary Health Care,J01EE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,SULFONAMIDES AND TRIMETHOPRIM,"Combinations of sulfonamides and trimethoprim, incl. derivatives",Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,200 mg + 40 mg/5 mL Suspension in 120 mL *Primary Health Care,J01EE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,SULFONAMIDES AND TRIMETHOPRIM,"Combinations of sulfonamides and trimethoprim, incl. derivatives",Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,400 mg + 80 mg/5 mL Suspension in 60 mL *Primary Health Care,J01EE01
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,SULFONAMIDES AND TRIMETHOPRIM,"Combinations of sulfonamides and trimethoprim, incl. derivatives",Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Inj.:,400 mg + 80 mg in 5 mL Ampul (IV infusion) ,J01EE01
DERMATOLOGICALS,ANTI-ACNE PREPARATIONS,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,Preparations containing sulfur,Sulfur,Topical:,2% Cream in 10 g Plastic tube ,D10AB02
DERMATOLOGICALS,ANTI-ACNE PREPARATIONS,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,Preparations containing sulfur,Sulfur,Topical:,10% Ointment in 15 g Aluminum collapsible tube ,D10AB02
DERMATOLOGICALS,ANTI-ACNE PREPARATIONS,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,Preparations containing sulfur,Sulfur,Topical:,10% Ointment in 30 g Aluminum collapsible tube ,D10AB02
NERVOUS SYSTEM,ANALGESICS,ANTIMIGRAINE PREPARATIONS,Selective serotonin (5HT1) agonists,Sumatriptan,Oral:,50 mg Tablet ,N02CC01 
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",Choline derivatives,Suxamethonium/Succinylcholine,Inj.:,20 mg/mL (as Chloride) in 10 mL Vial (IV) ,M03AB01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,Tacrolimus,Oral:,1 mg Capsule ,L04AD02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,Tacrolimus,Oral:,5 mg Capsule ,L04AD02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,Tacrolimus,Oral:,1 mg Slow release capsule ,L04AD02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors,Tacrolimus,Oral:,5 mg Slow release capsule ,L04AD02 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Prostaglandin analogues,Tafluprost,Ophthalmic:,15 mcg/mL Ophthalmic drop solution in 0.3 mL Single Dose Bottle ,S01EE05 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-estrogens,Tamoxifen,Oral:,10 mg (as Citrate) Tablet ,L02BA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-estrogens,Tamoxifen,Oral:,20 mg (as Citrate) Tablet ,L02BA01 
GENITO URINARY SYSTEM AND SEX HORMONES,UROLOGICALS,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,Alpha-adrenoreceptor antagonists,Tamsulosin,Oral:,200 mcg (as Hydrochloride) Capsule *Primary Health Care,G04CA02 
GENITO URINARY SYSTEM AND SEX HORMONES,UROLOGICALS,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,Alpha-adrenoreceptor antagonists,Tamsulosin,Oral:,200 mcg Orally disintegrating tablet (ODT) ,G04CA02 
GENITO URINARY SYSTEM AND SEX HORMONES,UROLOGICALS,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,Alpha-adrenoreceptor antagonists,Tamsulosin,Oral:,400 mcg Prolonged release film coated tablet ,G04CA02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues,Tegafur + Uracil,Oral:,100 mg + 224 mg Capsule ,L01BC53 
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN","Angiotensin II receptor blockers (ARBs), plain",Telmisartan,Oral:,40 mg Tablet ,C09CA07 
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN","Angiotensin II receptor blockers (ARBs), plain",Telmisartan,Oral:,80 mg Tablet ,C09CA07 
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",Angiotensin II receptor blockers (ARBs) and diuretics,Telmisartan + Hydrochlorothiazide,Oral:,40 mg + 12.5 mg Tablet ,C09DA07 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Tenofovir + Lamivudine + Dolutegravir,Oral:,300 mg + 300 mg + 50 mg Tablet (Fixed-dose combination) ,J05AR27 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Tenofovir + Lamivudine + Dolutegravir,Oral:,"300 mg + 300 mg, 50 mg Tablet",J05AR27 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Tenofovir alafenamide,Oral:,25 mg (as Fumarate) Tablet ,J05AF13 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Tenofovir disoproxil,Oral:,300 mg (as Fumarate) Tablet ,J05AF07 
GENITO URINARY SYSTEM AND SEX HORMONES,UROLOGICALS,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,Alpha-adrenoreceptor antagonists,Terazosin,Oral:,1 mg (as Hydrochloride) Tablet ,G04CA03 
GENITO URINARY SYSTEM AND SEX HORMONES,UROLOGICALS,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,Alpha-adrenoreceptor antagonists,Terazosin,Oral:,2 mg (as Hydrochloride) Tablet ,G04CA03 
GENITO URINARY SYSTEM AND SEX HORMONES,UROLOGICALS,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,Alpha-adrenoreceptor antagonists,Terazosin,Oral:,5 mg (as Hydrochloride) Tablet ,G04CA03 
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR SYSTEMIC USE,Antifungals for systemic use,Terbinafine,Oral:,250 mg (as Hydrochloride) Tablet ,D01BA02 
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR SYSTEMIC USE,Antifungals for systemic use,Terbinafine,Topical:,1% (as Hydrochloride) Cream in 3 g Tube ,D01BA02 
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR SYSTEMIC USE,Antifungals for systemic use,Terbinafine,Topical:,1% (as Hydrochloride) Cream in 5 g Tube ,D01BA02 
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR SYSTEMIC USE,Antifungals for systemic use,Terbinafine,Topical:,1% (as Hydrochloride) Cream in 10 g Tube ,D01BA02 
DERMATOLOGICALS,ANTIFUNGALS FOR DERMATOLOGICAL USE,ANTIFUNGALS FOR SYSTEMIC USE,Antifungals for systemic use,Terbinafine,Topical:,1% (as Hydrochloride) Cream in 15 g Tube ,D01BA02 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,ADRENERGICS FOR SYSTEMIC USE,Selective beta-2-adrenoreceptor agonists,Terbutaline,Oral:,5 mg (as Sulfate) Tablet ,R03CC03 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,ADRENERGICS FOR SYSTEMIC USE,Selective beta-2-adrenoreceptor agonists,Terbutaline,Oral:,1.5 mg/5 mL (as Sulfate) Syrup in 60 mL ,R03CC03 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,ADRENERGICS FOR SYSTEMIC USE,Selective beta-2-adrenoreceptor agonists,Terbutaline,Inj.:,"500 mcg/mL (as Sulfate) in 1 mL Ampul (IM,IV,SC) ",R03CC03 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,ADRENERGICS FOR SYSTEMIC USE,Selective beta-2-adrenoreceptor agonists,Terbutaline,Inhalation:,2.5 mg/mL (as Sulfate) in 2 mL Unit dose (For nebulization) ,R03CC03 
GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,ANDROGENS,3-oxoandrosten (4) derivatives,Testosterone,Inj.:,250 mg/mL (as Undecanoate) Solution for injection in 4 mL ,G03BA03 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Tetanus Immunoglobulin (Human),Inj.:,1000 IU/mL in 1.5 mL Vial (IM) *Primary Health Care,J06BB02 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Tetanus Immunoglobulin (Human),Inj.:,1500 IU/mL in 1 mL Ampul (IM) *Primary Health Care,J06BB02 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 1 mL Ampul (IM) *Primary Health Care,J06BB02 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 2 mL Ampul (IM) *Primary Health Care,J06BB02 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 4 mL Ampul (IM) *Primary Health Care,J06BB02 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 1 mL Pre-filled syringe (IM) *Primary Health Care,J06BB02 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 1 mL Vial (IM) *Primary Health Care,J06BB02 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 2 mL Vial (IM) *Primary Health Care,J06BB02 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Tetanus vaccines,Tetanus Toxoid,Inj.:,in 0.5 mL Ampul (IM) *Primary Health Care,J07AM01 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Tetanus vaccines,Tetanus Toxoid,Inj.:,in 10 mL Vial (IM) *Primary Health Care,J07AM01 
SENSORY ORGANS,OPHTHALMOLOGICALS,LOCAL ANESTHETICS,Local anesthetics,Tetracaine,Inj.:,20 mg (as Hydrochloride) Sterile powder Ampul (Spinal) ,S01HA03 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,TETRACYCLINES,Tetracyclines,Tetracycline,Oral:,250 mg Capsule ,J01AA07 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,TETRACYCLINES,Tetracyclines,Tetracycline,Oral:,500 mg Capsule ,J01AA07 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Xanthines,Theophylline (Anhydrous),Oral:,150 mg Tablet ,R03DA04 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Xanthines,Theophylline (Anhydrous),Oral:,200 mg Tablet ,R03DA04 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Xanthines,Theophylline (Anhydrous),Oral:,200 mg Modified Release (MR) tablet ,R03DA04 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,Xanthines,Theophylline (Anhydrous),Oral:,25 mg/5 mL (26.7 mg/5 mL) Syrup in 100 mL ,R03DA04 
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12","Vitamin B1, plain",Thiamine/Vitamin B1,Oral:,100 mg (as Hydrochloride) Tablet ,A11DA01 
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B13","Vitamin B1, plain",Thiamine/Vitamin B1,Oral:,300 mg (as Hydrochloride) Tablet ,A11DA01 
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B14","Vitamin B1, plain",Thiamine/Vitamin B1,Inj.:,100 mg/mL (as Hydrochloride) in 1 mL Ampul/Vial (IV) ,A11DA01 
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B15","Vitamin B1, plain",Thiamine/Vitamin B1,Inj.:,"100 mg/mL (as Hydrochloride) in 10 mL Vial (IM,IV) ",A11DA01 
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL","Barbiturates, plain",Thiopental Sodium,Inj.:,500 mg Vial (IV) ,N01AF03 
NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL","Barbiturates, plain",Thiopental Sodium,Inj.:,1 g Vial + 50 mL diluent (IV) ,N01AF03 
CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,BETA BLOCKING AGENTS,"Beta blocking agents, non-selective",Timolol,Ophthalmic:,0.5% (as Maleate) Ophthalmic drop solution in 5 mL ,C07AA06 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Heparin group,Tinzaparin,Inj.:,"10,000 anti-Xa IU/mL (as Sodium) in 0.35 mL Pre-filled syringe (SC) ",B01AB10 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Heparin group,Tinzaparin,Inj.:,"10,000 anti-Xa IU/mL (as Sodium) in 0.45 mL Pre-filled syringe (SC) ",B01AB10 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Heparin group,Tinzaparin,Inj.:,"10,000 anti-Xa IU/mL (as Sodium) in 2 mL Vial (SC) ",B01AB10 
RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",Anticholinergics,Tiotropium,Inhalation:,18 mcg/dose  (as Bromide) DPI with appropriate accompanying dispenser ,R03BB04 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIINFECTIVES,Antibiotics,Tobramycin,Ophthalmic:,0.3% Ophthalmic drop solution in 5 mL Bottle *Primary Health Care,S01AA12 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIINFECTIVES,Antibiotics,Tobramycin,Ophthalmic:,0.3% Ophthalmic ointment in 3.5 g  Tube *Primary Health Care,S01AA12 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION,Corticosteroids and antiinfectives in combination,Tobramycin + Dexamethasone,Ophthalmic:,0.3% + 0.1% Ophthalmic drop suspension in 5 mL Bottle *Primary Health Care,S01CA01 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION,Corticosteroids and antiinfectives in combination,Tobramycin + Dexamethasone,Ophthalmic:,0.3% + 0.1% Ophthalmic ointment in 3.5 g  Tube *Primary Health Care,S01CA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,Tocilizumab,Inj.:,80 mg/4 mL (20 mg/mL) Concentrate for solution for IV infusion ,L04AC07 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,Tocilizumab,Inj.:,200 mg/10 mL (20 mg/mL) Concentrate for solution for IV infusion ,L04AC07 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Interleukin inhibitors,Tocilizumab,Inj.:,400 mg/20 mL (20 mg/mL) Concentrate for solution for IV infusion ,L04AC07 
CARDIOVASCULAR SYSTEM,DIURETICS,OTHER DIURETICS,Vasopressin antagonists,Tolvaptan,Oral:,15 mg Tablet ,C03XA01 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Topiramate,Oral:,25 mg Tablet ,N03AX11
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Topiramate,,50 mg Tablet ,N03AX11
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics,Topiramate,Oral:,100 mg Tablet ,N03AX11
ALIMENTARY TRACT AND METABOLISM,VITAMINS," MULTIVITAMINS, COMBINATIONS",Multivitamins with minerals,Trace Elements,Oral:,"Ampule Composed of:
Zn, Cu, Mn, Mg, Mb, etc.,
(IV nutrition) ",A11AA04 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Other opioids,Tramadol,Oral:,50 mg (as Hydrochloride) Capsule *Primary Health Care,N02AX02 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Other opioids,Tramadol,Oral:,50 mg (as Hydrochloride) Dispersible tablet ,N02AX02 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Other opioids,Tramadol,Oral:,100 mg (as Hydrochloride) Modified Release (MR) tablet ,N02AX02 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Other opioids,Tramadol,Oral:,150 mg (as Hydrochloride) Modified Release (MR) tablet ,N02AX02 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Other opioids,Tramadol,Oral:,200 mg (as Hydrochloride) Modified Release (MR) tablet ,N02AX02 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Other opioids,Tramadol,Inj.:,"50 mg/mL (as Hydrochloride) in 1 mL Ampul (IM, IV, SC) ",N02AX02 
NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Other opioids,Tramadol,Inj.:,"50 mg/mL (as Hydrochloride) in 2 mL Ampul (IM, IV, SC) ",N02AX02 
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,ANTIFIBRINOLYTICS,Amino acids,Tranexamic Acid,Oral:,250 mg Capsule *Primary Health Care,B02AA02 
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,ANTIFIBRINOLYTICS,Amino acids,Tranexamic Acid,Oral:,500 mg Capsule *Primary Health Care,B02AA02 
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,ANTIFIBRINOLYTICS,Amino acids,Tranexamic Acid,Oral:,500 mg Tablet ,B02AA02 
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,ANTIFIBRINOLYTICS,Amino acids,Tranexamic Acid,Inj.:,"100 mg/mL in 2.5 mL Ampule (IM,IV) ",B02AA02 
BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,ANTIFIBRINOLYTICS,Amino acids,Tranexamic Acid,Inj.:,"100 mg/mL in 5 mL Ampule (IM,IV) ",B02AA02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,Trastuzumab,Inj.:,150 mg Lyophilized powder (IV infusion) ,L01FD01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,Trastuzumab,Inj.:,600 mg/5 mL (120 mg/Ml) Solution for injection in 5 mL Vial (SC) ,L01FD01 
SENSORY ORGANS,OPHTHALMOLOGICALS,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,Prostaglandin analogues,Travoprost,Ophthalmic:,0.004% Ophthalmic drop solution in 2.5 mL ,S01EE04 
"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTITREMATODALS,Other antitrematodal agents,Triclabendazole,Oral:,250 mg Tablet ,P02BX04 
CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,OTHER CARDIAC PREPARATIONS,Other cardiac preparations,Trimetazidine,Oral:,35 mg (as Hydrochloride) Tablet ,C01EB15 
SENSORY ORGANS,OPHTHALMOLOGICALS,MYDRIATICS AND CYCLOPLEGICS,Anticholinergics,Tropicamide,Ophthalmic:,0.5% Ophthalmic drop solution in 5 mL ,S01FA06 
SENSORY ORGANS,OPHTHALMOLOGICALS,MYDRIATICS AND CYCLOPLEGICS,Anticholinergics,Tropicamide + Phenylephrine hydrochloride,Ophthalmic:,5 mg + 5 mg/mL Ophthalmic drop solution in 10 mL (Fixed-dose combination) ,S01FA56 
Not available,Not available,Not available,Not available,Tsaang Gubat [Carmona retusa (Vahl) Masam] ,Oral:,250 mg Tablet (Fam. Boraglinaceae) ,Not available
VARIOUS,DIAGNOSTIC AGENTS,OTHER DIAGNOSTIC AGENTS,Tuberculosis diagnostics,"Tuberculin , Purified Protein Derivative (PPD)",Inj.:,2 TU/0.1 mL Solution in 1 mL Vial (ID) ,V04CF01 
VARIOUS,DIAGNOSTIC AGENTS,OTHER DIAGNOSTIC AGENTS,Tuberculosis diagnostics,"Tuberculin , Purified Protein Derivative (PPD)",Inj.:,2 TU/0.1 mL Solution in 5 mL Vial (ID) ,V04CF01 
VARIOUS,DIAGNOSTIC AGENTS,OTHER DIAGNOSTIC AGENTS,Tuberculosis diagnostics,"Tuberculin , Purified Protein Derivative (PPD)",Inj.:,5 TU/0.1 mL Freeze-dried powder Vial + 2 mL diluent ampul (ID) ,V04CF01 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Typhoid vaccines,Typhoid Vaccine,Oral:,Enteric-coated tablet (encapsulated) Live attenuated S. typhi (not less than 109) viable strain *Primary Health Care,J07AP01 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,BACTERIAL VACCINES,Typhoid vaccines,Typhoid Vaccine,Inj.:,"25 mcg Pre-filled syringe Vi-capsular polysaccharide S. typhi
(IM) *Primary Health Care",J07AP01 
ALIMENTARY TRACT AND METABOLISM,BILE AND LIVER THERAPY,BILE THERAPY,Bile acids and derivatives,Ursodeoxycholic Acid,Oral:,250 mg Capsule ,A05AA02
ALIMENTARY TRACT AND METABOLISM,BILE AND LIVER THERAPY,BILE THERAPY,Bile acids and derivatives,Ursodeoxycholic Acid,Oral:,250 mg Tablet ,A05AA02
ALIMENTARY TRACT AND METABOLISM,BILE AND LIVER THERAPY,BILE THERAPY,Bile acids and derivatives,Ursodeoxycholic Acid,Oral:,500 mg Tablet ,A05AA02
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Valaciclovir,Oral:,500 mg (as Hydrochloride) Tablet ,J05AB11 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,Valganciclovir,Oral:,450 mg Tablet ,J05AB14 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Fatty acid derivatives,Valproic Acid,Oral:,250 mg/5 mL Syrup in 120 mL *Primary Health Care,N03AG01 
NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Fatty acid derivatives,Valproic Acid,Inj.:,500 mg/5 mL in 5 mL Vial (IV infusion) ,N03AG01 
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN","Angiotensin II receptor blockers (ARBs), plain",Valsartan,Oral:,80 mg Tablet/Film-coated tablet ,C09CA03 
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN","Angiotensin II receptor blockers (ARBs), plain",Valsartan,Oral:,160 mg Tablet/Film-coated tablet ,C09CA03 
CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS","Angiotensin II receptor blockers (ARBs), other combinations",Valsartan + Hydrochlorothiazide,Oral:,80 mg + 12.5 mg Tablet ,C09DX01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Glycopeptide antibacterials,Vancomycin *Reserve antimicrobial,Inj.:,500 mg (as Hydrochloride) Vial (IV) ,J01XA01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,OTHER ANTIBACTERIALS,Glycopeptide antibacterials,Vancomycin *Reserve antimicrobial,Inj.:,1 g (as Hydrochloride) Vial (IV) ,J01XA01 
SENSORY ORGANS,OPHTHALMOLOGICALS,OTHER OPHTHALMOLOGICALS,Other ophthalmologicals,Varenicline,Oral:,0.5 mg Tablet *Primary Health Care,S01XA28 
SENSORY ORGANS,OPHTHALMOLOGICALS,OTHER OPHTHALMOLOGICALS,Other ophthalmologicals,Varenicline,Oral:,1 mg Tablet *Primary Health Care,S01XA28 
ANTIINFECTIVES FOR SYSTEMIC USE,IMMUNE SERA AND IMMUNOGLOBULINS,IMMUNOGLOBULINS,Specific immunoglobulins,Varicella Zoster Immunoglobulin (VZIG),Inj.:,125 units/1.25 mL Vial (IM) ,J06BB03 
"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,POSTERIOR PITUITARY LOBE HORMONES,Vasopressin and analogues,Vasopressin,Inj.:,"20 IU/mL (IM,IV) ",H01BA01 
MUSCULO-SKELETAL SYSTEM,MUSCLE RELAXANTS,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",Other quaternary ammonium compounds,Vecuronium,Inj.:,4 mg/mL (as Bromide) Freeze-dried powder Ampul + 1 mL solvent (IV) ,M03AC03 
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Phenylalkylamine derivatives,Verapamil,Oral:,80 mg (as Hydrochloride) Tablet ,C08DA01 
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Phenylalkylamine derivatives,Verapamil,Oral:,240 mg (as Hydrochloride) Modified Release (MR) tablet (For maintenance therapy) ,C08DA01 
CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,Phenylalkylamine derivatives,Verapamil,Inj.:,2.5 mg/mL (as Hydrochloride) in 2 mL Ampul (IV) ,C08DA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,Vinblastine,Inj.:,"10 mg (as Sulfate) Powder Vial (IV)(For reconstitution)
 ",L01CA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,Vinblastine,Inj.:,1 mg/mL (as Sulfate) in 10 mL Vial (IV) ,L01CA01 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,Vincristine,Inj.:,1 mg/mL (as Sulfate) in 1 mL Vial (IV) ,L01CA02 
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Vinca alkaloids and analogues,Vincristine,Inj.:,1 mg/mL (as Sulfate) in 2 mL Vial (IV) ,L01CA02 
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12","Vitamin B1, plain",Vitamin B1  + B6 + B12,Oral:,100 mg + 5 mg + 50 mcg Tablet/Capsule *Primary Health Care,A11DB
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B13","Vitamin B1, plain",Vitamin B1  + B6 + B12,Oral:,"10 mg + 5 mg + 5 mcg per 0.6 mL drops, Drops ",A11DB
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B14","Vitamin B1, plain",Vitamin B1  + B6 + B12,Inj.:,"100 mg + 100 mg + 1 mg per 3 mL, Ampule (IV) ",A11DB
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B15","Vitamin B1, plain",Vitamin B1  + B6 + B12,Inj.:,"100 mg + 100 mg + 1 mg per 10 mL, Vial (IV) ",A11DB
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B16","Vitamin B1, plain",Vitamin B1  + B6 + B12,Inj.:,"100 mg + 100 mg + 1 mg per mL, in 3 mL Ampul (IV) ",A11DB
ALIMENTARY TRACT AND METABOLISM,VITAMINS,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B17","Vitamin B1, plain",Vitamin B1  + B6 + B12,Inj.:,"100 mg + 100 mg + 1 mg per mL, in 10 mL Vial (IV) ",A11DB
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTION ADDITIVES,Vitamins,"Vitamin Intravenous, Fat-soluble",Inj.:,"in 10 mL Ampul (IV) contains Vitamins A, D, E, and K ",B05XC
BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTION ADDITIVES,Vitamins,"Vitamin Intravenous, Water-soluble",Inj.:,"Contains vitamin B complex and vitamin C, 1 mL vial
and 2 mL ampule",B05XC
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Triazole and tetrazole derivatives,Voriconazole *Reserve antimicrobial,Oral:,200 mg Film-coated tablet ,J02AC03
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Triazole and tetrazole derivatives,Voriconazole *Reserve antimicrobial,Inj.:,200 mg Lyophilized  powder for solution for IV infusion in 30 mL Vial ,J02AC03
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Vitamin K antagonists,Warfarin,Oral:,"1 mg (as Sodium) Tablet Ampul Composed of:
Vitamins A, D, E, K ",B01AA03 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Vitamin K antagonists,Warfarin,Oral:,1 mg (as Sodium) Tablet ,B01AA03 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Vitamin K antagonists,Warfarin,Oral:,2.5 mg (as Sodium) Tablet ,B01AA03 
BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Vitamin K antagonists,Warfarin,Oral:,5 mg (as Sodium) Tablet ,B01AA03 
ANTIINFECTIVES FOR SYSTEMIC USE,VACCINES,VIRAL VACCINES,Yellow fever vaccines,Yellow Fever Vaccine,Inj.:,"1000 DL 50 mouse min (Attenuated) Vial + 0.5 mL solvent syringe (IM, SC)(For Bureau of Quarantine use only) ",J07BL01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Zidovudine,Oral:,100 mg Capsule ,J05AF01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Zidovudine,Oral:,300 mg Tablet ,J05AF01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Nucleoside and nucleotide reverse transcriptase inhibitors,Zidovudine,Oral:,50 mg/5 mL Suspension in 240 mL Bottle ,J05AF01 
ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations",Zidovudine + Lamivudine,Oral:,60 mg + 30 mg Dispersible tablet ,J05AR01 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,,Zinc,Oral:,(equiv. to 10 mg elemental zinc) (as Gluconate) Chewable tablet *Primary Health Care,A12CB 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,,Zinc,Oral:,(equiv. to 30 mg elemental zinc) (as Gluconate trihydrate) Tablet ,A12CB 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,,Zinc,Oral:,88 mg (equiv. to 20 mg zinc) (as Sulfate) Dispersible tablet ,A12CB 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,,Zinc,Oral:,(equiv. to 10 mg elemental zinc per mL) (as Sulfate monohydrate) Drops in 15 mL *Primary Health Care,A12CB 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,,Zinc,Oral:,(equiv. to 20 mg elemental zinc per 5 mL) (as Sulfate monohydrate) Syrup in 60 mL *Primary Health Care,A12CB 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,,Zinc,Oral:,70 mg/5 mL (equiv. to 10 mg elemental zinc) (as Gluconate) Syrup in 60 mL *Primary Health Care,A12CB 
ALIMENTARY TRACT AND METABOLISM,MINERAL SUPPLEMENTS,OTHER MINERAL SUPPLEMENTS,,Zinc,Oral:,70 mg/5 mL (equiv. to 10 mg elemental zinc) (as Gluconate) Syrup in 120 mL *Primary Health Care,A12CB 
MUSCULO-SKELETAL SYSTEM,DRUGS FOR TREATMENT OF BONE DISEASES,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,Bisphosphonates,Zoledronic Acid,IV:,4 mg/5 mL Concentrated solution for IV infusion ,M05BA08 
NERVOUS SYSTEM,ANALGESICS,ANTIMIGRAINE PREPARATIONS,Selective serotonin (5HT1) agonists,Zolmitriptan,Oral:,2.5 mg Tablet ,N02CC03 
NERVOUS SYSTEM,PSYCHOLEPTICS,HYPNOTICS AND SEDATIVES,Benzodiazepine related drugs,Zolpidem,Oral:,10 mg Tablet ,N05CF02 